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inTrODUCTiOn
Endovascular aortic aneurysm repair (EVAR) is now 
an accepted treatment option in the management 
of abdominal aortic aneurysm (AAA).1-2 The reduction 
in surgical insult occurs at the expense of long-term 
durability and these patients require long-term 
follow-up indefinitely. Continuing perfusion and 
pressurisation of the aneurysm sac (Endoleak) is 
a unique complication associated with EVAR and 
remains the Achilles heel of the procedure. Of 
particular importance is the achievement of an 
adequate seal at the proximal and distal attachment 
zones in the aorta and iliac vessels. Failure to 
achieve a seal here results in a Type I endoleak 
which, if left uncorrected, may eventually result in 
aneurysm rupture.3  The anatomy of the aneurysm 
neck (the portion of normal aorta between renal 
arteries and aneurysm, which is used as a proximal 
sealing zone between stent-graft and aortic wall) 
is therefore a keystone of EVAR. The importance of 
neck length, neck diameter, and angulation has been 
well documented by others.4-6 The actual shape of 
the proximal sealing zone, and its influence on the 
planning process, degree of oversizing, and outcome 
has not previously been examined. Criado and 
colleagues, when reporting the results of the Talent 
LPS pivotal clinical trial comment on the fact that the 
Type I endoleak rate was higher than expected, and 
speculate that this may reflect difficulties related 
to unfavourable proximal neck anatomy. Factors 
that they examined include neck length, width, 
angulation, and the presence of mural thrombus.7 As 
with other studies, however, overall neck morphology 
was not taken into consideration. 
Oversizing the endograft relative to the aneurysm 
neck ensures adequate apposition between graft 
and aneurysm wall and is critically important in 
achieving a proximal seal. Oversizing serves two 
purposes: (a) Ensuring good graft-aortic wall contact, 
thus preventing a Type I endoleak, and (b) Adding to 
the radial compression force of the graft which helps 
prevent graft migration. Various graft manufacturers 
differ in their methods of determining how the 
aneurysm neck is measured and what degree of 
graft oversizing should be applied. What all have 
in common, however, is that little attention has 
been paid to the morphology of the aneurysm neck, 
and its planning implications. Excessive oversizing 
may produce a “guttering” effect at the graft-aortic 
sealing zone, increasing the risk of Type I endoleak, 
distal migration, and aortic neck dilatation.8
Herein we propose a classification system for the 
shape of the proximal aneurysm neck and examine 
its relevance to endoluminal graft planning.
Abdominal Aortic Aneurysm neck 
morphology: Proposed classification system
aBsTraCT
Background  While aneurysm neck length, angulation and width have all been previously 
assessed in endovascular abdominal aortic aneurysm repair (EVAR), aneurysm neck 
shape has not been considered. 
Aims To analyse the influence of aneurysm neck morphology on outcome following EVAR.
Methods  Aneurysm neck morphology in 70 patients undergoing EVAR from April 2001 
to May 2004 was determined using pre-operative CT scans and graft plans. Necks 
were classified as flared, parallel, irregular, conical, barrel or hourglass. End-points 
were death, Type I endoleak and graft migration.
Results  Forty-six per cent of necks were flared, 34% parallel, 9% irregular, 6% conical, 3% 
barrel and 3% hourglass. Mean follow-up was 20.2 months (range 4-35). There was 
one Type I endoleak and one graft migration. There were no aneurysm related deaths.
Conclusions  Assessment of aneurysm neck morphology should be part of the routine 
preoperative workup for EVAR. A classification system of AAA necks is suggested to 
facilitate this.
ABDOMINAL AORTIC ANEURYSM NECk MORPHOLOGY: PROPOSED CLASSIFICATION SYSTEM 
CO McDonnell, 
M Halak, 
A Bartlett*, 
SR Baker
Dept of Vascular 
Surgery, Sir Charles 
Gairdner Hospital, 
Perth, Western 
Australia; Zenith 
Planning Service*, 
Perth, Western 
Australia
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PaTienTs & MeTHODs
The CT scans and manufacturers’ endoluminal graft 
plans were reviewed in a consecutive series of 81 
patients who underwent endovascular repair of 
abdominal aortic aneurysm at Sir Charles Gairdner 
Hospital from April 2001 to May 2004. Insufficient 
aneurysm neck length in 11 patients required the use 
of a fenestrated stent-graft and these patients were 
therefore excluded. The remaining 70 patients form 
the basis of this study. 
Wall-to-wall aneurysm neck measurements 
including thrombus, atheroma and/or calcium 
were taken at 3mm intervals, commencing at the 
level of the renal arteries and continuing inferiorly 
until a neck length of 21mm had been assessed. In 
an angulated neck the minimum diameter seen 
in an axial image was taken as the real diameter. 
A difference in diameter of 3mm or greater 
between consecutive measurements was taken 
as representing a significant contour change.9 
Aneurysm necks fell into one of six categories based 
on neck morphology: flared, parallel, conical, barrel, 
hourglass and irregular (Figure 1).
Aneurysms were repaired using the Zenith stent-
graft (W.A. Cook, Brisbane, Australia) in 67 cases and 
the Talent LPS device (Medtronic AVE, Santa Rosa, 
U.S.A.) in three cases. Mean aneurysm diameter was 
57mm (Range 48-85).
Graft oversizing during planning was performed 
in accordance with the manufacturers’ 
recommendations. With the Zenith device, graft 
oversizing of 15% to 25% based on the largest aortic 
neck diameter was performed. With the Talent device, 
an average neck diameter was calculated using 
all the available neck measurements, as described 
elsewhere10 and the graft was subsequently 
oversized by 10-20% (Figure 2).
All patients undergoing EVAR at Sir Charles Gairdner 
Hospital have been entered onto a prospectively 
maintained database with follow-up clinical and CT 
data entered at six weeks, six months and twelve 
months postoperatively and annually thereafter. 
Mean postoperative follow-up was 20.2 months 
(range 4-35). Primary end-points were the presence 
of Type I endoleak, graft migration and death and 
secondary end-points were the existence of any 
other type of endoleak and need for secondary 
intervention.
resUlTs
Flared necks were the commonest (n=32, 46%), 
then parallel (n=24, 34%), six (9%) were classified 
as irregular, four (6%) were conical, two (3%) were 
barrel and two (3%) were hourglass (Figure 3). Mean 
maximum neck diameter was 27.1mm (Range 20-
34mm), while mean endograft diameter implanted 
was 29.5mm (Range 22-36mm). 
There were nine endoleaks in total (13%), one Type I, 
seven Type II and one Type III. The Type I endoleak 
occurred in an aneurysm with a flared neck treated 
with a Zenith® graft and required the deployment of 
a proximal extension piece which was successful in 
excluding the leak. The secondary intervention rate 
was 11.4% (eight patients). None of the other seven 
interventions were related to the proximal sealing 
zone or aneurysm neck. Thirty day mortality was zero 
and there were six late deaths, none of which were 
aneurysm related. 
Only one incidence of graft migration was recorded. 
This occurred in an aneurysm with a flared neck 
treated with a Talent LPS device. While the entire supra-
renal portion of the graft now lies below the renal 
arteries, the patient has not yet developed an endoleak. 
No instances of graft migration has been identified 
in the patients treated with the Zenith device.
DisCUssiOn
While others have made reference to the shape 
or contour of the aneurysm neck when planning 
an endovascular repair,4-7, 11 to our knowledge no 
formal classification system has ever been proposed. 
We suggest a classification system based on our 
experience which is an essential aspect of endograft 
planning in our institution. Rose and colleagues, in 
their series of 46 patients, describe 37% of necks as 
“conical”, 28% as “straight”, 13% as “reverse conical” 
and 9% as “barrel”.11 These figures differ somewhat 
from our series and this may be a reflection of differing 
definitions of shape, strengthening the case for a 
common classification system, such as we propose.
Reviewing the planning instructions of two of the 
principal endograft manufacturers in Australia, 
we failed to find specific guidelines pertaining 
to oversizing and neck morphology. As shown, 
significant diameter differences can exist between 
different stent grafts for a specific aortic neck 
configuration (Figure 2). Our planning strategy with 
the Zenith graft is based on the manufacturers’ 
recommendations and mid term follow-up of this 
CO MCDOnnell et al
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FIGURE 1 —
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FIGURE 2 —
INFLUENCE OF 
ANEURYSM NECk 
MORPHOLOGY 
ON DIFFERENT 
OVERSIZING 
TECHNIQUES IN 
GRAFT PLANNING
A. BARREL
B. FLARED NECk
20
18
24
21
26
BA
OPTION A (Zenith)
15%-25% oversizing of Max diameter 
Maximal Diameter - 24mm
Graft Diameter: 28-30 mm
OPTION B (Talent)
10%-20% oversizing of
Average Diameter - (20+24+18): 3= 21.7mm
Graft Diameter: 23-26 mm
OPTION A (Zenith)
15%-25% oversizing of Max diameter 
Maximal Diameter - 26mm
Graft Diameter: 30-33 mm
OPTION B (Talent)
10%-20% oversizing
Average Diameter - (21+26):2= 23.5mm
Graft Diameter: 26-28 mm
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series using the neck morphology classification 
system, and the oversizing strategies during 
planning revealed no late graft migration or late 
Type I endoleaks. Our experience with the Talent 
device is too limited to reach any firm conclusions 
with regards to the incidence of distal migration. 
Criado and colleagues make the association between 
“higher than expected” incidence of Type I endoleaks, 
and “unfavourable proximal neck anatomy” in their 
series of Talent grafts but make no specific reference 
to neck shape.7
Sternbergh and colleagues found that endograft 
oversizing of >30% was associated with a greater 
incidence of increased aortic neck diameters at 
six months, device migration at one year and AAA 
expansion at two years. On the basis of this study they 
recommended avoidance of excessive oversizing but, 
as with others, make no reference to the influence of 
neck shape on either graft planning or outcome.8
The total endoleak rate of 13%, while in keeping 
with other reports, is almost twice that reported 
in the U.S. pivotal trial of the Zenith® stent-graft.12 
The vast majority of endoleaks in this series were 
Type II, detected immediately post-operatively 
and subsequently resolved spontaneously. In our 
experience almost all aneurysms will demonstrate 
a Type II endoleak in the immediate postoperative 
period provided enough intravenous contrast is 
administered and the x-ray exposure time is long 
enough. Not surprisingly, there was no association 
between aneurysm neck classification and endoleak 
type with respect to the Type II or Type III endoleaks 
which were observed, reinforcing the view that these 
phenomena are unrelated to the proximal seal 
(Table 1). The secondary intervention rate of 11.4% is 
well within accepted international limits.13-14
The low Type I endoleak rate observed in this series 
despite the variety of neck shapes is encouraging 
but makes meaningful interpretation of the data 
difficult. One possibility is that alterations in stent-
graft design since the first reported case in 1991 
have resulted in continually improving results.15 The 
latest modification in the Zenith stent-graft design, 
the Zenith Flex™ graft, has 5mm gaps between the 
1st and 2nd and 2nd and 3rd stents, allowing for greater 
conformity of the graft to neck angulation and 
theoretically an improved proximal seal. This may 
mean that the shape of the aneurysm neck is less 
relevant today than it would have been in the past, 
rendering the present study largely irrelevant. 
An alternative interpretation of our results is that the 
numbers included are simply inadequate to provide 
sufficient data to reach any firm conclusions. A larger 
series of patients followed-up for a longer period 
of time will be helpful in resolving this issue and 
we continue to recruit patients to this study with 
this in mind. Until then, we feel that assessment 
of aneurysm neck morphology should form part of 
the routine pre-operative workup for AAA patients 
undergoing endovascular aneurysm repair and hope 
that others will find the proposed classification 
system in this paper useful. 
We believe that taking the aneurysm neck shape 
into account when planning the graft and oversizing 
to the largest neck diameter is an important aspect 
of graft planning as evidenced by the low Type I 
endoleak observed in this series. The suggested 
classification system provides straightforward 
nomenclature of the aortic neck morphology. Its use, 
along with clear guidelines on oversizing will permit 
comparison and standardization of the differing 
views on this contentious issue. 
FIGURE 3 —
DISTRIBUTION OF 
NECk SHAPES
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Table 1
ANEURYSM NECk TYPES IN PATIENTS WITH ENDOLEAkS
ENDOLEAK 
TYPE NO.
ANEURYSM 
NECK TYPE
I 1 Flare
II
4
2
1
Parallel
Flare
Hourglass
III 1 Parallel
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inTrODUCTiOn
There is a progressively increasing demand on 
intensive care beds. As the surgical workload increases, 
more centres perform complex procedures requiring 
high levels of post-operative care. As a result of the 
increasing demand, ICU beds may not be available for 
post-operative monitoring for patients undergoing 
elective aortic aneurysm surgery.  A further problem in 
this group of patients is the high number of co-morbid 
conditions present.  It is now accepted that patients 
presenting for elective AAA surgery are increasingly 
physiologically compromised1.  This results in frequent 
case cancellations and postponement of surgery, 
which is distressing for both patient and family. 
Significant waste of hospital expenditure on repeated 
fruitless elective admissions results. 
We recently upgraded a regular six-bedded ward 
to a four-bedded surgical high dependency unit 
(HDU). Three years after its establishment we have 
performed a comparative outcome analysis on elective 
aortic aneurysm operations carried out eighteen 
months before and after establishment of the unit.
aiMs
The aims of this study were to determine whether 
provision of a high dependency step-down unit 
improves management of elective abdominal aortic 
aneurysm patients and whether the cost associated 
with elective AAA repair could be reduced.
MeTHODs
Two time periods were analysed. From January 1998 
to June 1999, 57 patients underwent elective AAA 
repair. Forty-seven patients had surgery in the second 
time period, January 2002 to July 2003. Only patients 
having surgery for aortic aneurysmal disease were 
included in this analysis. Demographic data, intra-
operative and post-operative data were recorded. 
ASA grade (American Society of Anaesthesia) 
and POSSUM Scores (Physiological and Operative 
Severity Score for the enumeration of Mortality and 
The impact of the establishment of a surgical 
high dependency unit on management of 
Abdominal Aortic Aneurysm
aBsTraCT
Background  Our ability to maintain satisfactory levels of outcome after elective 
abdominal aortic aneurysm (AAA) surgery is increasingly strained by rising levels of 
co-morbidity in the presenting population. In this study we present a comparative 
outcome analysis of patients undergoing elective AAA surgery 18 months before 
and after the establishment of a surgical high dependency unit (HDU).
Methods  The preoperative status (ASA & POSSUM scores), operative factors and 
postoperative outcomes as well as duration of stay were calculated for 104 patients 
undergoing elective AAA repair (57 prior to the HDU opening and 47 patients 
afterwards).
Results  Patients undergoing surgery in the latter period had significantly higher ASA 
(2.5±0.06 versus 2.7±0.7; p=0.007), overall POSSUM (33.2±0.5 versus 35.5±0.8; 
p=0.02) and physiological POSSUM (16.3±0.3 versus 15.5±0.2; p=0.048) scores than 
those operated on prior to establishment of the HDU (data are mean±SEM; 2-tailed 
p-score). The two groups had similar total lengths of hospital stay (518 versus 534 
days).  However, following establishment of the HDU patients occupied fewer ICU 
bed days (110 versus 181). This resulted in a saving of €50,750. 
Conclusion  The efficiency and quality of care following elective AAA surgery can be  
improved by provision of HDU step-down facilities without significantly increased 
expenditure.
THE IMPACT OF THE ESTABLISHMENT OF A SURGICAL HIGH DEPENDENCY UNIT ON MANAGEMENT OF ABDOMINAL AORTIC ANEURYSM
M Cleary, 
RA Cahill, 
F Younis, 
SJ Sheehan, 
D Mehigan, 
MC Barry
Dept of Vascular 
Surgery, St Vincent’s 
University Hospital, 
Elm Park, Dublin 4
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Morbidity) were calculated on the basis of data 
collected from anaesthetic notes, admission notes 
and operative notes.  
The conventional POSSUM score has two 
components, a physiological score which comprises 
12 preoperative physiological variables and an 
operative score which contains six operative 
variables.2  Each variable is scored and then 
combined to produce a physiological score and 
an operative score that increase with increasing 
physiological dysfunction or severity of operation. 
Total POSSUM Scores were calculated as the sum of 
operative and physiological scores.  
STATISTICAL ANALYSIS
Differences in distribution of demographics, 
diagnostic categories and outcomes were examined 
using Chi-squared proportional analysis. A p-value of 
less than 0.05 was considered significant.  
resUlTs
Patients undergoing surgery in the period 2002-
2003 had significantly higher physiological POSSUM 
scores (pPOSSUM) (19.2±0.7 v 17.5±0.5 p=0.048) 
(Figure 1) and total POSSUM scores (tPOSSUM)  
(35.5±0.8 v 33.2±0.5 p=0.02) (Figure 3) compared 
to those operated on prior to establishment of the 
HDU. No difference was seen in operative POSSUM 
scores (oPOSSUM) between the two groups. A higher 
proportion of the patients presenting in the period 
2003-2003 had ASA Grades of >3 compared to the 
earlier period (p<0.007) (Figure 4).
Mean age, operative POSSUM score, anaesthetic 
time, operative time, intraoperative blood loss, 
aortic cross-clamp time and maximum aneurysmal 
diameter were not significantly different between 
the two groups (Table 1).
Four patients died post-operatively in the HDU 
compared to two deaths in the ICU during the 
preceding 18 months. However, the number of major 
cardiac, respiratory and renal complications was 
similar between the groups (Table 2). Although the 
two groups had similar total lengths of hospital stay 
(518 versus 534 days), the latter group occupied fewer 
ICU bed days (110 versus 181) requiring a total stay of 
224 days in HDU instead.
When costs of stay were compared, the earlier 
group’s ICU expenditure averaged €287,100 
compared to €236,350 for those who were 
discharged to HDU, a saving of €50,750. This however 
needs to be offset against a cost of HDU provision of 
€100,800 in total.
In order to explain the differences in pPOSSUM 
scores between the groups, we examined the 
proportion of elective and ruptured aortic 
aneurysms operated upon over both time periods. 
Elective repairs formed a higher proportion of the 
total group in the later period but this was not 
statistically significant.   
DisCUssiOn
High dependency units (HDUs) are becoming 
increasingly important in bridging the gap between 
the level of care provided in an intensive care unit 
and the level of care provided on a general surgical 
ward.3 They have a vital role in reducing elective case 
cancellations and, although difficult to quantify, are 
likely to improve ICU bed turnover. HDUs have been 
shown to reduce ICU readmission rates and allow 
earlier discharge of patients.4,5 While there has been 
support for high dependency units in recent years, 
only a minority of hospitals in Ireland and the UK 
have dedicated surgical high dependency units.3,6,7 
One possible reason for this is a lack of evidence 
supporting their benefit.3
Although several studies have suggested that the 
introduction of HDU facilities alone does not lead 
to a reduction in hospital mortality, postoperative 
management on an HDU has been associated with 
fewer cardiorespiratory complications, compared 
to post operative patients treated on a general 
surgical ward.4  Postoperative stays in HDU allow 
patients to be stabilised before returning to the 
general surgical ward.  The facility to provide 
invasive monitoring should reduce the incidence 
of unexpected postoperative cardiorespiratory 
complications.9 Studies by Gamil et al and Leeson-
Payne et al suggested that many patients on the 
general wards would benefit from closer observation 
and monitoring.10,11
The impact of high dependency units on the 
workload and occupancy of the intensive care unit is 
particularly relevant to vascular surgeons. Frequent 
case cancellation due to ICU unavailability is an 
ever-increasing problem. This strain on ICU facilities, 
coupled with the rising levels of co-morbidity in our 
elective aortic aneurysm population, challenges our 
ability to provide satisfactory delivery of service and 
postoperative care to our patients.
M Cleary et al
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Table  1
DEMOGRAPHIC AND INTRA-OPERATIVE DATA
1998-1999 2002-2003
Age 71.5 ± 0.95 71.2 ± 1.4
Male : Female 49M : 8F 36M : 11F
AAA Size 5.8 ± 0.16 6.2 ± 0.17
Anaesthetic 
Time (Mins) 220 ± 9 219 ± 7
Duration of 
Surgery (Mins) 204 ± 9 200 ± 8
Cross Clamp 
Time (Mins) 71.88 ± 2 78 ± 3
Blood Loss (mls) 2355 ± 158 2062 ± 175
Table 2
POST-OPERATIVE COMPLICATIONS
1998-
1999
2002-
2003
Re
sp
ir
at
or
y
Respiratory Failure 2 4
Lower Respiratory 
Tract Infection 7 11
Ca
rd
ia
c Arrhythmia 4 9
Myocardial Infarct 2 5
Pulmonary Oedema 2 3
Urinary Tract Infection 0 1
Bleeding 1 1
Inflammatory Syndrome 1 1
Wound Infection 1 1
Colonic Ischaemia 3 2
Deep Vein Thrombosis/ 
Pulmonary Embolus 0 1
Acute Renal Failure 5 4
Lower Limb Ischaemia 1 2
Mortality 2 4
1998-1999 2002-2003
55
50
45
40
35
30
25
20
15
10
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ta
l P
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su
m
3
1998-1999 2002-2003
30
25
20
15
10
5
0
0
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U
M
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1998-1999 2002-2003
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15
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O
SS
U
M
1
60
50
40
30
20
10
0
1998-1999 2002-2003
ASA=/>3
ASA<3
4
Ruptures Elective
60
50
40
30
20
10
0
2002-2003
1998-1999
5
Figure 1 —
Physiological 
POSSUM (pPOSSUM) 
scores shown for the 
two time periods 
– 1998-1999 and 
2002-2003. * p=0.048
Figure 2 —
Operative POSSUM 
(oPOSSUM) scores 
shown for the two 
time periods – 1998-
1999 and 2002-2003. 
Figure 3 —
Total POSSUM 
(POSSUM) scores 
shown for the two 
time periods – 1998-
1999 and 2002-2003.  
*p=0.02
Figure 4 —
Proportion of 
patients presenting 
over the time periods 
studies with ASA 
scores =/>3 and ASA 
score <3.  *p<0.007
Figure 5 —
Proportion of 
emergency and 
elective presentation 
of abdominal aortic 
aneurysm during the 
time periods studied 
– 1999-2000 and 
2002-2003.
*p=non-significant.
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Although care provided in a HDU is cheaper than 
in ICU, there has been no observed reduction in 
demand for ICU care with the introduction of high 
dependency units.9 There are several controversies 
surrounding the organisation of a HDU, one of 
which is nurse to patient ratio. Boots et al suggest 
that a defined high dependency service becomes 
cost-effective when patient care requires more than 
one nurse for three patients.7 HDUs vary in terms of 
their proximity to the ICU, with the majority being 
geographically distinct from the ICU. They have a 
variable number of designated consultants, who may 
be surgeons, anaesthetists or physicians. These units 
are highly variable in size, ranging from 3 – 13 beds.8
In the current study, reduced bed occupancy was 
compensated for by more prolonged HDU stays.  This 
eliminated any cost saving on ICU expenditure. HDU 
costs are higher than those of a general surgical ward 
because of the level of sophisticated care provided. 
Significantly higher nurse/patient ratios are required. 
Added to that are the higher costs of consumables, 
pharmacy costs and capital assets. However, the 
cost is at most only 50% of that of ICU.12   The cost 
can be difficult to quantify as illustrated by other 
observational studies. Any cost implications are likely 
to be offset by improvements in the quality of care as 
inferred by our findings and those of others.3,9 Once 
a HDU is established, only observational studies are 
really possible because of clinical pressure to admit 
patients if capacity permits. Other well recognised 
confounding factors, such as fluctuating rates of 
referral when HDU and ICU are full, and admission 
criteria vary as the critical care services become busier, 
making measurement of supply and demand difficult.9
Dhond et al reported that mid-week was the busiest 
period for HDU activity as the unit accommodated 
elective surgical procedures. This would suggest that, 
although the occupancy in ICU remains the same, 
the HDU allows a greater elective workload to be 
undertaken.9 
COnClUsiOn
As outcome after AAA rupture remains poor, 
it is essential that high-risk patients continue 
to be treated electively. In our own experience 
there appears to be a trend towards a greater 
proportion of elective aortic aneurysm repairs, 
which may be a result of earlier intervention in 
high-risk groups. Despite the fact that our patient 
population is becoming increasingly physiologically 
compromised, we have maintained acceptable 
levels of postoperative morbidity. In addition their 
post-operative stay in ICU was reduced with little 
increased cost. Although difficult to quantify, as 
demand for ICU beds is a constant strain, it is likely 
that vacating ICU beds earlier has a beneficial effect 
on ICU bed turnover. The quality, and therefore value, 
of inpatient care can be improved by provision of 
high dependency step-down facilities. 
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inTrODUCTiOn
Pulse wave velocity (PWV), the speed of pulsatile 
wave transit along an arterial segment, is a sensitive 
and reliable surrogate of vascular stiffness.1,2 Resting 
PWV increases with advancing age, reflecting 
elevated arterial stiffness, or its inverse, reduced 
compliance. The progression of arterial stiffness 
is also accelerated by a number of cardiovascular 
disorders.3-6 Studies designed to examine the 
physiological relationships between PWV and 
standard resting haemodynamics report conflicting 
results. Whilst strong, but variable, correlations 
between PWV and blood pressure (BP) are frequently 
documented,3-10 its association with other measured 
and derived parameters (e.g. heart rate (HR), rate 
pressure (double) product and pulse pressure) is less 
clear.7,11-16 Furthermore, the potential influence of HR 
on the PWV continues to evoke much controversy 
despite the use of cardiac pacing to induce 
tachycardia.12,14,15,17 
 
The effects of elevated HR and BP on the PWV of 
normal subjects during acute exercise are also 
unclear. Movement artefact tends to restrict reliable 
measurement of PWV during dynamic exercise. 
Hence, recent isotonic studies only report acute 
alterations of compliance during the post-exercise 
recovery phase.16,18 Stable recording of PWV can be 
acquired using isometric exercise and although 
some studies are reported,19-21 the detailed inter-
relationships between the various haemodynamic 
parameters and PWV during isometric exercise 
remain unclear. Most reports on PWV relate to the 
elastic, carotid-femoral circulation. Less attention has 
been addressed to the more muscular carotid-radial 
arterial segment even though it is easily accessed, 
allows precise measurement using synchronous, 
dual transducer techniques and is a part of the 
vasculature that is relatively spared from the effects 
of both ageing and occlusive atheromatous disease.2,5 
The current study describes, in control subjects, 
aspects of the direct physiological inter-relationships 
between dominant arm carotid-radial PWV and 
standard non-invasively measured haemodynamics, 
during acute non-dominant arm isometric handgrip 
exercise (ISOMEX). This particular mode of exercise was 
chosen for study not only because of the stability of 
the recordings, but also due to the acute nature of its 
sympathetically mediated vasoconstrictive effect.22-24 
Isometric exercise invokes a notable elevation of 
diastolic BP, in addition to modest increases of systolic 
Haemodynamic determinants of elevated 
pulse wave velocity during acute isometric 
handgrip exercise
aBsTraCT
Background Measurement of pulse wave velocity (PWV) provides a reliable index of 
vascular stiffness. Despite its widespread application, the physiological inter-
relationships between PWV, blood pressure (BP) and in particular, heart rate (HR), 
have yet to be fully elucidated. Furthermore, little is known about altered arterial 
compliance during acute exercise. 
Aim To examine the effects of 3-min supine non-dominant isometric handgrip exercise 
(ISOMEX), performed at 30% of maximum voluntary contraction, on carotid-radial 
PWV, BP and HR in the dominant arm of 51 healthy subjects. 
Results During exercise, PWV correlated strongly with diastolic BP (r = 0.55, p < 0.01) and 
mean arterial pressure (r = 0.51, p < 0.01). PWV and HR failed to correlate at rest or 
during exercise. 
Conclusion ISOMEX invoked an elevated PWV, which is predominantly related to BP 
or factors determining it, and not HR. The carotid-radial PWV stress test is a 
simple measurement that may have prognostic potential for use in large-scale 
population studies.
KF Reid,1 
MA Conway
Dept of Cardiology, 
St. Luke’s Hospital, 
Kilkenny 
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at the Jean Mayer 
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BP and HR. By measuring PWV during ISOMEX, the 
effect of a concurrent rise of HR, on a background 
of amplified vascular tone, can be examined. The 
hypothesis underlying the current study is that BP, 
or factors causing the BP response, rather than HR, 
determine the speed of pulse wave transit during 
ISOMEX. We also propose that measurement of PWV in 
the upper limb during the standard isometric exercise 
protocol is practicable for use as a vascular stress test 
in human population studies. 
MeTHODs
SUBJECTS 
The study took place at the exercise laboratory of 
the Cardiovascular and Coronary Care Unit, St. Luke’s 
Hospital, Kilkenny, Ireland. Institutional ethics approval 
was obtained and all volunteers provided informed 
consent. Full data sets were recorded from 51 controls 
(22 males and 29 females, Table 1), recruited from a 
local population with a mean total cholesterol of 5.5 
± 1 mmol/l. Participants with a history of diabetes 
mellitus, a resting BP greater than 140/90 mmHg, 
Marfan’s syndrome or those taking any form of 
pharmaceutical or alternative medication were 
excluded from the study. All subjects were free of 
symptoms or signs of disease with active lifestyles 
and no previous history of valvular, atheromatous or 
hypertensive cardiovascular disease. Six subjects were 
excluded from the final analysis because of failure to 
obtain a complete compliment of resting and exercise 
PWV measurements.  
PROCEDURES
Following a demonstration of the experimental 
protocol, each subject rested supine for approximately 
10 minutes. After this period, three individual 
recordings of brachial BP (systolic and diastolic BP) 
and HR were taken from the dominant arm with an 
automated digital oscillometric sphygmomanometer 
(Omron, model 705 – CP, Omron Matsuaka Corp., 
Japan). Upper limb PWV was determined directly 
afterwards using an automatic device, Complior II® 
(Colson, Paris). This allows online pulse wave recording 
and automatic calculation of PWV, as previously 
described and validated.1 Synchronous measurements 
were obtained by simultaneously positioning two 
pressure sensitive transducers, one at the base of the 
neck for the common carotid artery and the other 
directly over the radial artery of the dominant arm. The 
PWV was derived using the time delay between the 
foot of the proximal (carotid) and distal (radial) waves 
and the superficially calculated distance separating 
the respective transducers, according to the following 
equation: PWV (m/sec) = distance (cm) / transit time 
(secs).1 The procedures used for calculation of the 
baseline PWV were identical for exercise and recovery. 
Since comparison of the PWV was performed at the 
same sitting for each individual, the length between 
the transducers was not adjusted to allow for the 
short distance that the pulse wave travels from the 
origin of the common carotid into the neck. The pre-
exercise values for each subject were based on three 
individual sets of resting steady state data.
 
The rate pressure product and the mean arterial 
pressure were estimated according to standard 
formulae (rate pressure product = HR x systolic 
BP and mean arterial pressure = 1/3 (systolic BP 
– diastolic BP) + diastolic BP). 
PROTOCOL
ISOMEX was performed uninterrupted for three 
minutes at 30% of maximal voluntary contraction 
using a Baseline ® hydraulic hand dynamometer 
KF reiD & Ma COnway
Table 1
PERSONAL CHARACTERISTICS
n MALES (n=22) FEMALES (n=29)
Age, years 37. 6 ± 13 37.7 ± 16
Height, cm 175 ± 1 162 ± 1
Weight, kg 84.4 ± 3 65.7 ± 2
BMI, kg/m2 27.5 ± 1* 24.9 ± 1
MVC dominant, kg 45 ± 2* 27 ±1
MVC non-dominant, kg 43.8 ± 2* 26.4 ± 1
30% MVC, kg 13.5 ± 0.6* 7.9 ± 0.4
Values are mean ± SE, except age (SD) . BMI, body mass index; 
MVC, maximum voluntary contraction.
* = Significant difference compared to females, p ≤ 0.01
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Table 2
HAEMODYNAMIC RESPONSES TO ISOMEX
 REST EXERCISE RECOVERY
SBP, mmHg (males n = 22) 120 ± 3 133 ± 4†‡ 120 ± 3
 (females n = 29) 115 ± 3 123 ± 3 114 ± 4
DBP, mmHg
69 ± 1 80 ± 2†‡ 69 ± 2
66 ± 1 74 ± 2† 68 ± 1
MAP, mmHg
86 ± 2 98 ± 3†‡ 86 ± 2
82 ± 2 91 ± 2† 83 ± 2
PP, mmHg
51 ± 2 52 ± 2 52 ± 2
50 ± 2 49 ± 2 47 ± 3
HR, beats/min
66 ± 2‡ 72 ± 2*‡ 65 ± 2
62 ± 2 66 ± 2* 61 ± 2
RPP
7933 ± 288‡ 9646 ± 479†§ 7881 ± 312‡
7087 ± 246 8143 ± 266† 6934 ± 286
PWV, m/sec
8.16 ± 0.18‡ 9.18 ± 0.25†§ 8.25 ± 0.23
7.69 ± 0.15 8.38 ± 0.16† 7.78 ± 0.15
Values are mean ± S.E. DBP, diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; PP, pulse 
pressure; PWV, pulse wave velocity; RPP, rate pressure product; SBP, systolic blood pressure. 
(* = Significant difference compared to baseline, P ≤ 0.05; † = p ≤ 0.009)
(‡ = Significant difference compared to females, P ≤ 0.05; § = p ≤ 0.005)
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Figure 3 —
CORRELATION 
BETWEEN PWV AND 
SBP DURING ISOMEX
Figure 4 —
CORRELATION 
BETWEEN PWV AND 
HR DURING ISOMEX
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(FEI, Irvington, New York 10533, U.S.A.). Subjects were 
encouraged to maintain constant tension on the 
dynamometer and to breathe normally throughout 
(avoiding the Valsalva manoeuvre). Recording of all 
haemodynamic parameters took place during the 
third minute of ISOMEX in order to determine the 
BP, HR and PWV during steady state contraction. 
On completion of exercise, subjects relaxed for one 
minute before recording of the recovery BP, HR and 
PWV commenced. 
STATISTICAL ANALYSIS
Statistical analyses were applied comparing baseline 
data to values obtained during exercise and recovery 
using paired Student t-tests for dependant variables, 
where appropriate. The Pearson product moment 
correlation was computed to assess the degree 
of association amongst variables and all results 
were analysed with GB-STAT (version 8.0, Dynamic 
Microsystems, U.S.A.). Statistical significance was 
accepted at a p value ≤ 0.05. Data are presented as 
mean ± SE.
resUlTs
Haemodynamic changes were recorded successfully 
from the 51 subjects at the first sitting. Each 
participant tolerated the protocol comfortably and 
elicited the expected, although individually variable 
haemodynamic changes. Resting PWV correlated 
significantly with age (r = 0.31, p = 0.02), resting 
diastolic BP (r = 0.33, p = 0.02) and resting mean 
arterial pressure (r = 0.29, p = 0.04). 
ISOMEX significantly elevated the standard 
haemodynamics such as systolic BP, diastolic BP and 
HR compared to rest. The systolic BP increased by 
an average of 10.1 ± 1 mmHg (9 ± 1%) (p = 0.002). 
The percentage increase of diastolic BP was greater 
(15 ± 1%, p < 0.0001), although the absolute change 
was similar: 10.0 ± 1 mmHg. The HR increased by an 
average of 9.5 ± 1% (P = 0.003), from a resting rate of 
63 ± 1 beats/min to 69 ± 1 beats/min. ISOMEX also 
significantly elevated the derived parameters, rate 
pressure product (18 ± 2%; p < 0.0001) and mean 
arterial pressure (12 ± 1%; p < 0.0001). Hand-grip 
exercise also significantly increased the PWV by 
10.9 ± 1 %, from 7.89 ± 0.1 m/sec to 8.73 ± 0.2 m/sec 
(p < 0.0001). The pulse pressure was the only 
standard haemodynamic variable that did not 
change (p = 0.94). 
Strong correlations were found between exercise 
PWV and exercise haemodynamics such as diastolic 
BP (r = 0.55, p = 0.002, Figure 1) and mean arterial 
pressure (r = 0.51, p = 0.002, Figure 2). The systolic 
BP (r = 0.41, p = 0.003, Figure 3) and rate pressure 
product (r = 0.35, p < 0.01) also correlated with the 
ISOMEX PWV. Despite the significant rise in HR and 
the similar % change of the PWV, these parameters 
did not correlate (Figure 4). 
Table 2 displays the resting, exercise and recovery 
haemodynamic parameters for males (n =22) and 
females (n = 29). The former presented with higher 
resting values for all haemodynamics. However rate 
pressure product, HR, and PWV were the only 
indices that were significantly greater (p ≤ 0.05). 
During exercise, males elicited significantly greater 
PWV (9.19 ± 0.3 m/sec vs. 8.38 ± 0.2 m/sec, 
p = 0.007) and the systolic BP, diastolic BP, mean 
arterial pressure, HR and rate pressure product were 
also significantly elevated (p ≤ 0.05), compared to 
females. However, the magnitude of the % changes 
invoked by ISOMEX were similar for each gender. The 
PWV, and all of the aforementioned haemodynamic 
parameters, returned to resting pre-exercise levels 
during the recovery phase. Gender also had no effect 
on the recovery values.
REPRODUCIBILITY
Reproducibility of the methods was confirmed in 
eight, randomly chosen members of the study group, 
in whom the protocol was repeated less than 5 days 
after the original measurements. The % increase of 
PWV during ISOMEX in this subset at the second 
recording was similar to that initially observed 
(15.5 ± 6 vs. 15.2 ± 4%, p = ns). Similarly, the induced 
changes in mean arterial pressure (15.7 ± 4 vs. 16.1 ± 
3%, p = ns) and HR (14.1 ± 4 vs. 14.3 ± 4%, p = ns) were 
comparable between the two days.
DisCUssiOn
This study documents the physiological relationships 
between synchronous dual point carotid-radial PWV 
and other non-invasive haemodynamics at rest, 
during acute isometric exercise and recovery. It also 
provides novel insight into non-dominant forearm 
exercise, focusing attention on the readily accessible 
carotid-radial circulation where applicability is widely 
practicable.5 The findings support the hypothesis 
that elevated PWV during isometric exercise is 
strongly associated with the hypertensive response 
to this form of physiological exercise stress rather 
than the rise in HR.
KF reiD & Ma COnway
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RESPONSES TO ISOMETRIC EXERCISE
A number of previous studies describe the 
physiological effects of isometric exercise in 
humans.22,23,25,26 The present report focuses not only 
on standard BP and HR changes but also explores 
the effects of ISOMEX on mean arterial pressure, 
rate pressure product and pulse pressure. The 
findings relating to the latter are consistent with 
those derived from published BP and HR data, 
even though exercise was performed using the 
non-dominant arm.23,27,28 Such an exercise protocol 
avoids forearm movement, but, as with dominant 
arm isometric exercise, invokes arterial stiffening 
or vasoconstriction due to enhanced sympathetic 
activity to the heart and blood vessels.22-24 The 
elevation of BP (particularly diastolic), is directly 
related to both the intensity and duration of 
muscle contraction, and to the size of the muscle 
mass recruited.25-27 Since the BP changes during 
ISOMEX are coupled with modest changes in HR, 
the haemodynamic response that amplifies arterial 
stiffness operates predominantly through BP related 
mechanisms.
BLOOD PRESSURE AND PWV
The current findings show that at rest, diastolic BP 
and mean arterial pressure are significantly related 
to carotid-radial PWV. This corroborates the findings 
of Kanda et al5 in healthy males, and Cameron et 
al.29 who report that the resting carotid-radial PWV 
of controls, but not diabetic subjects, is associated 
with diastolic BP and mean arterial pressure. 
Yasmin and Brown9 concluded that the diastolic 
BP was the strongest correlate of resting carotid-
radial PWV in the healthy offspring of hypertensive 
patients. Diastolic BP is also reported as the major 
determinant of aortic PWV in young males.10 
However, in both healthy and diseased subjects, 
other investigations have found that mean arterial 
pressure or systolic BP is preferentially related to the 
PWV in the resting state.3,4,6-8 
The elevated PWV during ISOMEX in the current 
study correlates strongest with the exercise diastolic 
BP. ISOMEX induced elevation of diastolic BP is 
thought to result from increased peripheral arterial 
resistance,22 likely as a consequence of amplified 
sympathetic nervous system activity. The weaker 
relationship between exercise systolic BP and 
exercise PWV may relate to the greater magnitude 
of the diastolic BP response. The latter was raised by 
~15 % compared to the ~9% rise in systolic BP. The 
pulse pressure did not change significantly during 
ISOMEX as a consequence of the greater percentage 
increase of diastolic BP, relative to systolic BP. This 
is consistent with the original observations of Lind 
et al.25 The mean arterial pressure and to a lesser 
extent, the rate pressure product, which may provide 
a non-invasive estimate of the ventricular-vascular 
shear stress component, were also linked to the PWV 
response during ISOMEX. 
HEART RATE AND PWV
Controversy exists with regard to HR and PWV 
and some authors suggest that PWV should be 
standardised for the HR level.15 One postulated 
mechanism whereby HR may influence PWV is 
that at faster heart rates, the time available for 
vessel wall recoil is reduced, thereby decreasing 
distensibility. A cross-sectional study by Nurnburger 
et al.10 describes a significant association between 
resting HR and aortic PWV amongst healthy young 
men. Also, ambulatory HR appears to influence aortic 
PWV amongst older subjects.11 The present results 
demonstrate no effect of HR on the upper-limb PWV 
either at rest, during ISOMEX or recovery. Despite 
the elevated HR occurring on the background of 
more taut or stiffened vessels during ISOMEX, it still 
had no relationship with the PWV. Also, the derived 
parameter, rate pressure product, elicited a weaker 
association with PWV than the systolic BP alone, 
implying that HR in combination with systolic BP has 
little effect on the PWV, at least in this population of 
healthy controls.
Similarly, pacing studies designed to simulate 
exercise tachycardia report conflicting results. 
Wilkinson et al17 detected no PWV alteration during 
incremental atrial pacing, whilst other investigations 
found that PWV increased significantly by elevating 
the HR from 40 beats/min to 130 beats/min.12,15 
Albaladejo et al.13 suggest that a relationship exists 
between aortic PWV and HR for males but not for 
females. We found no relationship between PWV and 
HR in our gender comparisons. 
NEUROGENIC REFLEXES AND ISOMEX PWV
The mechanism underlying the raised BP and PWV 
during ISOMEX in the current study may relate 
to amplified efferent sympathetic activity. The 
rise in diastolic BP is consistent with increased 
peripheral vascular resistance and stiffening of 
the vasculature, which alters the inherent arterial 
cushioning function that underlies normal rates of 
resting PWV. On cessation of exercise, the BP and HR 
decrease is mirrored by a corresponding fall in PWV, 
a response consistent with a neurogenic trigger for 
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the haemodynamic alterations being switched off. 
This rapid reversal contrasts with the PWV response 
to acute dynamic exercise. Compliance is elevated by 
about 66% 30 minutes following moderate intensity 
cycling exercise and only returns fully to baseline 
when measured one hour after exercise.18 Similarly, 
both upper limb and lower limb PWV are ~10% lower 
60 minutes following maximum treadmill exercise.16 
Such delayed responses to isotonic exercise may 
better reflect metabolic phenomena resulting from 
this particular mode of physiological stress. 
THE CAROTID-RADIAL ARTERIAL SEGMENT
The majority of reports regarding synchronous 
dual arterial site PWV measurement focus on the 
carotid-femoral circulation. Few synchronous carotid-
radial PWV studies are documented, even though 
studies employing this component of the circulation 
have notable advantages.5 Factors such as ageing 
and disease, that have a pronounced effect on the 
aorta, do not overtly affect this part of the arterial 
tree. Indeed, the first measurements of PWV were 
recorded in the upper limb vasculature because 
of its accessibility. Furthermore, the carotid-radial 
circulation comprises a muscular type vasculature 
which may also be more dependent on endothelial 
nitric oxide bioavailability. In addition, because of 
this large smooth muscle component, for any given 
increase in sympathetic outflow, greater modification 
of the intrinsic viscoelastic properties of the arterial 
wall along this particular segment should occur, 
compared to elastic type arteries. 
COnClUsiOn
The current study describes the abrupt, but 
temporary, elevation of PWV resulting from a single 
bout of ISOMEX in healthy subjects. This increase 
is significantly related to BP, particularly diastolic 
BP and mean arterial pressure, but not HR. The 
pattern of the haemodynamic response to ISOMEX 
is consistent with a likely neurogenic mechanism. 
Studies characterising controls and patients with 
cardiovascular disease and related disorders using 
the standard isometric exercise protocol described 
here, in conjunction with longitudinal lifestyle 
changes including diet, exercise, pharmaceutical and 
other interventions, are indicated in order to verify 
the diagnostic and prognostic potential of assessing 
PWV during ISOMEX. 
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inTrODUCTiOn
Although the cardiovascular consequences, ischaemic 
and peripheral vascular disease, of cigarette smoking 
are well recognised the relative contribution of 
the underlying pathophysiological mechanisms 
e.g. atherosclerosis, increased intimal medial 
thickness, inflammation, endothelial dysfunction, 
hypercoagulatibility, platelet activation are less well 
described.1 Recently we noted that acute cigarette 
smoking increased blood pressure and arterial 
stiffness.2 An increase in blood pressure (BP) per se can 
increase vascular stiffness. As BP is largely determined 
by cardiac output and peripheral vascular resistance 
we wished to determine if changes in one or both 
was responsible for the change in BP and whether 
BP changes antedated changes in arterial stiffness/
compliance. We also hypothesised that by using a 
continuous, non-invasive beat-to-beat recording of 
the haemodynamic changes induced by smoking 
one could compare data obtained in a young healthy 
population to that from a patient population using 
more invasive techniques.
MeTHODs
A group of 12 healthy subjects (six female), aged 22-25 
years of age, of which six were regular smokers and 
six non-smokers, volunteered for this study. Subjects 
were studied supine in a quiet room resting for 10-15 
minutes until a stable baseline was achieved. None 
were on any medication and all had refrained from 
smoking for at least two hours. Subjects smoked a 
single cigarette (nicotine content 1.2 mg) over five 
minutes and completion was taken as time 0. Data 
recorded in the five minutes prior to smoking were 
taken as baseline. The six control subjects followed 
the same protocol with the exception that their 
cigarette was not lit (sham smoking). Haemodynamic 
measurements were recorded non-invasively from 
finger infra-red photopletismographic recordings of 
arterial BP – Finometer (TNO Biomedical Instruments, 
Amsterdam, Netherlands) which derives blood pressure 
(following calibration to brachial blood pressure) 
cardiac output and peripheral vascular resistance 
and arterial (aortic) compliance from the computed 
aortic flow waveform. It has been shown to accurately 
reflect pressures recorded invasively 3 and has been 
validated4 to the standards of the Association for the 
Advancement of Medical instrumentation (AAMI).
Results, expressed as mean ±SEM, were analysed 
through JMP (Version 3.2.1. SAS Institute Inc). The 
difference between the response to smoking and 
controls was analysed using MANOVA. The study has 
Institutional Ethics approval.
resUlTs
There were no significant differences in baseline 
values between the two groups. As there were no 
Acute haemodynamic effects of cigarette 
smoking in healthy young subjects
aBsTraCT
Background  Invasive studies in middle-aged patients suggest an acute adverse 
haemodynamic effect of smoking.
Aims To study acute changes in blood pressure (BP), cardiac output, peripheral resistance 
and aortic compliance following cigarette smoking in healthy young subjects.
Methods  Using a non-invasive photoplethysmographic technique we compared the 
effects of smoking one cigarette with sham smoking in 12 healthy volunteers (22-25 
years). Data was analysed using JMP version 5.0.
Results  In contrast to sham smoking there was a prompt increase in blood pressure 
with a maximum effect at 15 min (123±7/75±5 to 143±6/86±6 mmHg, mean±SEM, 
p<0.01) which is attributed to a rise in cardiac output (p<0.05) rather than changes 
in peripheral vascular resistance. There was also a significant (p<0.05) increase in 
heart rate and a reduction in aortic compliance.
Conclusion  These results suggest that health or young age do not protect from the 
adverse effects of smoking.
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changes in any haemodynamic measurement with 
sham (control) smoking, only the active smoking 
data are displayed (Figure).
SYSTOLIC BP
There was a rise from baseline (123 ±7 mmHg) in 
systolic pressure by one minute after smoking and 
the main changes were observed during the 5 to 
15 minute period when the peak (143 ±6 mmHg) 
effect after smoking was achieved (Figure). However 
systolic pressure did not return to baseline even 
some 20 minutes following smoking. The difference 
between the two groups was significant (p<0.01).
DIASTOLIC BP
The diastolic blood pressure showed similar changes 
to that of systolic pressure from a baseline 75 ±5 
reaching a peak 86 ±6 mmHg at 15 minutes but had 
not returned to baseline 20 minutes after smoking 
(Figure). Again the difference between the two 
groups (smoking/control) was significant (p<0.01).
HEART RATE
The baseline heart rate (68 ±4/min) with smoking 
increased significantly (p<0.01) following smoking, 
reaching a maximum (78 ±5/min) at 10 minutes and 
declined thereafter. In controls (sham smoking) there 
was no variation in heart rate.
CARDIAC OUTPUT
Cardiac output rose from a baseline of 5.6 ±1.62 l/min 
to 6.4 ±0.8 l/min after 3 minutes following smoking, 
achieving a peak 6.8 ±1.0 l/min at 10 minutes. It then 
remained quite static without much fluctuation until 
the end of the study. The difference observed due to 
smoking was significant (p<0.001) as sham smoking 
did not cause any variation in cardiac output.
TOTAL PERIPHERAL RESISTANCE (TPR)
In the Finometer this is computed from mean 
pressure/cardiac output and expressed as dyn.s/cm5 
and converted as a unit called MU (medical unit 
system). There was no change from baseline values 
in smokers (1.03+0.1) following smoking (Figure).
ARTERIAL COMPLIANCE
Some five minutes after smoking compliance had 
declined significantly (p<0.01) from 2.55 ±0.1 at 
baseline to 2.34 ±0.1 reaching 2.3 ±0.1 by 15 minutes. In 
controls it showed no change and again the difference 
between the two groups was significant p<0.01.
COnClUsiOn
This study reveals additional information on the acute 
haemodynamic response to smoking. It also suggests 
the adverse effects seen in older patients with disease 
states are applicable to healthy young subjects. This 
indicates that young age and a healthy vascular 
system does not offer protection from the adverse 
haemodynamic effects of smoking. The number of 
subjects studied was relatively small, in part due to 
implementation during the course of the study of a 
ban in Ireland precluding any smoking indoors.
The study illustrates how a sensitive non-invasive 
photophlethysmographic technique may accurately 
reflect the effects of smoking. The Finometer 
device is now established in the detection of acute 
changes in cardiac function4 providing data that 
has hitherto only been available using invasive 
intra-aortic recording devices, which by their nature 
are not applicable in healthy subjects. Indeed with 
appropriate calibration it can quantitatively reflect 
change in blood pressure, cardiac output and total 
peripheral resistance in cardiac surgery patients.5 
Using Doppler echocardiography Kool et al6 
reported an increase in cardiac index, largely 
due to an increased heart rate, and increased BP 
but no change in systemic vascular resistance 
following smoking in middle-aged subjects. Using 
radionucleotide ventriculography in 12 habitual 
smokers with suspected ischaemic heart disease 
Hoilund-Carlsen et al7 have shown that two 
cigarettes acutely increased heart rate by 27%, 
the rate pressure product by 23% and cardiac 
output by 14%. The total peripheral resistance 
remained constant. This was accompanied by 
a 100% increase in plasma adrenaline (but not 
plasma noradrenaline). In 40 male smokers (mean 
age 47 years) undergoing diagnostic cardiac 
catheterisation studied while smoking a cigarette 
or sham smoking there was a prompt increase 
in both systolic and diastolic BP reaching a peak 
after five minutes which had not returned to 
baseline by 20 minutes. In that study the heart rate 
increasing from 68±2 to 78±2/min by five minutes 
and cardiac index (cardiac output divided by body 
surface area in m2) by approximately 10% but there 
was no change in systemic vascular resistance 
index.8 There was a significant change in the aortic 
pressure-diameter relation denoting a deterioration 
of the elastic properties which was maintained 
throughout the study with the maximum effect on 
aortic distensibility at five minutes.
Z aMir et al
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Our primary findings were a prompt increase in 
blood pressure, heart rate and cardiac output 
immediately following smoking but peripheral 
resistance remained unchanged. The decline in aortic 
compliance, or increase in stiffness appeared to lag 
temporarily behind the changes in blood pressure.
Our study using a new non-invasive technique 
provides results similar to those seen with 
echocardiography, radio-nucleotide and intravascular 
catheterisation with micromanometer recordings in 
a patient population. Although the number of young 
subjects studied is small it appears that changes in 
blood pressure pre-date those of aortic compliance 
suggesting that some of this effect is blood pressure 
dependent. Nonetheless invasive flow loop studies also 
show a direct effect on the vascular wall.6 Our results 
confirm that the acute rise in blood pressure following 
smoking is predominantly due to an increase in cardiac 
output rather than an increase in peripheral resistance.
Figure —
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inTrODUCTiOn
Recent studies have shown that the risk of stroke 
following transient ischaemic attack (TIA) is 8-12% 
at seven days and 11-15% at one month.1 These risks 
are higher than previously quoted and emphasise 
the need for rapid assessment with institution of 
preventive treatment, particularly for carotid stenosis 
and atrial fibrillation. The Royal College of Physicians 
National Guidelines on Stroke, recommend that 
patients with TIA or minor stroke be assessed 
and investigated in a specialised neurovascular 
clinic within seven days.2 An additional role of a 
neurovascular clinic is the identification of patients 
with non-cerebrovascular causes for their symptoms, 
such as syncope, arrhythmias, epilepsy or primary 
eye disorders, which may require specific treatment. 
Despite the emphasis on out-patient assessment 
for stroke and TIA, there is a paucity of information 
on the efficacy of such a facility.3,4 In January 2003 a 
dedicated once weekly TIA clinic was established in 
the Medicine for the Elderly Day Hospital at 
St. Vincent’s University Hospital, with the co-
operation of the Department of Radiology, Vascular 
Surgery, Neurology and Ophthalmology. Here we 
report on the activity of the first 18 months.
OPERATIONAL POLICY
Patients over 65 years of age, presenting to the 
Accident and Emergency (A & E) Department, with 
symptoms suggestive of a TIA, were referred to the 
clinic using a specific referral form. It was emphasised 
that the indications for referral were acute onset 
of focal neurological symptoms, lasting less than 
24 hours. Non-focal symptoms such as dizziness or 
syncope, on their own, were not TIAs. Furthermore 
the patient should be 65 years or over and deemed 
not to need acute hospital admission. Referrals were 
co-ordinated by the Stroke Nurse Specialist (SNS) 
and appointments scheduled for the next available 
clinic. Investigations (radiological and blood) were 
performed prior to clinical assessment, to ensure that 
results would be available at time of consultation, 
in order to facilitate a single visit where possible. 
The investigations carried out were CT brain scan, 
carotid doppler ultrasound, ECG, full blood count 
(FBC), urea, creatinine and electrolytes (U & E), fasting 
lipids, glucose and erythrocyte sedimentation rate 
(ESR). CT brain scans were requested unless carried 
out in A & E. Patients were contacted by telephone 
on the day preceding clinic attendance by the SNS 
and appointments for phlebotomy and radiological 
procedures outlined in detail. The patients attended 
the day hospital at 8.30am on the appointed morning 
Assessment and management of transient 
ischaemic attack - the role of the TIA clinic
aBsTraCT
Background  As the risk of early stroke following transient ischaemic attack (TIA) is 
increasingly recognised, the management of patients presenting with symptoms 
suggestive of TIA presents a clinical challenge. 
Methods  Analysis of prospectively collected data on patients referred to a TIA clinic in St. 
Vincent’s University Hospital, between January 2003 and July 2004.
Results  One-hundred-and-seventeen (117) patients (mean age 75.5 years) were assessed. 
The majority (79%) were referred from Accident and Emergency and 61% were 
seen within one week of referral. Seventy-two patients (62%) had a final diagnosis 
of cerebrovascular disease (56 TIA, 16 completed strokes), of whom five (7%) and 
four (5.5%) had severe (>70%) and moderate (>50%) symptomatic carotid artery 
stenosis, respectively, whilst seven patients (10%) had newly diagnosed atrial 
fibrillation, five of whom were anticoagulated. Non-cerebrovascular diagnoses were 
made in twenty-seven patients (24%).
Conclusion  A TIA clinic, in co-ordination with Accident & Emergency Services, provides a 
safe and efficient alternative to hospital admission for patients with TIA symptoms 
and a low early stroke risk.
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and were directed to the appropriate venue for 
investigation. They subsequently returned to the 
day hospital where clinical assessment was carried 
out and lunch was provided. The results of all 
investigations were made available for the consensus 
multidisciplinary conference at 2pm on the day of 
assessment, where the diagnosis was reviewed and 
management plans instituted. 
MeTHODs
The following information was gathered 
prospectively on all patients on an agreed proforma; 
demographic details, referring source, summary of 
symptoms, past medical history with pre-existing 
risk factors, smoking, alcohol, current medications, 
social situation, neurological assessment, results 
of investigations, classification of the event, drug 
therapy and other risk factor advice given, and 
referrals to other services. Patients diagnosed 
with TIA or completed stroke were classified as 
cerebrovascular disease. Analysis of this prospectively 
gathered information forms the basis of this study.
resUlTs
There were 117 new patients seen at the clinic. 
(Table 1) The mean age was 75.5 years, 71 (61%) were 
female and 71 (61%) were seen within one week of 
referral to the clinic. The majority (79%) of patients 
were referred from the Accident & Emergency 
Department. Of the 117 referrals to the clinic, 72 (62%) 
had a final diagnosis of cerebrovascular disease (TIA, 
completed stroke). The remaining 44 patients had a 
variety of other primary diagnoses (Table 2).
CT brain scan was performed on 115 patients (98%), 
with one patient having an MRI brain scan. Non-
vascular abnormalities (subdural haematoma 1, 
cerebral metastases 1) were found in two patients. 
Carotid Doppler ultrasound studies were carried out 
on 116 patients (99%).
Sixty-two patients (53%) were seen and completely 
assessed on one visit to the neurovascular clinic. Five 
patients were admitted to the acute general hospital 
for investigations. Fifty-two patients (44%) were 
recalled for review of requested investigations, whilst 
42 patients (35%) were referred to other services, 
notably ophthalmology, vascular surgery, cardiology, 
neurology and endocrinology (Table 1).
CVA/TIA GROUP
Of the 117 patients referred to the clinic, 72 (62%) had 
a final diagnosis of cerebrovascular disease (56 TIA, 16 
completed stroke) (Table 2). Pre-existing modifiable 
risk factors included hypertension (38 patients), 
diabetes mellitus (11), hypercholesterolaemia (21), 
cigarette smoking (20) and atrial fibrillation (9), of 
whom only three had been anticoagulated. There 
were 60 patients on anti-platelet therapy, which in 
most cases had been commenced in A & E. 
Following assessment (Table 3) new diagnoses 
included hypertension (7), diabetes mellitus (2), 
hypercholesterolaemia (28). Of seven patients 
with newly diagnosed atrial fibrillation, five were 
anticoagulated, one patient refused warfarin, whilst 
in one case anticoagulation was deferred pending 
carotid artery surgery. New treatment, consisting of 
hypotensive therapy (13), aspirin (7), dipyridamole 
(26), clopidogrel (3), statin therapy (32) and oral 
hypoglycaemics (2) was commenced. Duplex carotid 
studies were carried out in 116 patients (Table 4). 
Of the 72 patients with TIA/stroke, nine (12.5%) had 
symptomatic carotid artery stenosis (>50%). In five 
patients (7%) the degree of stenosis was greater 
than 70%, whilst two patients had a completely 
occluded carotid artery, corresponding to their 
symptomatic hemisphere. Of the patients in the 
non-TIA/CVA group, two had severe carotid stenosis 
(asymptomatic carotid artery stenosis). 
DisCUssiOn
Our experience suggests that a TIA service is an 
effective method of assessing patients with a 
suspected TIA or minor stroke. Over 55% of our 
patients were comprehensively investigated and 
assessed at one visit, whilst over 60% of patients 
were seen within one week of referral.
In our series, 62% had a final diagnosis of 
cerebrovascular disease, of whom 7% had 
symptomatic severe carotid stenosis and 10% 
were diagnosed with new onset atrial fibrillation, 
the majority of whom were anticoagulated. In 
two previous studies3,4 of patients referred to a 
neurovascular clinic 61.5% and 50% were found to 
have cerebrovascular disease, respectively. Of these 
16% and 12% respectively had severe carotid stenosis. 
The lower incidence of severe symptomatic carotid 
artery disease in our study may reflect hospital 
admission of patients with more severe transient 
ischaemic attack or minor stroke via Accident & 
Emergency, who have a higher seven-day risk of 
stroke10 and may have more severe carotid artery 
stenosis. A further four and two patients had 
moderate symptomatic and severe asymptomatic 
carotid stenosis, respectively, in whom carotid 
C FallOn et al
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Table 3
CEREBROVASCULAR RISk FACTORS AND SECONDARY 
PREVENTION MEDICATION IN TIA / CVA GROUP (N =72)
PRIOR NEW
Hypertension 38 7
Atrial Fibrillation 9 7
Diabetes Mellitus 11 2
Hypercholesterolaemia 21 28
Ischaemic heart disease 19 3
Cigarette smoking 20 -
Family history 31 -
Prior CVA / TIA 20 -
Antihypertensives 38 13
Antiplatelet agents 60 *7/26/3
Anticoagulant 3 5
Statin 21 32
Oral hypoglycaemic agents 4 2
*Aspirin / dipyridamole / clopidogrel
Table 4
CAROTID DOPPLER EXAMINATION (N = 116)
% STENOSIS CVA / TIA (N = 72)
NON CVA / TIA 
(N= 45)
> 70% 5 2
50 – 70% 4 7
Occluded 2 1
Not done 1
Where patients in the CVA / TIA group had bilateral 
internal carotid stenosis only the stenosis in the 
carotid artery ipsilateral to the affected hemisphere 
was classified.
Table 1
CHARACTERISTICS OF PATIENTS, SOURCE OF REFERRAL 
TO CLINIC AND TO OTHER SPECIALITIES
MEAN AGE (YRS) 75.5 (RANGE 61 – 93)
Age profiles (n = 117) %
≤ 65 14 12
66 – 70 29 25
71 – 80 37 32.4
81 – 90 32 27.3
≥ 90 5 4.4
Male: Female 46.71 39.61
Source of referral
A/E 92 79
GP 17 14
Consultant 8 7
Delay to clinic visit
< 7 Days 71 61
> 7 Days 46 39
Referral to specialities
Ophthalmology 12 10.2
Vascular surgery 13 11
Cardiology 9 7.6
Neurology 3 2.5
Endocrinology 5 4.2
Table 2
FINAL DIAGNOSIS
N=117 %
TIA 56 48
Completed stroke 16 14
Arrhythmia/ Syncope 12 10
Headache / Migraine 2 1.7
Seizure 3 2.5
Transient global amnesia 3 2.5
Temporal arteritis 1 0.8
Parkinsonism 1 0.8
Cerebral metastases 1 0.8
Mononeuropathy 1 0.8
Vertigo 1 0.8
Hypoglycaemia 1 0.8
Benzodiazepines 1 0.8
Uncertain 18 15.3
artery surgery may reduce the risk of further stroke, 
particularly in men older than 75 years.5 There is no 
information about the incidence of new onset atrial 
fibrillation in either of the above studies, but patients 
with atrial fibrillation, associated with symptomatic 
cerebrovascular disease, are a high risk group in 
whom appropriate anticoagulant therapy reduces 
the risk of further stroke by 66%.6
The clinic was also valuable in identifying new, 
potentially treatable, risk factors, including 
hypertension, hypercholesterolaemia, diabetes 
mellitus and ensuring all patients were on optimal 
antiplatelet therapy. An additional feature of 
our service was the presence of a stroke nurse 
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specialist, to discuss the diagnosis, relative benefits 
of therapeutic interventions and lifestyle changes, 
including diet, exercise, smoking cessation and 
driving, with patients and their relatives. 
A neurovascular clinic has an important diagnostic 
role as significant numbers of patients with a label 
of “TIA” may have alternative conditions, requiring 
specific treatment. In our experience the most 
common alternative diagnoses were syncope/
arrhythmias, migraine, seizures, transient global 
amnesia, with single cases of biopsy proven temporal 
arteritis, Parkinson’s disease, subdural haemorrhage 
and cerebral metastases being recorded. Many of 
these patients required referral to other specialities 
and the development of the TIA service, with the 
co-operation of ophthalmology, neurology, vascular 
surgery and cardiology, facilitated prompt access to 
the relevant specialty.
Recent evidence10 suggests that patients with TIA 
symptoms, such as prolonged motor weakness, 
suggesting a high early stroke risk, require immediate 
in-patient assessment. For TIA patients with a low 
early risk of stroke, a rapid access TIA clinic provides a 
safe and efficient alternative to hospital admission.
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inTrODUCTiOn
Disorders of fluid and electrolyte balance are 
common in elderly patients, often manifesting as 
abnormalities in plasma sodium concentrations 
( [Na+] ). Hyponatraemia is the most important 
electrolyte disorder in elderly people and can be a 
complication of a wide variety of diseases.1 Abnormal 
sodium balance is associated with significantly 
higher mortality, patients with hyponatraemia 
having twice the risk of death compared to those 
with normal serum [Na+].2
Hyponatraemia is common in elderly in-patients 
with an incidence of over 11% in one series.3 This 
incidence rate is significantly higher than that of the 
general hospital population of 1.5%.4 The incidence of 
hyponatraemia is reported to be even higher among 
long-term care residents.5 Age-related impairment 
of renal sodium conservation and common illnesses 
in old age leading to the syndrome of inappropriate 
antidiuretic hormone (SIADH) are the principal 
causative factors of hyponatraemia in old age.6
The aim of this paper is to calculate the prevalence of 
plasma [Na+] abnormalities in an unselected series 
of elderly people presenting with acute illness to an 
acute elderly care unit. We also sought to identify 
the associated illnesses and potentially causative 
medication in those elderly patients admitted with 
deranged plasma [Na+].
MeTHODs
STUDY DESIGN
This was a descriptive cross-sectional study 
to calculate the period prevalence of sodium 
abnormalities in an elderly hospitalised population. 
The study was carried out in a busy urban teaching 
hospital, focusing on patients ≥65 years admitted with 
acute illness to the acute elderly care ward during the 
four months from January to April inclusive.
STUDY PARTICIPANTS
All patients were aged 65 years and over. We studied 
all patients admitted in a four-month period to 
an acute geriatric unit with a variety of medical 
conditions. Patients were admitted acutely from the 
emergency department or by direct referral to the 
ward by the general practitioner. 
DATA COLLECTION
Patients included in the study were identified from 
the hospital’s computerised record of admissions. 
The pattern of plasma sodium abnormalities 
in an acute elderly care ward: A cross-
sectional study
aBsTraCT
Introduction  The combination of ageing, illness, and medications can lead to 
hyponatraemia or hypernatraemia. 
Aims To describe the distribution of plasma sodium levels in older patients admitted to 
hospital.
Methods  We carried out a hospital based cross-sectional study examining 1,511 serum 
sodium concentrations ([Na+]) among 336 elderly patients and attempted to 
elucidate the cause(s) of the abnormal serum [Na+].
Results  The study population had a mean age of 81.4. Ninety-two (27.4%) patients 
had hyponatraemia and seven patients (2.1%) had hypernatraemia during their 
hospitalisation. The distribution of [Na+] results was towards the lower end 
of the normal range. The mortality rate of patients with hyponatraemia was 
14.1% and that of patients with normal serum [Na+] was 8.9%. Six patients with 
hypernatraemia died in hospital. Lower respiratory tract infection and medication 
accounted for the majority of cases. 
Conclusions  Deranged [Na+] is common among elderly patients admitted to hospital.
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Patients’ plasma [Na+] results were obtained from 
the hospital’s biochemistry results database. All 
the plasma [Na+] results for each subject were 
obtained by searching the database under both the 
patient’s name and hospital reference number. For 
the purposes of this study, we used the hospital’s 
biochemistry laboratory’s reference range of normal 
values. This defined hyponatraemia as a plasma 
[Na+] less than 132mmol/l and hypernatraemia as a 
plasma [Na+] greater than 145mmol/l. 
The conditions associated with abnormal sodium 
results were investigated retrospectively by 
examining the in-patient notes of all patients with 
an abnormal plasma [Na+]. The casenotes were 
obtained in all cases. A standardised review of 
the casenotes was undertaken. This included the 
diagnoses made on admission, all medication used 
prior to admission, the need for fluid resuscitation 
and a review of the discharge summaries. Where 
there was more than one possible cause for the 
plasma [Na+] derangement, the investigators 
came to a consensus on the most significant 
contributing factor. The in-hospital mortality rate 
for the entire group and for the hyponatraemic and 
hypernatraemic subgroups were obtained from 
routine hospital data records.
resUlTs
The study population was typical of an elderly care 
ward, with a mean age of 81.4 ± 7.1 years. During the 
four-month period, there were 336 patients admitted 
to the ward with acute illness. Each patient had 
at least one measurement of plasma [Na+] during 
their admission. Among the 336 patients, there were 
a total of 1,511 plasma [Na+] measurements. The 
median number of plasma [Na+] measurements 
per patient was three, but this ranged from one to 
twenty-six tests.
Of the 336 patients admitted, 77 (22.9%) had a 
sodium less than 132mmol/l on admission. There 
was a wide range of sodium values from 115 – 170 
mmol/l. A further 15 patients (4.5%) developed 
hyponatraemia in hospital. This gave a total of 92 
patients (27.4%) who manifested hyponatraemia 
at some stage during their hospital admission. 
Nineteen patients (5.7%) had a plasma [Na+] 
less than 125mmol/l ie moderate or severe 
hyponatraemia. Seven patients (2.1%) had a plasma 
[Na+] of greater than 145mmol/l ie hypernatraemia, 
during admission. Of this group, only one developed 
the abnormality in hospital.
The distribution of plasma [Na+] on admission has 
its central tendency towards the lower end of the 
normal range of [Na+] for the population (Figure 1). 
The mean value of plasma [Na+] for the whole patient 
population was 134.4mmol/l with the median being 
134mmol/l. The distribution has a positive skewness, 
with an extended right-hand tail in the plasma [Na+] 
distribution curve. Both extremes of the plasma [Na+] 
distribution were associated with increased mortality. 
All but one of the patients with hypernatraemia died 
in hospital. The mortality rate for the hyponatraemic 
group was 14.1% (13 deaths from 92 patients). This 
compared with a mortality rate of 8.9% among those 
patients with no abnormality in plasma [Na+]. The 
differences between these groups did not reach 
statistical significance.
Lower respiratory tract infections (40.2%) and 
adverse medication (21.7%) accounted for the 
majority of cases of hyponatraemia in this group 
of patients (Table 1). Thiazide diuretics, selective 
serotonin reuptake inhibitor antidepressants (SSRIs) 
and carbamazepine were the medications most 
commonly implicated in causing hyponatraemia. 
Only three patients (3.3%) did not have a recognised 
cause for hyponatraemia after reviewing the cases. 
All, but one of the seven patients presenting with 
hypernatraemia had a known diagnosis of dementia. 
Two of these patients had diarrhoeal illnesses. 
Four patients were nursing home residents with 
significant functional impairment. The other patient 
had a large middle cerebral artery territory infarct 
with major dysphagia. 
DisCUssiOn
One third of these consecutive acutely ill patients 
admitted to hospital had a derangement of plasma 
[Na+] at some stage during their hospitalisation. 
Hyponatraemia occurred in 27.4% of cases and 
hypernatraemia in 2.1%. These rates were higher than 
those reported in previous work, probably reflecting 
the older mean age of our patient cohort. Most of the 
abnormalities were present on admission.2,3 Overall, 
the distribution of plasma [Na+] for this population is 
to the left of the distribution in the general population, 
with a mean value at the hyponatraemic end of the 
normal range. Both high and low plasma [Na+] during 
the hospital stay was associated with tendency to 
increased hospital mortality, compared to the mortality 
rate in those patients with normal plasma [Na+].
The normal regulation of water and sodium 
balance involves the interplay of many homeostatic 
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mechanisms, including thirst perception, the actions 
of antidiuretic hormone, atrial natriuretic hormone 
and aldosterone. The normal ageing process is 
associated with significant changes in some of these 
homeostatic mechanisms.6,7 Previous studies have 
shown that thirst perception is impaired in healthy 
older compared to healthy younger individuals.8,9 In 
particular, elderly patients with dementia fail to drink 
adequately when exposed to water deprivation.10 
This is in keeping with the high proportion of 
dementia sufferers in our hypernatraemic group. 
Evidence suggests that the ageing kidney is more 
prone to sodium loss.11 The impaired diluting capacity 
of the ageing kidney coupled with an enhanced 
antidiuretic response in old age, make older 
individuals more prone to hyponatraemia.12,13 This 
may, in part, explain why our distribution curve for 
plasma [Na+] was centred at the lower end of the 
normal reference range.
Both hyponatraemia and hypernatraemia are 
markers of underlying disease and are associated 
with a poorer prognosis.2,14,15 Previous studies 
also confirm our results which suggest an 
increased mortality with hypernatraemia and 
hyponatraemia.2,14 However, our study was not 
designed to demonstrate increased mortality in 
these groups, and consequently was not sufficiently 
powered to do so.
Our cross-sectional study design provides reliable 
and important information on the distribution 
of plasma [Na+] in this elderly group. Because all 
patients had their plasma [Na+] measured on 
admission, we provide an accurate reflection of 
the prevalence of plasma [Na+] abnormalities on 
admission to hospital of elderly sick patients. There 
is little possibility for information bias in these 
results, as they come from objective data already in 
existence. However, there may be under-reporting of 
new cases occurring in hospital since not all patients 
will have repeated plasma [Na+] measurement. As 
with any cross-sectional study there are limitations 
with investigating the aetiology of plasma [Na+] 
abnormalities. The main associations we report 
with hyponatraemia are related to respiratory tract 
infections and medication. Pulmonary disease, 
particularly pneumonia, can lead to a syndrome of 
inappropriate antidiuretic hormone release, by a 
mechanism which remains unclear.16 Elderly patients, 
in particular, are predisposed to this abnormal 
antidiuretic hormone response to infection.13 
Numerous drugs prescribed for elderly patients affect 
Table 1
PRIMARY CAUSES FOR HYPONATRAEMIA
DIAGNOSIS NUMBER (%)
Acute Respiratory Tract infection 37 (40.2%)
Thiazide Diuretic 12 (13.0%)
Acute Stroke 8 (8.7%)
Heart Failure 7 (7.6%)
SSRI Antidepressant 6 (6.5%)
Bronchial Tumour 6 (6.5%)
Hypothyroidism 5 (5.4%)
Inappropriate fluid resuscitation 4 (4.4%)
Carbemazepine 2 (2.2%)
Advanced Renal Failure 1 (1.1%)
Pseudohyponatraemia- 
Hyperparaprotinaemia 1 (1.1%)
No Obvious Cause found 3 (3.3%)
Figure 1 —
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water balance. As one would expect, some of our 
hyponatraemic subjects (13%) were taking thiazide 
diuretics. Also, SSRIs were implicated as the cause 
in 6.5% of hyponatraemic cases. The association 
between SSRIs and hyponatraemia is well known, 
especially in older patients.17,18
In conclusion, we report a high prevalence of sodium 
abnormalities in hospitalised elderly patients 
with acute illness. Overall, there is a trend towards 
low plasma [Na+] in elderly hospitalised patients, 
reflecting derangement of regulatory systems 
involved in sodium and water balance due to acute 
illness and adverse medications. A smaller but 
significant proportion of elderly patients present 
to hospital with hypernatraemia. Awareness of the 
increased mortality burden of both hyponatraemia 
and hypernatraemia should alert clinicians to 
the more serious impact of illness associated 
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with plasma [Na+] abnormalities in acutely ill 
elderly patients and to respond to these metabolic 
derangements with a greater sense of urgency. 
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Ireland, similar to other Western countries, has 
an increasing ageing population. Those aged 70 
years and older account for 8% of the national 
population.1 This trend is set to continue with an 
increase in life expectancy observed in both men 
and women. There is an associated increase in the 
number of years spent with a disability, and it is 
estimated that women live four and men two extra 
years with a disability.2 About 80% of those aged 
65 years and over suffer from a chronic condition,3 
and both the prevalence of chronic conditions and 
co-morbidities increases with age. In one study over 
87% of community dwelling 75-year-olds received 
prescription drugs,4 and in a Swedish study the 
biggest rise in drug use over a 15-year period was 
among those aged 80 years and over, followed by 
those aged 60-79 years.5
Previous studies have identified inequalities in the 
management of chronic conditions such as diabetes 
and cardiovascular disease with associated risk 
factors including increasing age, female gender and 
deprivation.6-10
There are very few national or international studies 
that have attempted to quantify and examine the 
distribution of chronic disease or explore regional 
variation in prescribing for chronic conditions among 
a national elderly population. The most recent 
estimate of prevalence of chronic conditions in an 
elderly population was provided by the first Health 
and Social Service for Older People survey (HeSSOP I) 
in 200011. This was a random sample of community 
dwelling people aged 65 years or older living in 
either the Eastern or Western health boards. People 
surveyed were asked to identify from a written list 
which chronic conditions they experienced. This was 
the largest survey of elderly people in Ireland but 
only a single question focused on types of chronic 
illness. Similar to other surveys there are limitations, 
with those who experience ill health less likely to 
participate in surveys, also relying on self reported 
illness is likely to underestimate chronic conditions12. 
In addition only two health boards were sampled 
and people in nursing homes were excluded.
The potential for national claims prescribing 
databases to explore such topics is increasingly being 
recognised.5;13;14 Data are continuously collected, 
are often population based and usually contain 
individual patient level data. The primary limitation is 
lack of direct diagnosis data, therefore combinations 
of drug therapies are used as surrogate markers of 
disease e.g. insulin and diabetes.15
Regional variation in prescribing for chronic 
conditions among an elderly population 
using a pharmacy claims database
aBsTraCT
Background  Age, gender and geographical regions are recognised factors in inequalities 
in prescribing for chronic diseases in the elderly. 
Aim To compare the health board regional distribution of chronic disease among the 
elderly and to examine variation in quality prescribing across age, gender and regions.
Methods  Population based study of prescribing for chronic disease using a national pharmacy 
claims database. All individuals aged 70 years and over (n=271,518) were eligible.
Results  Over 60% of the elderly in all regions received cardiovascular related medication. 
The South Eastern, North Western and Western Health Boards had below average 
prescribing for many chronic conditions. Logistic regression identified age, gender and 
regional variations in prescribing of preventative therapies for CVD and diabetes.
Conclusion  There is a high prevalence of prescribing for chronic conditions in the 
elderly in Ireland, and there is evidence of gender, age and residing health board 
inequalities in prescribing.
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The aim of this study is to compare the regional 
distribution of chronic disease among those aged 70 
years and older and to examine variation in quality 
prescribing across age, gender and regions. 
SETTING
The Irish HSE-Primary care reimbursement services 
(HSE–PCRS) pharmacy database was used. The 
HSE-PCRS provides free health services, including 
provision of medicines, without charge to 1.2 million 
people in Ireland. Since July 2001 it incorporates all 
those aged 70 years and over. In 2004 there was an 
estimated 316,928 people aged 70 years and older 
with HSE-PCRS medical cards; one survey suggests 
over 95% uptake of the scheme.16 The HSE-PCRS 
prescription database records the unique patient 
identifying number, basic demographic information 
(age, sex and region residing), and full details of 
all items dispensed by community pharmacists 
for people within the scheme. The information is 
centrally held and coded using the WHO Anatomical 
Therapeutic Chemical (ATC) classification system.17 
The primary limitation of the prescribing database 
is the lack of information on diagnosis, thus 
combinations of drug therapies must be used as 
surrogate markers of disease. The majority of drugs 
available in Ireland are eligible for reimbursement 
under this scheme, with the exception of drugs 
provided under the ‘High Tech medicines scheme’ 
such as some anti-neoplastic, anti-rejection drugs or 
growth hormones.
Ireland is divided into eight healthcare regions. The 
largest is the Eastern Regional Health Authority 
(ERHA) with over 1.4 million people, followed by 
the Southern (SHB) and South-Eastern (SEHB) 
with 0.42-0.58 million, the Western (WHB), North-
Eastern(NEHB) and Mid Western(MWHB) have over 
0.3 million people each and the two smallest Midland 
(MHB) and North-Western (NWHB) each have over 
0.22 million people.18 The health board the patient is 
resident in is identified through the unique patient 
identification number, with each number being 
specific to the health board in which the number was 
issued. If a patient avails of healthcare in a different 
health board they will still be considered according to 
their health board of residence.
DISEASE IDENTIFICATION
A framework for identifying conditions from the 
pharmacy database was developed from the chronic 
disease classification reported by Von Korff et al, 
and Maio et al and adapted to an Irish healthcare 
system.14;15 Nine conditions were identified using the 
associated drug ATC codes, as indicated in Table 1. 
Cancer prevalence was estimated using both PCRS 
and High Tech data, but pharmacy databases 
underestimate cancer prevalence as over 70% of 
cancers do not receive drug therapy. More complete 
information on regional distribution of cancer can 
be obtained from the national cancer registry.19 In 
conditions with overlapping drug therapy only broad 
disease classification is possible e.g. CVD includes 
ischaemic conditions such as ischaemic heart disease 
(IHD), cerebrovascular and peripheral vascular 
disease (PVD), also heart failure and hypertension. In 
addition to insulin and oral hypoglycaemic agents, 
diabetic test kits were included in an attempt to 
identify those patients managed by diet only, but this 
is not likely to identify all such patients.
Quality prescribing indicators were used to compare 
patterns of prescribing across regions. The indicators 
selected were: (1) a high level of co-prescribing 
of statins with antiplatelet therapy +/- coronary 
vasodilators (markers for ischemic cardiovascular 
conditions), (2) a high level of antiplatelet prescribing 
in patients receiving coronary vasodilators (marker 
for IHD) (3) a high level of prescribing of antiplatelet 
therapy and statins in patients with diabetes,20 (4) a 
low level of long acting benzodiazepine prescribing 
in the elderly (flurazepam, chlordiazaxide and 
diazepam) and (5) low prescribing of antidepressants 
with strong anticholinergic and sedation properties 
(amitripyline, doxepin and imipramine).21
The PCRS prescribing database for 2004 covering 
the eight health boards was used. The individual 
drug or drug class was identified in the database 
using their ATC codes. The study population was 
defined as all individuals aged 70 years and over 
who were dispensed three or more items associated 
with a specific chronic condition during the 12-
month period. This restriction reduced identification 
of prescribing associated with misdiagnosis or 
incidental users.
STATISTICAL ANALYSIS
Simple chronic disease prevalence rates were 
calculated for the elderly population based on the 
total number of eligible patients aged 70 years and 
over with a medical card in each region.22
Age and sex standardised prescribing ratios (SPR) 
were calculated for each region. The SPR is similar 
to the standardised mortality ratio, where a high 
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SPR (>100) indicates that prescribing for a particular 
condition in that region is above the national 
average. The SPR ratio is the ratio of maximum to 
minimum prescribing in each category.23 Logistic 
regression was used to explore the association 
between each of the five quality prescribing 
indicators and the study population age, gender and 
regional prescribing patterns. Odds ratios and 95% 
confidence intervals are presented. The availability of 
specialist consultant services per 100,000 population 
were calculated based on the number of specialists 
employed in each HB in 2004,18 and the associated 
HB total population size. All analysis was performed 
using SAS (v 9.1 SAS institute, Cary,NC).
resUlTs
In this population 86% (271,518) of those over 70 
years received a minimum of three drug items 
for a chronic condition in 2004, and a further 8% 
received less than three items. Males accounted 
Table 1
COMBINATIONS OF DRUGS USED AS SURROGATE MARkERS OF DISEASE 
DISEASE GROUP SPECIFIC CONDITIONS ASSOCIATED MEDICATION WHO ATC CODES 
Cardiovascular 
disease (CVD)
Ischemic Heart disease (IHD),
Cerebrovascular disease,
Peripheral vascular disease (PVD) 
Antianginals e.g. Nitrates
Platelet inhibitors
C01DA & C01DA
B01AC
Arrhythmic Anti- arrhythmic warfarin C01AA05 & C01B B01AA03 
Hypertension/Heart failure
Antihypertensives
Diuretic
ACE/AIIA inhibitors 
Beta blockers
Calcium channel blockers
C02
C03
C09
C07
C08
Hypercholesteraemia Anti-lipids including statins C10
Central nervous 
system (CNS )
Parkinson’s disease L-dopa N04
Epilepsy Anticonvulsants N03
Depression psychosis Psycholeptics N05A & N06A
Anxiety Anxiolytics N05B
Sleep disturbance/Sedation Hypnotics/sedatives N05C
Dementia Antidementia N06D
Musculo-skeletal 
Rheumatoid Arthritis Anti-inflammatoryAnti-rheumatoid
M01A
M01C
Osteoporosis/Pagets disease Mineral substitutes & Vit D analogues
M05
A11CC
Gout M04
Upper Gastro-
intestinal (GI) Antiacids/ anti-ulcer A02A & A02B
Respiratory COPD/Asthma
iIpratropium
Beta-adrenergic
Glucocorticoids
R03BB 
R03A & R03C
R03BA
Diabetes
Insulin
Oral hypoglycaemics
Diabetic test kits
A10A 
A10B
V04CA
Thyroid H03
Glaucoma Ophthalmic miotics S01E
Cancer Anti-neoplastics Immunostimulants
L01 & L02
L03
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for 41% (136,473) of the total population which 
dropped to 38% in those aged 75 years or older. 
There was a significant difference in the gender 
distribution between the two age groups (p<0.001). 
Not surprisingly the highest concentration of elderly 
patients was in the most densely populated areas, 
32% in the ERHA, 16% in the SHB, 10-11% in the SEHB 
and WHB, with 6-8% distributed in the MHB, MWHB, 
NEHB and NWHB.
In Table 2 the most prevalent condition in all regions 
was cardiovascular disease with over 60% of the 
elderly population receiving regular cardiovascular 
medication, followed by CNS with over 30% on 
regular medication, musculo-skeletal and upper GI 
prescribing was between 20-30% in most regions. 
Diabetes, respiratory and thyroid conditions had a 
prevalence of between 7-17%, while glaucoma and 
cancer had the lowest prevalence at 2-6%, but cancer 
is likely to be underestimated in this population.
Table 3
VARIATION IN PREVALENCE OF CHRONIC CONDITIONS ACROSS REGIONS STANDARDISED FOR AGE AND SEX (SPRs)
RE
G
IO
N
CV
D
CN
S
M
U
SC
U
LO
-
SK
EL
ET
A
L
U
PP
ER
 G
I
RE
SP
IR
AT
O
RY
D
IA
BE
TE
S
TH
YR
O
ID
G
LA
U
CO
M
A
CA
N
CE
R
ERHA 101.7 100.6 98.1 111.8 104.8 97.7 103.0 107.3 111.4
MHB 108.2 108.2 113.5 99.6 118.5 120.5 106.7 104.9 101.8
MWHB 100.4 101.2 105.8 103.8 102.1 106.2 95.3 96.9 83.9
NEHB 99.8 105.0 99.0 104.1 102.0 111.1 96.8 90.2 99.4
NWHB 94.4 90.8 86.4 77.7 90.6 91.8 106.9 73.6 87.9
SEHB 89.4 91.9 89.1 93.5 87.9 101.9 104.4 111.4 87.8
SHB 105.6 102.9 106.1 98.5 96.7 93.9 94.6 114.0 93.6
WHB 97.2 99.1 105.3 83.5 96.7 93.7 92.9 73.2 108.3
Ratio* 1.21 1.19 1.31 1.44 1.35 1.31 1.15 1.56 1.33
*Ratio=ratio of maximum to minimum prescribing SPR
Table 2
PREVALENCE OF CHRONIC CONDITIONS AMONG ELDERLY POPULATION ACROSS HEALTH BOARD REGIONS
RE
G
IO
N
PO
P 
≥
 7
0
 Y
EA
RS
CV
D
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S
M
U
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U
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-
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A
L
U
PP
ER
 G
I
RE
SP
IR
A
-T
O
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D
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n % % % % % % % % %
ERHA 99,350 73 38 28 27 15 7 8 5 4
MHB 18,810 78 40 32 24 17 9 8 5 5
MWHB 28,271 72 37 30 25 14 8 7 5 4
NEHB 26,687 72 39 28 25 14 9 7 4 4
NWHB 21,636 68 33 24 19 13 7 8 4 4
SEHB 36,301 64 34 25 22 12 8 8 5 3
SHB 49,456 76 38 30 23 14 7 7 6 4
WHB 36,417 70 37 30 20 14 7 7 4 5
C naughtOn et al
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Prescribing for CVD, CNS, and thyroid conditions 
showed the least variation between regions (see 
Table 3). Musculo-skeletal, GI, respiratory, diabetes 
and cancer showed over a 30% variation between 
the region with the lowest and highest prescribing. 
Glaucoma had over a 50% variation but this may be 
exaggerated due to small patient numbers. There were 
persistent trends across the health boards with the 
ERHA, MHB, NEHB, and MWHB having similar or above 
average prescribing for the majority of conditions 
examined, while the NWHB, SEHB and WHB had below 
average prescribing for many of the conditions.
Table 4 shows the performance based on the quality 
prescribing indicators for CVD, diabetes and CNS 
across the regions adjusting for the effects of age 
and gender. In ischaemic CVD and diabetes those 
aged 70-74 years were more likely to receive a 
statin compared to those aged 75 years and older. 
Also statin and antiplatelet prescribing tended to 
be higher in males but this did not always reach 
statistical significance. The ERHA, MHB, SEHB and 
WHB had similar or above average stain prescribing 
in CVD, and higher co-prescribing of antiplatelet 
and statin in diabetes. In contrast the NEHB, MWHB, 
Table 5
CONCENTRATION OF SPECIALISTS CONSULTANTS PER HB RATES PER100,000 TOTAL HEALTH BOARD POPULATION
HB TOTAL HB POPULATION GERIATRICIAN CARDIOLOGIST
ENDOCRINE/
DIABETIC
ADULT 
PSYCHIATRY
PSYCHIATRY OF 
OLD AGE
n n rate n rate n rate n rate n rate
ERHA 1,401,314 19 1.4 25 1.8 15 1.1 62 4.4 5 0.4
MHB 225,588 2 0.9 3 1.3 0 0.0 9 4.0 2 0.9
MWHB 339,930 4 1.2 2 0.6 2 0.6 14 4.1 2 0.6
NEHB 344,926 5 1.4 2 0.6 2 0.6 12 3.5 3 0.9
NWHB 221,376 5 2.3 2 0.9 0 0.0 11 5.0 2 0.9
SEHB 423,540 8 1.9 3 0.7 3 0.7 16 3.8 4 0.9
SHB 580,605 8 1.4 7 1.2 4 0.7 25 4.3 1 0.2
WHB 380,057 6 1.6 4 1.1 5 1.3 18 4.7 2 0.5
Table 4
ODDS RATIOS AND 95% CI FOR QUALITY PRESCRIBING INDICATORS IN CVD, DIABETES & CNS
CARDIOVASCULAR DISEASE DIABETES CENTRAL NERVOUS SYSTEM
Statins in 
ischaemic CVD
Antiplatelet with 
coronary dilators
Antiplatelet & 
statin 
Long acting 
benzodiazepines
Anticholanergic 
antidepressants
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
70-74 yrs 2.17 2.12-2.22 1.23 1.16-1.30 1.62 1.53-1.70 1.35 1.28-1.42 1.30 1.23-1.37
Male 1.10 1.08-1.12 1.04 0.98-1.09 1.02 0.97-1.08 1.01 0.96-1.06 0.99 0.94-1.04
ERHA 1.11 1.09-1.14 1.04 0.98-1.09 1.37 1.30-1.45 1.16 1.10-1.21 0.85 0.80-0.89
MHB 1.47 1.41-1.54 0.98 0.88-1.09 1.98 1.79-2.19 0.93 0.84-1.02 1.14 1.04-1.25
MWHB 0.82 0.79-0.85 0.83 0.76-0.91 0.72 0.66-0.79 1.27 1.18-1.37 0.71 0.64-0.78
NEHB 0.81 0.78-0.84 0.81 0.74-0.89 0.72 0.66-0.79 1.16 1.07-1.25 0.91 0.83-1.0
NWHB 0.86 0.83-0.90 1.08 0.98-1.20 0.73 0.66-0.82 0.69 0.62-0.77 1.15 1.04-1.27
SEHB 1.12 1.07-1.16 1.06 0.97-1.16 0.95 0.88-1.03 1.01 0.93-1.09 1.13 1.05-1.22
SHB 0.86 0.83-0.88 1.18 1.09-1.27 0.78 0.73-0.84 0.85 0.79-0.91 1.21 1.13-1.29
WHB 1.04 1.00-1.08 0.95 0.87-1.03 0.95 0.88-1.03 0.78 0.72-0.85 1.10 1.03-1.19
1. Ischaemic conditions= patient receiving antiplatelet or coronary artery vasodilators; 2. Coronary vasodilators 
e.g. nitrates are used as a surrogate marker for angina; 3. Reference group = age ≥75 years & female gender; 
4. Individual regions are compared to all other regions.
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NWHB and SHB had consistently lower levels 
of prescribing of these therapies in the elderly 
population after standardising for different gender 
and age structures within the regions.
The quality prescribing indicators related to CNS 
prescribing show that the 70-74 year age group were 
more likely to receive long acting benzodiazepines 
or antidepressants with anticholenergic side-effects 
than those aged 75 years and older, however there 
were no gender differences. The prescribing of the 
two drug types appear inversely related. Long acting 
benzodiazepines were more likely to be prescribed 
in the ERHA, MWHB, NEHB, while anticholinergic 
antidepressants were more likely to be prescribed in 
the MHB, NWHB, SEHB, SHB, and WHB.
Table 5 shows the concentration of specialist 
consultants per HB. There is little association between 
number of consultant specialist and the prevalence 
or pattern of prescribing in chronic conditions, 
except for CVD. Regions with a higher number of 
cardiologists per 100,000 population tend to have 
higher prescribing of cardiovascular medication, 
these regions also performed better on the CVD and 
diabetes quality prescribing indicators. Concentration 
of geriatricians was not proportional to the size of the 
regional populations. The ERHA had 1.4 geriatricians 
per 100,000 population which is less than both 
the NW and SE health boards with smaller elderly 
populations. There was no obvious trend between 
psychiatric consultants and prescribing in CNS 
conditions or in the CNS quality prescribing indicators.
DisCUssiOn
This study, based on pharmacy claims data, suggests 
a high prevalence of chronic conditions among the 
elderly population. In each of the health boards 
over 60% of those aged 70 years and older were 
prescribed regular cardiovascular medication. There 
was also a significant number receiving treatment 
for CNS, musculo-skeletal and gastrointestinal 
conditions. The other conditions had a lower 
prevalence but added to the burden of chronic 
disease among this population. The SPRs indicate 
that there is a 20%-40% variation in the treatment of 
the most common conditions between the regions. 
Quality prescribing indicators provide more detailed 
insight into these regional differences. Those aged 
70-74 years are more likely to receive CVD and 
diabetic preventative therapy than those aged 75 
years and over while elderly men with CVD are more 
likely than elderly women to receive statin therapy, 
but this gender differences is not statistically 
different in other conditions.
Direct comparison of disease prevalence with the 
HeSSOP I study is difficult because of the variation 
in the disease definitions used; also the population 
in the current study is older and includes people in 
nursing homes. However for many conditions there 
is broad agreement. In HeSSOP I, CVD was identified 
by 56% of the population compared to 60-70% in 
our study and the reported prevalence in HeSSOP I of 
CNS conditions (47%) respiratory (14%) and diabetes 
(6%) were similar to that identified in our study. The 
widest discrepancy was seen in musculo-skeletal 
conditions, in HeSSOP I this was reported by 46% of 
the population compared to 20-30 % in our study. 
In addition upper GI conditions in HeSSOP I was 
confined to peptic ulcers which was reported by 6% 
of the population.11
The current study has identified variation in 
prescribing practices across the regions which can 
be explored using robust prescribing indicators. 
Current European CVD guidelines and clinical trials 
recommend statin therapy in all patients with 
established cardiovascular disease and diabetes, 
regardless of age and gender.20, 24, 25 This study suggests 
that statins are under prescribed in those aged 75 
years and over, females and in some regions. The 
MWHB, NEHB, NWHB, SHB had 15-30% less prescribing 
of preventative therapies for patients with ischaemic 
CVD or diabetes compared to the rest of the country. 
Age and sex differences in CVD prescribing have been 
reported elsewhere,26, 27 but there are few studies 
looking at regional variation. This study is similar 
to others which found that prescribing for chronic 
conditions is not uniform within countries with the 
same healthcare systems.28-30
We find evidence of wide disparities in prescribing 
for chronic conditions between the regions after 
adjusting for the age and gender differences in the 
regional populations. The reasons are likely to be 
mutifactorial but possible explanations are genuine 
differences in the health status of individuals within 
regions, or a more compelling factor may be the 
level of primary, secondary and specialist healthcare 
provision within the regions. Cardiovascular disease 
has only a 20% variation in prevalence across the eight 
regions, but CVD quality prescribing indicators show 
that patients in some regions are 10-20% less likely to 
receive a statin than others. Disparity is also apparent 
in prescribing secondary preventative therapies 
C naughtOn et al
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in diabetes. Elderly patients with diabetes in the 
midlands region, which participated in the ‘Diabetic 
Shared Care Scheme’, are nearly twice as likely to 
receive antiplatelet and statin therapy compared to 
other regions especially MWHB, NEHB and SHB.
The NWHB had the lowest prevalence for nearly all the 
conditions investigated and the lowest performance 
in the quality prescribing indicators. This region is 
also recognised as having the lowest concentration 
of healthcare service provision. In contrast, the 
Eastern region has the highest concentration of acute 
hospital and specialist services. In our analysis the 
ERHA had above average drug treatment for all the 
conditions investigated including higher prescribing 
of preventative therapies in CVD and diabetes and 
low use of antidepressants with anticholinergic 
side-effects. There is a broad association between 
number of cardiologists employed in the health 
boards and both the identification of and quality 
prescribing indicators in CVD. Regions with the highest 
concentration of cardiologists (ERHA and MHB) had 
higher levels of statin prescribing in both patients 
with CVD and diabetes than regions with less than 
one cardiologist per 100,000 population (NWHB, 
NEHB and MWHB). Prescribing in the SEHB and MHB 
may be influenced by proximity to the ERHA and 
perhaps easier referral to cardiologists.
Concentration of specialist services is one possible 
factor in explaining regional variation but others 
are control of drug budgets, individual health 
board priorities, patient access to services, patient 
education and socioeconomic status. More specific 
research is required to fully explain the observed 
variations and to determine whether this applies 
across all age groups.
STUDY LIMITATIONS
Using a pharmacy database to estimate prevalence 
is a new methodological approach and needs to be 
further validated against Irish survey data ideally 
with clinical evidence of diagnosis. Validation against 
such data would allow for identification of under 
or overestimation of prevalence of a condition. In 
this database a condition which is not managed 
with standard medication or for which regular 
medication is not prescribed e.g. musculo-skeletal 
disease will be underestimated, while prophylactic 
use of medication e.g. proton pump inhibitors in GI 
conditions may overestimate disease prevalence. 
The database does not contain information on 
patient socioeconomic status, or whether the 
original prescription was given by a GP or specialist 
consultant. Therefore it was not possible to control 
for these factors in our analysis. 
COnClUsiOn
There is a lack of primary data estimating disease 
prevalence in the Irish population. The HSE-PCRS 
pharmacy claims database can be used to identify 
disease prevalence and regional variation in those 
aged 70 years and older. Significant regional variation 
in the prescribing for chronic diseases, adjusting 
for population age and gender, was observed. In 
particular the very elderly, women and those living 
in more isolated regions such as the north-western 
and north-eastern areas appear less likely to receive 
optimal treatment for certain conditions. Current 
levels of specialist health care provision within these 
regions may be a factor but more in depth research is 
required to validate and explain these observations 
and make recommendations on the appropriate 
provision of health care in this population.
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inTrODUCTiOn
Parasuicide remains a cause for concern in Ireland1 
with an annual incidence of more than 10,000 
cases reported by the National Parasuicide Registry. 
Drug overdoses are the most common method of 
parasuicide in Ireland making up more than 75% of 
all incidents, and paracetamol remains one of the 
top three drugs involved in these cases.2 It has been 
shown previously that paracetamol overdoses are 
often spontaneous or impulsive acts3 and the ready 
availability of over-the-counter products allows 
easy access to large quantities of tables. In October 
2001, legislation was introduced in Ireland to restrict 
the pack-size of single-ingredient paracetamol 
preparations. Under this legislation, non-pharmacy 
retail outlets may supply single-ingredient 
paracetamol products provided that; “in the case of 
dosage units each of which contains… not more than 
500mg, the pack-size does not exceed 12 such units.”4
The legislation also prohibits the sale of multiple 
packs of paracetamol in the course of a single 
transaction. Pharmacy outlets may supply more 
tablets at the discretion of an authorised person in 
the pharmacy. A major determinant in the outcome 
of paracetamol poisoning is the number of tablets 
taken in the overdose. A limit on the number of 
tablets available for purchase should reduce the 
number of tablets being taken in overdose. In 
other countries with similar legislation, smaller 
pack-sizes have been associated with a fall in the 
number of fatalities due to paracetamol, and a fall 
in the number of people attending liver units after 
paracetamol overdoses.5 In 1997, recommendations 
on pack-size were issued by the Irish Medicines Board 
and restrictions were implemented on a voluntary 
basis. These voluntary restrictions did not appear 
to have any impact on incidents of self-poisoning 
however,6 possibly due to non-compliance by 
retailers.7 This study asks the question; has legislation 
governing the pack-size of paracetamol products had 
any effect on the severity of paracetamol overdoses 
in Ireland?
MeTHODs
The National Poisons Information Centre (NPIC) 
in Ireland receives enquiries about overdose cases 
from all general hospitals in the Republic of Ireland. 
We carried out a retrospective study of paracetamol 
enquiries received by the NPIC during two 24-
month periods before and after October 2001. NPIC 
records were reviewed by a single investigator to 
identify cases of paracetamol overdoses. Inclusion 
criteria for our data-set were all acute deliberate 
overdoses involving single-ingredient tablet or 
capsule formulations in patients over 10 years of age. 
Pack-size legislation reduces severity of 
paracetamol overdoses in Ireland
aBsTraCT
Background  Legislation was introduced in Ireland in October 2001 to control the sale of 
paracetamol in non-pharmacy outlets. Preparations are now limited to 12 tablets 
per pack and only one pack can be sold per transaction.
Aim To assess the impact of this legislation on acute deliberate paracetamol overdoses.
Methods  We reviewed acute deliberate paracetamol overdoses reported during two 24-
months periods before and after October 2001. We grouped cases according to the 
number of tablets taken and compared the periods using chi-square and Mann-
Whitney tests. 
Results  The number of tablets taken in acute deliberate paracetamol overdose fell 
significantly after October 2001 (χ2 =11.663, P=0.0029). Fewer cases involved 12-24 
tablets (U=74, P<0.001) and fewer cases involved more than 24 tablets (U=131.5, 
P=0.0006)
Conclusion  Legislation controlling sale and packaging of paracetamol preparations 
appears to be associated with a significant fall in the number of tablets taken in 
acute deliberate paracetamol overdoses.
E Donohoe, 
N Walsh, 
JA Tracey
National Poisons 
Information Centre, 
Beaumont Hospital, 
Dublin 9
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Overdoses were classified as acute if they occurred 
as a once-off incident over a short period of time. 
Exclusion criteria were children under 10, chronic 
overdose, and staggered overdoses. Also excluded 
were any cases where the number of tablets taken in 
the overdose not known at the time of the enquiry. 
STATISTICAL ANALYSIS
We performed a Relative Risk assessment on the 
number of paracetamol overdoses relative to the 
total number of deliberate self-poisonings reported 
during the same period. We then analysed our data 
by grouping the cases according to the number of 
tablets taken (0-12, 13-24, >24). We used the non-
parametric Chi square test to compare the incidence 
of cases in each group before and after legislation 
was introduced. We then assessed each group using 
directional Mann-Whitney tests to determine where 
changes had occurred. P values less than 0.05 were 
considered statistically significant. 
resUlTs
A total of 2132 paracetamol overdoses met the 
inclusion criteria for this study; 1198 cases in the 
period before October 2001, and 934 cases in the 
period after October 2001. The ratio of paracetamol 
overdoses to deliberate self-poisoning cases 
remained the same before and after October 2001 
(Table 1). There was, however, a significant change in 
the size of acute deliberate paracetamol overdoses 
after introduction of pack-size restrictions 
(χ2 = 11.663, P = 0.0029) (Table 2). There was a small 
but not significant decrease in the number of cases 
involving 12 tablets or less (UA = 253.5, P(1) =0.242). 
There was a significant decrease in the number of 
cases involving 13-24 tablets (UA =74, P(1) <0.001). 
There was also a significant drop in the number of 
cases involving potentially hepatotoxic doses of 
paracetamol (i.e. more than 24 tablets) 
(UA = 131.5, P(1) = 0.0006). 
DisCUssiOn
It has been suggested that smaller pack-sizes of 
paracetamol preparations can reduce paracetamol 
related morbidity and mortality.8 In the majority 
of cases, the number of tablets ingested in a 
paracetamol overdose largely determines the 
outcome; it is rare for doses <150mg/kg to cause 
toxicity in patients unless additional risk factors 
are present.9 Over-the-counter preparations of 
paracetamol in Ireland contain no more than 500mg 
of the drug. An average sized adult of 60-70kg 
can tolerate no more than 18-20 tablets without 
toxicity. Single packets of paracetamol preparations 
available in non-pharmacy retail outlets previously 
contained up to 24 tablets (12g). The main aim of 
pack-size restrictions is to reduce the severity of toxic 
paracetamol overdoses. Similar legislation introduced 
in Britain in 1998 seemed to result in less severe 
paracetamol poisoning,10,11 In this study, we looked at 
the size of paracetamol overdoses in terms of tablets 
taken. We observed a significant drop in the number 
of cases involving between 12 and 24 tablets. There 
was also a significant drop in the number of overdoses 
involving more than 24 tablets of paracetamol. 
The spontaneous nature of paracetamol overdoses 
implies that patients will often take whatever 
Table 2
PARACETAMOL OVERDOSES GROUPED ACCORDING TO NUMBER OF TABLETS TAkEN
# OF TABLETS BEFORE LEGISLATION (N=1198) AFTER LEGISLATION (N=934) P
0-12 379 358 0.242
13-24 412 272 <0.001
>24 407 304 0.0006
χ2 = 11.663, P=0.0029
Table 1
TOTAL PARACETAMOL OVERDOSES EXPRESSED AS A PROPORTION OF TOTAL DELIBERATE SELF-POISONINGS
BEFORE 
LEGISLATION
% OF DSP
AFTER 
LEGISLATION
% OF DSP
RELATIVE RISK 
(95% CI)
Total paracetamol 1198 14.09% 934 14.10% 0.99 (0.90-1.0)
Total DSP 8502 6618
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medication is readily to hand.3 A partially used or 
unused packet of paracetamol found in the home 
will now contain a maximum of 12 tablets where 
previously it could contain up to 24. The legislation 
introduced in Ireland does not limit the number of 
retail outlets where paracetamol can be obtained. 
However, purchase of numerous packs of paracetamol 
in one outlet is not permitted. We observed no 
change in the frequency of paracetamol overdoses 
after October 2001 but the possibility of taking a 
large number of tablets, and therefore a toxic dose of 
paracetamol, has been reduced. There is no reason to 
believe that compliance by retailers will diminish in 
the future, and it is reasonable to believe that access 
to large numbers of paracetamol tablets will remain 
difficult. Further follow-up studies over a longer period 
of time will be useful to determine whether pack-size 
restrictions have continuing benefits. 
STUDY LIMITATIONS
Our study was carried out as a retrospective 
observational “before and after” study using data 
reported to the Poisons Information Centre. We 
acknowledge that other unknown factors may have 
contributed to a drop in our actual numbers, but by 
assessing the proportional incidence of paracetamol 
cases relative to total deliberate self-poisonings, we 
could allow for any underlying trends.
COnClUsiOn
There was a significant fall in the proportion of 
paracetamol overdoses involving more than 12 
tablets after October 2001. No significant change 
was seen in overdoses involving less than 12 tablets. 
It is reasonable to assume that these observations 
may be related to the reduction of paracetamol pack-
sizes from 24 tablets to 12. Legislation governing the 
sale of single-ingredient paracetamol preparations 
appears to have successfully reduced the availability 
of large quantities of tablets and thus the severity of 
paracetamol overdoses.
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inTrODUCTiOn
In 1922 the island of Ireland was partitioned into 
Northern Ireland (NI) and Ireland. The last census to 
be undertaken of the island as a whole was in 1911 
and the last all-Ireland Registrar General’s report was 
in 1921. Since then each jurisdiction has produced 
separate demographic statistics, separate recording 
of vital registration events and health policy has 
developed along separate lines. 
 
There has been a realisation in recent years that the 
respective health strategies have much in common 
and that it made sense for such close neighbours to 
share information and see what could be learnt from 
the others’ experiences. This is particularly so in the 
field of health inequalities which is now a priority 
for both governments. Research into inequalities 
in health has been slow to develop on the island1 
and it has been suggested that the health status of 
Ireland’s diaspora has probably been better studied 
than those who remained behind.2 Research has 
also progressed on independent, albeit parallel 
lines within the two jurisdictions and there has 
been a noticeable paucity of studies that have 
attempted to compare and contrast the relative 
health of the two populations or the magnitude 
and relative distribution of health inequalities. This 
has been due to a combination of methodological 
difficulties, differing perspectives and, initially, a 
lack of political will. 
Obtaining comparable data for socio-economic 
and health indicators has been a major problem 
for researchers. NI has tended to follow the UK and 
use deprivation indicators such as the Townsend3 
or Carstairs;4 Ireland has developed a modification 
of these that is quite distinct from either.5 
Alternatively, researchers in Ireland sometimes 
also use the proportion of GMS patients as a proxy 
for low income, but this has no equivalent in NI 
where, as in the rest of the UK, all services are free 
at the point of delivery. It was only recently that a 
comparison of mortality by cause, sex and socio-
economic status in Ireland and NI was attempted 
though the researchers experienced difficulties 
with data incompatibilities at all stages, occupation 
classifications proving particularly troublesome.6 
The respective Cancer Registries, because they are 
conforming to internationally agreed definitions and 
protocols, have been able to collate their findings and 
produce an all-Ireland report on the incidence and 
mortality from cancer.7 
Morbidity data are more relevant to public health8 but 
present the greatest dearth of comparable studies.9 A 
good example of the lack of coordination and missed 
Socio-economic gradients in self-reported 
health in Ireland and Northern Ireland
aBsTraCT 
Background  Research and policy related to reducing health inequalities has progressed 
separately within Ireland and Northern Ireland. This paper describes the first 
exploration of the socio-economic influences on health on the island of Ireland 
since 1922. 
Methods  Postal survey.  
Results  The response rate was 52%; 11,870 respondents.  Men reported more long-
standing illness (LLTI) or poor general health (PGH); depression was more common 
amongst women.   Socio-economic gradients in health were evident in both 
jurisdictions, with the effects of household income being particularly marked.  
Overall, morbidity levels were significantly better in Ireland than in Northern 
Ireland: adjusted odds ratio of 0.79 (95% CI 0.71- 0.88) for LLTI; 0.64 (0.57 – 0.72) for 
PGH; 0.90 (0.82 – 0.99) for depression. 
Conclusions  There is evidence of strong and similar socio-economic gradients in health 
throughout the island of Ireland. This would suggest joint policy approaches or at 
least further comparative evaluation of the initiatives in each jurisdiction.
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opportunities for North/South comparative work is 
the parallel development of health surveys. The SLÁN 
survey in Ireland10 and the Health and Wellbeing 
Survey in NI11 (modelled on the Health Surveys in 
England12) used completely different questionnaires 
and contrasting survey methods.
The development of health information systems 
with standardisation of datasets is seen as 
prerequisite for integrating public health within the 
European arena.13 However, recent reports on cross-
border cooperation in health services14 and mental 
health and social wellbeing15 have highlighted the 
absence of harmonized datasets, which is one of 
the obstacles to collaboration. Within the health 
inequalities arena this means that socio-economic 
and health status of the population be assessed 
using exactly the same measurement tools, which 
in the absence of harmonized existing datasets, 
requires a dedicated study. 
The aim of this paper is to report on an analysis of 
data from such a dedicated survey that was carried 
out simultaneously in Ireland and NI using the same 
questionnaire and survey methodology.
MeTHODs 
The data for this study was collected as part of a 
larger study comparing aspects of the primary care 
systems in the two jurisdictions. The first part of 
that study involved conducting a baseline survey of 
the health and socio-economic status of patients in 
selected practices. It is an analysis of these data that 
forms the basis for the current paper. 
Twenty practices were selected in Ireland to provide 
a representative mix of national practice according 
to location (rural, small town, city) and practice size 
(one of three groups based on whole-time-equivalent 
GPs principals).16 Practices in NI were then classified 
according to these criteria and a random selection 
of twenty practices drawn to match those in Ireland. 
A random selection of 625 patients were selected 
from the patient lists of each practice in Ireland 
and NI including no more than two people from a 
household. Randomisation was based on computer 
generated random numbers. The survey was preceded 
by a personalised letter from the patient’s GP and 
non-responders were sent two reminders, the second 
containing another copy of the questionnaire. Parents/
guardians were asked to complete questionnaires on 
behalf of patients aged less than 16 years old. Mailing 
took place during October and November 2003. 
Box 1 —
HEALTH QUESTIONS 
USED IN THE SURVEY
LLTI 
Do you have any long-term illness, health 
problem or disability which limits your daily 
activities or the work that you do? Include 
problems that are due to old age. 
Responses:   Yes:   No
GENERAL HEALTH 
In general, would you say your health is: 
Excellent; very good; good; fair; poor.
CASE-FINDING FOR DEPRESSION
Q1. During the past month, have you often felt 
bothered by feeling down, depressed or 
hopeless?  Responses:   Yes:   No
Q2. During the past month, have you been 
bothered by having little interest or pleasure 
in doing things?  Responses:   Yes:   No
The selection of variables for inclusion into the 
questionnaire was informed by those factors which 
previous studies had demonstrated to be important 
determinants of GP attendance. In addition to the 
usual demographic variables, an array of socio-
economic data was collected based on questions 
asked in the UK 2001 census. This included car 
ownership (categorised as no car, one or more car, 
two or more cars); tenure (dichotomised into renting 
and non-renting) and academic attainment (three 
levels of educational attainment; primary school 
only, secondary level, and tertiary level were used to 
accommodate differences in academic qualifications 
in Ireland and NI). The survey also captured data 
relating to gross annual household income, the 
question being identical to the one initially proposed 
for the 2001 UK census. Income from all sources 
was assessed, including earned income, pensions, 
benefits, allowances, interest or annuities etc., 
with no deductions for taxes, national insurance 
contributions, etc. Respondents were asked which 
of fourteen income bands (in pounds or Euros) best 
represented their household income. 
Health measures included the limiting long-term 
illness (LLTI) and general health questions and two 
questions on depression (see Box 1). The LLTI question 
was identical to that used in the UK 2001 census. The 
general health question has been used in both of the 
SLÁN surveys and also the Health Survey in England. 
Limitations on space and a desire to keep responder 
burden to a minimum precluded the inclusion of a 
more recognised measure of mental health status 
such as the GHQ1217 and so we used a two-question 
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instrument that has been recommended for use in a 
primary care setting as an aid for detecting patients at 
high risk of depression.18 Only adult respondents were 
asked to complete the two mental health questions.
A series of logistic regression analyses were 
undertaken to examine the relationship between 
each of the three measures of self-reported health 
and demographic and socio-economic factors within 
each jurisdiction. A final set of regression analyses 
was undertaken for the Island as a whole with 
jurisdiction entered as a covariate to compare the 
health of the respondents in Ireland and NI. 
resUlTs
The overall response rate was 52% (Ireland=50%, 
NI=54%). In Ireland almost 10% (1195) of the sample 
was returned as ‘undeliverable mail’ and were 
excluded from the study. In NI the figure was only 
3% (398). The high rate of undeliverable mail was 
most likely due to the difficulties of maintaining up-
to-date patient addresses in Ireland. For this reason, 
although the response rates were relatively similar, 
the number of respondents in NI was notably larger 
(6579) than in Ireland (5291). Respondents in Ireland 
and NI had a similar demographic profile (Table 1), 
though there were a slightly greater proportion of 
people who were never married in Ireland. Over 80% 
of people in both jurisdictions owned their own 
house and had access to at least one car, though 
the proportion renting or without a car in Ireland 
was almost twice that in NI. This may by partially 
explained by the greater proportion of city dwellers 
amongst the Irish sample. 
The age-specific rates of LLTI and poor general health 
were generally higher in NI than in Ireland (Figure 1) 
with the differences more marked for poor general 
health. The prevalence of depression does not vary 
greatly with age in either jurisdiction but, in NI, 
appears highest between the ages of 35 and 54. 
The results of the separate logistic regression 
analyses with each of the three health indicators 
as dependent are shown in Table 2. A second series 
of analyses, stratified by sex within jurisdiction was 
also undertaken but, as there were few differences, 
these are reported in the context of the overall results. 
The expected sharp increase in the likelihood of LLTI 
and poor general health with age was seen in both 
jurisdictions, though the gradients were more marked 
in NI than in Ireland. Men in both Ireland and NI 
showed greater age-related increases in the likelihood 
Table 1
BASIC DEMOGRAPHIC, SOCIAL AND SOCIO-ECONOMIC 
CHARACTERISTICS OF THE RESPONDENTS IN IRELAND 
AND NI
NI IRELAND
RESPONDENTS 5143 4175
AGE MEAN (SD) 47.9 (18.1) 47.7 (18.3)
SE
X Men 2985 (45.5%) 2297 (43.7%)
Women 3574 (54.5%) 2965 (56.3%)
M
A
RT
IA
L 
ST
AT
U
S
Single 1080 (21.4%) 1072 (26.0%)
Married 3303 (65.3%) 2534 (61.5%)
Sep/widowed/Div. 672 (13.3%) 517 (12.5%)
CA
R 
O
W
N
ER
SH
IP 0 496 (9.7%) 711 (17.2%)
1 2000 (39.1%) 1673 (40.4%)
2+ 2613 (51.1%) 1760 (42.5%)
TE
N
U
RE Not renting 4363 (85.5%) 3346 (80.9%)
Renting 742 (14.5%) 790 (19.1%)
ED
U
CA
TI
O
N
 
AT
TA
IN
M
EN
T Primary level 1520 (31.1%) 1216 (30.4%)
Secondary level 2189 (44.5%) 1706 (42.7%)
Tertiary level 1182 (24.2%) 1072 (26.8%)
LO
CA
TI
O
N
Rural 1893 (37.3%) 1424 (34.5%)
Small town 973 (19.2%) 452 (11.0%)
Large town 1528 (30.1%) 1048 (25.4%)
City 682 (13.4%) 1199 (29.1%)
IN
CO
M
E 
BA
N
D
Lowest 759 (15.6%) 926 (23.3%)
2nd 741 (15.2%) 615 (15.5%)
3rd 659 (13.5%) 545 (13.7%)
4th 974 (20.2%) 691 (17.4%)
5th 884 (18.1%) 573 (14.4%)
6th 642 (13.2%) 459 (11.6%)
Highest 222 ( 4.5%) 157 ( 4.0%)
of poor general health than women. The association 
between age and depression was markedly different 
to that of the other two health indicators. After 
controlling for other socio-demographic factors, in 
Ireland there was a gradual decline in the prevalence 
of depression with age for women, such that a woman 
aged 75 or over was only half as likely to suffer from 
depression as one aged 16-24. A marked increased 
likelihood of depression in middle age was evident for 
both sexes in NI and for men in Ireland.
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People with lower educational attainment and of 
lower socio-economic status were more likely to suffer 
from poorer health however measured, though the 
relationship with indicators of material deprivation 
varied somewhat between jurisdictions and according 
to the measure of health status. Tenure was more 
strongly linked with LLTI and poor health in NI than 
in Ireland, though for depression the converse was 
true. Educational attainment was more predictive 
of poor health in Ireland. Household income levels 
were strongly linked to health status with similar 
steep gradients evident in both jurisdictions. The 
slightly more muted relationship between income 
and likelihood of depression in Ireland was due to the 
virtual absence of an association between income and 
depression for Irish women.
Table 3 shows the results of the final regression 
models for the island of Ireland as a whole. As the 
data are combined, the odds ratios here are almost 
an average of those presented earlier. Women were 
respectively 22% and 23% less likely to have a LLTI or 
to have poor general health and 30% more likely to 
suffer from depression. When age, gender and socio-
economic factors had been considered, there was 
no significant association between marital status 
and the prevalence of LLTI though single people 
reported better general health and less depression 
while widowed, separated or divorced respondents 
had poorer general health and more depression. The 
main point of interest of this table is the comparison 
of health status in the two jurisdictions, which 
shows NI to be in the less favourable position. All 
other things considered, respondents in Ireland were 
21% (95% confidence intervals 12-29%) less likely to 
have a LLTI, 36% (95%CI 28-43%) less likely to report 
poor general health and 10% (1-18%) less likely to 
suffer from depression, than people in NI. 
DisCUssiOn
To the authors knowledge this is the first time 
that the same questions have been asked to 
assess both socio-economic status and health 
in a large-scale survey in both jurisdictions, 
thereby obviating problems of comparability and 
contemporaneousness. The shortcomings of the 
study should be acknowledged. The response 
rate raises concerns about response bias and the 
representativeness of the results to the wider 
population. Inaccuracies in the GP lists, which were 
used as the sampling frame, may have contributed 
to the low response rate, especially in Ireland where 
there is no universal registration and therefore it 
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Figure 1 —
VARIATIONS IN 
PREVALENCE OF 
LLTI, POOR GENERAL 
HEALTH AND 
DEPRESSION BY AGE 
IN IRELAND AND NI
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Table 2
THE ASSOCIATION BETWEEN HEALTH AND DEMOGRAPHIC, SOCIAL AND SOCIO-ECONOMIC FACTORS FOR EACH 
JURISDICTION SEPARATELY. DATA REPRESENTS THE RESULTS OF MULTIPLE LOGISTIC REGRESSION ANALYSES (ODDS 
RATIOS AND 95% CONFIDENCE INTERVALS) WITH HEALTH MEASURES AS THE DEPENDENT 
LLTI GENERAL HEALTH ‘POOR’ DEPRESSION *
N. Ireland Ireland N. Ireland Ireland N. Ireland Ireland
AGE P< 0.001 P< 0.001 P< 0.001 P< 0.001 P< 0.001 P= 0.011
16-24 1.00 1.00 1.00 1.00 1.00 1.00
25-34 1.7 (1.1, 2.6) 1.2 (0.8, 1.8) 1.8 (1.1, 2.9) 1.2 (0.7, 2.1) 1.4 (1.0, 1.8) 0.9 (0.7, 1.2)
35-44 2.4 (1.6, 3.6) 1.4 (0.9, 2.1) 2.8 (1.8, 4.5) 1.7 (1.1, 2.8) 1.8 (1.3, 2.4) 0.9 (0.7, 1.3)
45-54 3.4 (2.3, 5.2) 1.9 (1.3, 2.8) 4.7 (2.9, 7.5) 2.4 (1.5, 3.9) 1.7 (1.2, 2.2) 0.9 (0.7, 1.2)
55-64 5.5 (3.6, 8.3) 3.2 (2.2, 4.7) 6.4 (4.0, 10.3) 4.1 (2.5, 6.7) 1.2 (0.8, 1.6) 0.7 (0.5, 0.9)
65-74 6.1 (3.9, 9.4) 4.8 (3.2, 7.2) 6.5 (4.0, 10.6) 4.7 (2.8, 7.7) 0.8 (0.5, 1.1) 0.6 (0.4, 0.9)
75+ 9.5 (6.0, 15.1) 6.1 (3.9, 9.4) 7.2 (4.3, 11.9) 4.6 (2.7, 7.8) 0.8 (0.6, 1.2) 0.6 (0.4, 0.9)
SEX P= 0.002 P= 0.001 P= 0.073 P= 0.150 P= 0.001 P<0.001
Male 1.00 1.00 1.00 1.00 1.00 1.00
Female 0.78 (0.69, 0.92) 0.77 (0.65, 0.90) 0.87 (0.74, 1.01) 0.87 (0.73, 1.05) 1.24 (1.01, 1.41) 1.37 (1.19, 1.58)
MARITAL STATUS P = 0.171 P = 0.716 P= 0.236 P= 0.237 P= 0.902 P= 0.003
Single 1.00 1.00 1.00 1.00 1.00 1.00
Married 1.26 (0.98, 1.60) 0.91 (0.72, 1.15) 1.25 (0.96, 1.63) 1.24 (0.95, 1.62) 1.00 (0.82, 1.23) 0.96 (0.79, 1.17)
Sep/Wid/Div 1.26 (0.94, 1.68) 0.97 (0.71, 1.31) 1.22 (0.90, 1.66) 1.28 (0.92, 1.77) 1.05 (0.81, 1.36) 1.45 (1.10, 1.90)
TENURE P= 0.002 P= 0.782 P< 0.001 P= 0.343 P= 0.237 P< 0.001
Not renting 1.00 1.00 1.00 1.00 1.00 1.00
Renting 1.42 (1.14, 1.76) 0.97 (0.77, 1.21) 1.71 (1.37, 2.14) 1.29 (0.88, 1.45) 1.13 (0.92, 1.38) 1.46 (1.12, 1.77)
EDUCATION P= 0.305 P= 0.032 P= 0.001 P<0.001 P= 0.144 P= 0.002
Primary level 1.00 1.00 1.00 1.00 1.00 1.00
Secondary level 0.89 (0.74, 1.06) 0.86 (0.71, 1.05) 0.69 (0.57, 0.82) 0.71 (0.58, 0.86) 0.97 (0.82, 1.15) 0.80 (0.67, 0.95)
Tertiary level 0.86 (0.68, 1.07) 0.72 (0.56, 0.92) 0.54 (0.42, 0.69) 0.45 (0.34, 0.61) 0.83 (0.68, 1.02) 0.69 (0.56, 0.86)
CAR AVAILABILITY P= 0.08 P= 0.006 P= 0.004 P= 0.001 P= 0.002 P= 0.085
0 1.00 1.00 1.00 1.00 1.00 1.00
1 0.88 (0.67, 1.14) 0.80 (0.63, 1.00) 0.93 (0.72, 1.22) 0.72 (0.57, 0.92) 0.83 (0.65, 1.06) 0.84 (0.68, 1.04)
2+ 0.74 (0.55, 0.99) 0.64 (0.49, 0.84) 0.69 (0.51, 0.94) 0.57 (0.42, 0.76) 0.66 (0.51, 0.87) 0.76 (0.60, 0.97)
INCOME BAND P< 0.001 P< 0.001 P< 0.001 P< 0.001 P< 0.001 P< 0.001
Lowest 1.00 1.00 1.00 1.00 1.00 1.00
2nd 0.82 (0.65, 1.04) 0.93 (0.73, 1.18) 0.74 (0.59, 0.94) 0.79 (0.61, 1.01) 0.81 (0.64, 1.01) 1.08 (0.86, 1.35)
3rd 0.52 (0.40, 0.67) 0.63 (0.48, 0.83) 0.43 (0.33, 0.57) 0.60 (0.45, 0.80) 0.59 (0.47, 0.76) 0.83 (0.65, 1.06)
4th 0.44 (0.34, 0.57) 0.49 (0.37, 0.65) 0.40 (0.30, 0.52) 0.41 (0.30, 0.56) 0.49 (0.39, 0.62) 0.72 (0.56, 0.91)
5th 0.39 (0.29, 0.52) 0.49 (0.36, 0.68) 0.39 (0.29, 0.53) 0.34 (0.23, 0.50) 0.42 (0.32, 0.54) 0.59 (0.45, 0.78)
6th 0.23 (0.16, 0.33) 0.55 (0.39, 0.78) 0.23 (0.18, 0.34) 0.23 (0.14, 0.37) 0.38 (0.28, 0.51) 0.61 (0.45, 0.83)
Highest 0.19 (0.10, 0.29) 0.24 (0.12, 0.46) 0.23 (0.13, 0.40) 0.13 (0.05, 0.38) 0.29 (0.19, 0.44) 0.52 (0.33, 0.80)
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Table 3
THE ASSOCIATION BETWEEN HEALTH AND DEMOGRAPHIC, SOCIAL AND SOCIO-ECONOMIC FACTORS FOR THE WHOLE 
ISLAND OF IRELAND. DATA REPRESENTS THE RESULTS OF MULTIPLE LOGISTIC REGRESSION ANALYSES (ODDS RATIOS AND 
95% CONFIDENCE INTERVALS) WITH HEALTH MEASURES AS THE DEPENDENT
LLTI GENERAL HEALTH ‘POOR’ DEPRESSION 
AGE P< 0.001 P< 0.001 P< 0.001
16-24 1.00 1.00 1.00
25-34 1.45 (1.09, 1.92) 1.50 (1.05, 2.14) 1.15 (0.94, 1.40)
35-44 1.89 (1.42, 2.50) 2.29 (1.63, 3.22) 1.34 (1.09, 1.65)
45-54 2.64 (1.99, 3.49) 3.55 (2.54, 4.98) 1.23 (0.99, 1.52)
55-64 4.32 (3.25, 5.73) 5.33 (3.80, 7.49) 0.91 (0.73, 1.13)
65-74 5.41 (4.02, 7.28) 5.72 (4.03, 8.12) 0.68 (0.53, 0.86)
75+ 7.75 (5.65, 10.64) 6.04 (4.19, 8.70) 0.71 (0.54, 0.92)
SEX P< 0.001 P= 0.017 P<0.001
Male 1.00 1.00 1.00
Female 0.78 (0.70, 0.87) 0.87 (0.77, 0.97) 1.30 (1.18, 1.42)
MARITAL STATUS P = 0.555 P = 0.045 P= 0.021
Single 1.00 1.00 1.00
Married 1.08 (0.91, 1.28) 1.26 (1.04, 1.52) 1.00 (0.86, 1.15)
Sep/Wid/Div 1.12 (0.91, 1.37) 1.26 (1.01, 1.57) 1.24 (1.03, 1.49)
TENURE P= 0.022 P< 0.001 P< 0.001
Not renting 1.00 1.00 1.00
Renting 1.20 (1.03, 1.40) 1.42 (1.20, 1.67) 1.28 (1.12, 1.47)
EDUCATION P= 0.012 P< 0.001 P= 0.002
Primary level 1.00 1.00 1.00
Secondary level 0.87 (0.76, 0.99) 0.70 (0.61, 0.80) 0.88 (0.78, 0.99)
Tertiary level 0.79 (0.67, 0.93) 0.50 (0.42, 0.61) 0.77 (0.66, 0.89)
CAR AVAILABILITY P< 0.001 P<0.001 P< 0.001
0 1.00 1.00 1.00
1 0.84 (0.71, 0.99) 0.81 (0.68, 0.97) 0.84 (0.72, 0.98)
2+ 0.69 (0.56, 0.84) 0.62 (0.50, 0.76) 0.71 (0.59, 0.85)
INCOME BAND P< 0.001 P< 0.001 P< 0.001
Lowest 1.00 1.00 1.00
2nd 0.88 (0.75, 1.04) 0.76 (0.64, 0.90) 0.94 (0.80, 1.10)
3rd 0.57 (0.47, 0.69) 0.49 (0.40, 0.60) 0.71 (0.60, 0.85)
4th 0.47 (0.39, 0.57) 0.40 (0.33, 0.49) 0.60 (0.51, 0.72)
5th 0.45 (0.36, 0.55) 0.38 (0.30, 0.48) 0.51 (.042, 0.61)
6th 0.35 (0.27, 0.45) 0.23 (0.17, 0.31) 0.49 (0.39, 0.60)
Highest 0.20 (0.13, 0.31) 0.20 (0.12, 0.33) 0.39 (0.29, 0.53)
JURISDICTION P< 0.001 P< 0.001 P= 0.033
NI 1.00 1.00 1.00
Ireland 0.79 (0.71, 0.88) 0.64 (0.57, 0.72) 0.90 (0.82, 0.99)
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is difficult to keep patient lists current. Even in NI, 
where central monitoring of patient registration 
occurs, it is known that there are inaccuracies in 
the lists with an inflation (compared to census 
estimates) of approximately 6% and address 
inaccuracies of perhaps 20% in some practices. The 
low response rates are similar to other field studies, 
for example 53% for the 2001 SLAN survey (Friel S, 
personal communication) and perhaps reflects a 
growing disenchantment or survey fatigue amongst 
the general population. 
The study has demonstrated marked socio-economic 
gradients in self-reported health in both Ireland 
and NI. The likelihood that this represents health 
selection effects can be discounted, as it is now fairly 
well established that they have only a relatively 
minor role to play in explaining socio-economic 
gradients.19 It is difficult to know whether the 
differences in the explanatory power of the various 
indicators represents variation in the underlying 
determinants of health inequalities or, some subtle 
difference in the meaning of the indicators, as 
other studies have reported difficulties finding 
indicators that had the same understanding across 
international boundaries.20, 21 What the analyses 
do underscore is the importance of income in 
determining health status, which is in keeping with 
health inequalities research throughout Europe.22-28 
The study also shows that, when assessed using 
levels of self-reported ill-health, Ireland appears 
to be appreciably healthier than NI. This is not the 
picture that is obtained using other, ‘objective’ 
indicators of health status. Life expectancy at birth 
has been remarkably similar over the last 40 years 
in Ireland and NI29 and a comparison of all-cause 
mortality between 1989 and 1999 showed that, while 
they both compare unfavourably with the rest of 
Europe, they were 6% higher in Ireland than in NI.5 
A comparison of cancer incidence on the island of 
Ireland7 provides a mixed picture, for while incidence 
rates were very slightly higher in NI; mortality rates 
were slightly higher in Ireland. These findings may be 
due to differences in case ascertainment and/or case 
survival rates. Collectively, these objective measures 
of health suggest that the two jurisdictions enjoy 
remarkably similar levels of health, though where 
differences exist, it would appear to favour NI. There 
is therefore a dissonance between ‘objective’ and 
‘subjective’ measures of health which prompts the 
question; to what extent are these due to perceptual 
rather than ‘real’ differences?
One possibility is that self-reported measures of 
health are ‘picking up’ conditions, such as musculo-
skeletal complaints or minor psychological problems 
that are poorly reflected in mortality or cancer data. 
A comparison of national health surveys showed 
that NI has higher levels of minor psychological 
disturbance (as measured by the GHQ12) than 
the rest of the UK and (if differences in survey 
methodology are disregarded) also higher than those 
in Ireland.30 It is possible that the recent economic 
success in Ireland31 has produced a feel-good factor 
that has percolated through to produce a more 
generally favourable view of health.2 
Another possibility is that current mortality patterns 
reflect the morbidity status of previous decades but 
not current health status which is best assessed 
using the self-reported measures. If this is true then 
the better levels of self-reported health in Ireland 
now may predict a change in the trajectories of the 
relative mortality experience of the two jurisdictions.
A third possibility is that there are systematic 
differences between the two jurisdictions in the 
way that health is perceived and reported and the 
inclusion of anchoring vignettes has been proposed 
as a way of identifying and overcoming differences 
in both health expectations and reporting between 
populations.32 These describe fixed levels of health 
and responses to them can then be used to adjust the 
self ratings of health, making them more comparable 
across populations. This is something that could be 
considered as a next step before definitively concluding 
that the differences in levels of self-reported ill health 
between Ireland and NI are substantive. 
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inTrODUCTiOn
Evidence is increasingly used to inform public health 
policy and practice.1 An evidence-based approach 
requires the collection and use of high quality health 
information,2 which can identify priorities, steer the 
implementation of policies and plans and facilitate 
evaluation of interventions.3 In relation to drug 
misuse in Ireland, the current national drug strategy 
identifies the importance of valid, timely and 
comparable data on the extent of drug use as the 
cornerstone which underpins its actions.4 
Drug treatment data are viewed as an indirect 
indicator of drug misuse as well as a direct indicator 
of demand for treatment services.5 The National 
Drug Treatment Reporting System (NDTRS) is an 
epidemiological database on treated problem 
drug use in Ireland. It was established in 1990 
in the Greater Dublin Area and was extended 
in 1995 to cover other areas of the country. The 
reporting system was originally developed in line 
with the Pompidou Group’s Definitive Protocol,6 
and subsequently refined in accordance with the 
Treatment Demand Indicator Protocol.7 Data are 
collected on treatment status, demographic profile, 
current problem drug use, risk behaviour and initial 
intervention(s). Compliance with the NDTRS requires 
that one form be completed for each person who 
receives treatment for problematic drug use at each 
treatment centre in a calendar year: some clients 
are new or returning after a period of absence to 
treatment providers (“new or return clients”); some 
are continuing in treatment from the preceding year 
(“continuing clients”); and a subset of those new 
to treatment providers have never been previously 
treated (“true incident clients”).8 Service providers at 
drug treatment centres throughout Ireland collect 
data on each individual treated for drug misuse, and 
make reports to the NDTRS. At national level, staff 
at the Drug Misuse Research Division (DMRD) of 
the Health Research Board (HRB), who manage the 
NDTRS, compile anonymous, aggregated data for use 
at a local and national level. The NDTRS also provides 
data to the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA), a key component of 
the knowledge infrastructure underpinning drug 
policy for the European Union.9
There is concern over the quality of information 
used for drug policy.10 In the UK, drug treatment 
surveillance systems have been found to be 
incomplete and inaccurate.11-16 Given that the Irish 
Government endorses the intelligence role of the 
NDTRS in its drugs strategy, and that co-operation 
Completeness and accuracy of the drug 
treatment reporting system in Dublin, Ireland
aBsTraCT
Background  The National Drug Treatment Reporting System (NDTRS) is the Irish treated-
drug misuse surveillance system.
Aim To measure completeness and accuracy of the NDTRS
Methods  Cross-sectional survey of clinical records and matching NDTRS reporting forms 
of a random sample of 520 clients attending 4 Dublin treatment centres. Using 
clients’ clinical records as the gold standard, system completeness (proportion 
of sample reported to the NDTRS) and accuracy of selected variables (proportion 
of reported clients’ information on the NDTRS that matched clinical record 
information) were measured. 
Results  452/520 (87%) selected records were retrieved. The NDTRS was only 61.1% (95% CI 
56.5-65.5) complete; completeness differed across treatment centres (21.8%-85.6%, 
p<0.0001) and was greater for new and returning clients than for continuing clients 
(81.7% versus 53.9% respectively, p<0.0001). Problems were identified with the 
accuracy of some key variables.
Conclusions  Urgent actions have been taken to improve the completeness and accuracy 
of the reporting system.
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with the system is a stated action for treatment 
providers,4 we set out to estimate the completeness 
of reporting and measure the accuracy of the data 
reported to the NDTRS. 
MeTHODs
We restricted the study to statutory treatment 
centres in the Greater Dublin Area with more than 
100 clients who were treated with methadone. 
This allowed us to use the Central Treatment 
List (CTL) as a sampling frame. All individuals 
dispensed methadone in Ireland are, by statutory 
requirement, notified to this list. Eleven of the 55 
treatment centres in the Dublin area had over 100 
clients. These eleven treatment centres comprised 
46.3% of notifications to the CTL in 2001 (personal 
communication, Central Treatment List). The Dublin 
area has three health board areas and one large 
treatment centre was randomly selected from each. 
In addition, a large tertiary specialist drug treatment 
centre located in the city centre was included in 
the study. Thus, four large treatment centres were 
included in the study. 
Based on previous studies,11 13 14 we estimated that 
the completeness of the NDTRS was 70% (with a 
precision of ± 5% at the 95% confidence level) and 
the required sample size for measurement was 520. 
We randomly selected 130 records on the CTL from 
each of the study centres for the reporting year 2001. 
For each selected client, the clinical notes were 
examined for 2001 and data on each client, within 
a six-month period of entry, were extracted using a 
pre-designed data collection tool. The data collection 
tool contained key variables from the NDTRS reporting 
form: client’s case number, age, gender, date of 
treatment contact, incident versus prevalent client 
status, previous treatment status, name of main 
problem drug, route of main problem drug, frequency 
of main problem drug and lifetime injecting status. 
One author (PK) located the clinical records and 
extracted the data from each clinical file. Each client 
was identified using his/her case number. PK then 
matched the case number to the NDTRS form stored 
in the filing system at the DMRD and extracted the 
individual data already submitted to the NDTRS. 
Matching by date of birth was attempted for clients 
not initially identified by case number.
A client was classified as reported to the NDTRS if 
the client’s NDTRS form for 2001 was located in the 
filing system. The proportion of clients treated that 
were correctly reported to the NDTRS was calculated 
using a sensitivity calculation and this estimated the 
completeness of the NDTRS;17 95% confidence intervals 
(CI) were calculated around this estimate. Associations 
between treatment centre, client treatment status 
and completeness of data were tested. 
Using the clinical records as the gold standard, 
the clients’ information for a particular variable 
on the original NDTRS form was compared to the 
information extracted from the clinical record by 
PK. The accuracy of the data collected by the NDTRS 
for each of the selected variables was measured 
using a positive predictive value calculation:17 the 
denominator was the total number of clients 
classified as reported who had information 
extracted for the variable, and the numerator was 
the proportion whose corresponding information 
on their NDTRS original submission matched 
the extracted information. Clients who had no 
information in their clinical records for a particular 
variable were excluded from the denominator of 
this measurement. Ninety-five per cent confidence 
intervals were calculated around the estimates of 
accuracy for each variable. JMP-In and STATA were 
used for all data analysis.18 19 
resUlTs
Of the 520 records randomly selected, 452 (87%) were 
retrieved and reviewed; 68 records (13%) could not be 
located at the centre. Of these 452, 276 (61.1% (95% 
CI 56.5-65.5%)) of the clients receiving methadone 
treatment in the study centres were correctly 
reported to the NDTRS in 2001. Table 1 presents the 
distribution of completeness across client type and 
study centre. New and returning clients were more 
likely to be reported than those clients continuing in 
treatment from the preceding year (98/120 (81.7%) 
versus 178/330 (53.9%) respectively, p<0.01). The 
level of completeness differed across the four study 
centres and ranged between 24/110 (21.8%) and 
95/111 (85.6%), p<0.001. Stratified analysis illustrates 
that centres also varied in their completeness by 
client type. Of note, a higher proportion (78.6%) of 
continuing care cases was reported by treatment 
centre number 2 than their new and returning cases 
(62.5%). For the other three centres, the opposite 
reporting pattern was found. 
Table 2 presents the accuracy of the data reported 
to the NDTRS for each of the selected variables. The 
accuracy of the data reported to the NDTRS was 
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Table 2
ACCURACY (PREDICTIVE VALUE POSITIVE) OF SELECTED NDTRS VARIABLES
CHARACTERISTIC REPORTED (N)
PREDICTIVE POSITIVE 
VALUE (%)
95% CI
GENDER
Male 162 100.0 97.7-100.0
Female 111 96.4 91.1-98.6
AGE CATEGORIES
≤ 19 16 100.0 80.1-100.0
20-24 70 98.6 92.3-99.7
25-29 89 97.8 92.2-99.4
30-34 46 97.8 88.7-99.6
35-39 39 94.9 83.1-98.6
≥ 40 16 93.8 71.7-98.9
CLIENT TYPE
New or returning 98 95.7 89.6-98.3
Continuing 178 95.6 91.6-97.8
PREVIOUS 
TREATMENT
No 37 70.3 54.2-82.5
Yes 231 97.4 94.5-98.8
MAIN DRUG
Heroin 269 99.6 97.9-99.9
Other opiate 7 0.0
ROUTE
Inject 190 97.4 94.0-98.9
Smoke 76 73.7 62.8-88.8
Eat/drink 4 0.0
FREQUENCY
Daily 78 96.2 89.3-98.7
Less than daily use 
in last month
11 27.3 9.7-56.6
No use last month 13 23.1 8.2-50.3
EVER INJECTED 
STATUS
Yes 225 99.1 96.8-99.8
No 48 85.4 72.8-92.8
Table 1
DISTRIBUTION OF COMPLETENESS ACROSS CLIENT TYPE AND STUDY CENTRE
CHARACTERISTIC TOTAL COMPLETENESS 95% CONFIDENCE INTERVAL P VALUE*
n n %
A
LL
 C
LI
EN
TS CL
IE
N
T 
TY
PE New and 
returning
120 98 81.7 73.8-87.6
Continuing 330 178 53.9 48.5-59.2 p < 0.001
Total 450† 276
Study centre 1 111 95 85.6 77.9-90.9
Study centre 2 105 80 76.2 67.2-83.3
Study centre 3 126 77 61.1 52.4-69.2
Study centre 4 110 24 21.8 11.1-30.4 p < 0.0001
Total 452 276
N
EW
 A
N
D
 
RE
TU
RN
IN
G
 
CL
IE
N
TS
Study centre 1 28 26 92.9 77.4-98.0
Study centre 2 16 10 62.5 38.6-81.5
Study centre 3 44 41 93.2 81.8-97.7
Study centre 4 32 21 65.6 48.3-79.6 p < 0.001
Total 120 98
CO
N
TI
N
U
IN
G
 
CL
IE
N
TS
Study centre 1 83 69 83.1 73.7-89.7
Study centre 2 89 70 78.6 65.1-85.9
Study centre 3 82 36 43.9 33.7-54.7
Study centre 4 76 3 4.0 1.4-11.0 p < 0.0001
Total 330 178
*Chi square tests of difference in completeness across characteristics shown
†2 records had undetermined client type
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greater than 90% for the variables age, gender, new 
versus old client status and main problem drug. The 
data for some important variables had low levels 
of accuracy. Only 70% of true incidence cases (no 
previous treatment) were correctly reported. Non-
injector status was correctly reported for 85.4% of 
cases. Less than daily use of the main problem drug 
was correctly reported for only one-fifth of cases. 
DisCUssiOn
MAIN FINDINGS
Reporting to the NDTRS in 2001 was incomplete and 
not representative of the methadone treatment 
population in the Greater Dublin Area. Benchmarked 
against the clinical records, most variables reported 
to the NDTRS were accurate. However some key 
policy indicators, in particular true incidence and 
non-injector status, were less accurate.
STRENGTHS AND LIMITATIONS OF THE STUDY
The study sample was extracted from the CTL. Since 
it is a statutory requirement to notify all clients to 
be dispensed methadone in Ireland to this list, it is 
unlikely that the sampling frame was incomplete. 
In addition, a manual review of clinical records was 
undertaken to ensure that clients sampled were 
active in treatment at the study centres in 2001 
and therefore required a report to the NDTRS. This 
approach to measurement of completeness has 
greater internal validity than the use of incomplete 
or uncorroborated client lists12 15. The extent to which 
the clinical records represent a gold standard for 
accuracy is arguable. Since the reporting form may 
be completed by face-to-face interview, no other 
reference standard was available. However, the 
inaccurate variables of concern in this study (true 
incidence, non-injector and infrequent drug user 
status) are also important for clinical decision-
making in methadone initiation and maintenance. 
Therefore the clinical records would be expected to 
approach a gold standard for these variables. These 
results cannot be generalised outside the Greater 
Dublin Area (2% of clients dispensed methadone 
in 2001, personal communication CTL) or to clients 
not prescribed methadone. Within this population, 
we confined our study to four clinics, one of which 
(centre 4) had an extremely low completeness, 
particularly for continuing clients. While this may 
have biased the result for overall completeness 
of the system, further investigation by the NDTRS 
showed that it reflected reporting practices of 
centres in that health administrative area (personal 
communication NDTRS).
COMPARISON WITH OTHER STUDIES
The NDTRS was less complete than UK drug 
treatment monitoring systems evaluated using 
similar methods.11 13 14 However, at the time of these 
studies, UK systems only required reports of new 
clients and those returning to treatment after an 
absence of over six months, whereas the NDTRS 
required reports on all treated clients. NDTRS 
completeness for new and returning clients was 
81.7% (95% CI 73.8-87.6%) and compared favourably 
with the UK systems. Subsequent to a review in 
1999, the UK drug treatment monitoring system was 
extended to include reports on clients continuing 
in treatment from the previous year.20 Since this 
extension of reporting requirements, there has not 
been a published evaluation of the completeness 
and accuracy of UK drug monitoring systems. A 
recent paper examining the trends in demand for 
drug treatment in the South West of England from 
1996/7 to 2000/1 reported a rise in the incidence of 
treatment for drug misuse and unexplained variations 
in the pattern of reporting over the period.16 We 
found incomplete and inaccurate reporting that was 
not representative of true drug treatment service 
activity in a system requiring reports on all clients 
in treatment. This would suggest that changes in 
reporting practices of treatment providers, subsequent 
to the extension of reporting requirements, may be 
contributing to observed variations in the treatment 
population size and characteristics in the UK. There 
are no published evaluations of other systems 
in Europe that have implemented the EMCDDA 
treatment demand protocol. Such evaluations could 
improve the quality of this indicator for national and 
European drugs policy. Estimates of the completeness 
and accuracy of treatment demand indicators should 
be provided on a regular basis if valid comparisons 
between countries and time periods are to be drawn 
with confidence. 
IMPLICATIONS FOR POLICY, PROCEDURES AND 
PRACTICE
As soon as the results of this analysis became 
apparent urgent actions were taken by one of us 
(JL), to improve the completeness and accuracy of 
the reporting system for data from 2001 onwards. 
This included a crude comparison of the number 
of reports to NDTRS in the three area health boards 
with the number of notifications to the Central 
Treatment List for 2001, 2002 and 2003. It was noted 
that returns were incomplete for the majority of 
clinics in the three area health boards of the Greater 
Dublin area. The staff of the NDTRS presented 
summary findings to and negotiated solutions with 
P Kavanagh et al
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the management teams of these health boards. By 
June 2004 all health boards had submitted complete 
data. NDTRS staff agreed that they would revise 
the methods used to collect the number of clients 
continuing in care from the previous year from 2004 
onwards. Each health board would send the total 
number of clients in treatment on January 1st each 
year to the staff of the NDTRS and a form would 
be completed for each client new to or returning 
to treatment that year. It was also agreed that the 
Addiction Service’s performance indicators would 
be included in the NDTRS and that data would be 
collected on clients reporting alcohol as their main 
problem drug. This complies fully with the EMCDDA 
requirements for implementation of the treatment 
demand indicator. This demonstrates that when 
research institutions present facts and identify 
barriers to compliance to service managers, solutions 
can be found and the completeness, accuracy and 
usefulness of reporting systems can be improved.
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inTrODUCTiOn
Anterior shoulder pain can be particularly difficult 
to diagnose. The differential diagnosis includes 
impingement syndromes, rotator cuff injury and 
shoulder instability. Overlap between diagnoses 
can be present in certain cases leading to complex 
clinical findings. This can lead to diagnostic delay and 
therefore prolonged symptomatology. Many clinical 
shoulder tests have been documented but these 
sometimes prove difficult to interpret if the examiner 
does not routinely treat advanced shoulder problems.
Coracoid Impingement Syndrome is a relatively 
uncommon but treatable cause of shoulder pain. It 
usually presents with anterior shoulder discomfort 
in activities involving forward flexion, adduction and 
internal rotation. A literature review identifies three 
main causes of the condition: idiopathic, traumatic 
and iatrogenic.3 The condition is usually very difficult 
to diagnose due to the paucity of consistently 
reproducible clinical signs. This syndrome is sparsely 
documented but has been shown to be treatable 
with both conservative and operative measures. 
The coracoid impingement test is presently the best 
diagnostic indicator of the condition.1 We found that 
patients with a positive coracoid impingement test 
often reported that their pain was also aggravated 
by a shoulder position of abduction and internal 
rotation. In this case series we have demonstrated 
that diagnosed patients can expect good symptom 
relief from appropriate therapeutic regimens. An 
increased clinical awareness of this condition 
may obviate undue diagnostic delay in otherwise 
unresolved cases of chronic anterior shoulder pain.
MaTerial anD MeTHODs
A prospective review of patients presenting with 
anterior shoulder pain to a regional orthopaedic 
shoulder service was carried out. Each individual 
was assessed both clinically and radiologically in 
an outpatient clinic setting by a single consultant 
orthopaedic surgeon. 
Radiographic views comprised antero-posterior views 
in internal and external rotation of the shoulder 
in addition to axillary lateral views. In all cases 
these revealed no obvious radiological abnormality. 
Although magnetic resonance imaging and shoulder 
arthrography may prove helpful in diagnosing certain 
cases of anterior shoulder pain, we employed the 
former as a baseline investigation whenever other 
diagnoses were strongly suspected.
Tenderness was present in the antero-medial 
shoulder over the coracoid process in all patients 
Neurological function was normal and muscle 
power was MRC grade 5 in the affected limbs. Other 
causes of shoulder pain were excluded. Subacromial 
Coracoid Impingement Syndrome: 
A treatable cause of anterior shoulder pain
aBsTraCT
Background  Coracoid Impingement Syndrome is a relatively uncommon but generally 
treatable cause of anterior shoulder pain that can be easily overlooked. It typically 
presents with anterior shoulder joint pain in activities involving forward flexion, 
adduction and internal rotation. 
Aims To assess the outcome of a cohort of patients diagnosed with Coracoid 
Impingement Syndrome.
Methods  Patients were investigated clinically and radiologically. They received 
appropriate therapeutic measures and were followed-up in an orthopaedic 
outpatient setting. 
Results  Twelve patients were identified over a four-year period. All patients have made good 
progress. Thus far, none have needed operative intervention for symptom relief.
Conclusion  Coracoid impingement syndrome is an uncommon cause of anterior shoulder 
pain but diagnosed patients can expect good symptomatic relief following referral 
to a dedicated shoulder unit. An increase in clinical awareness of the condition may 
prevent undue diagnostic delay in such cases.
SJ Roche, 
MT Kennedy, 
AJ Butt, K Kaar
Dept of Orthopaedic 
Surgery, Merlin Park 
Regional Hospital, 
Galway
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impingement syndromes, rotator cuff pathology, 
biceps disorders, labral lesions and radiculopathy 
were out-ruled as the primary cause of each patient’s 
symptoms. Specific impingement tests were 
undertaken including Yergason’s and Speed’s tests 
and all proved to be negative. The entire cohort had a 
positive coracoid impingement test on the side of the 
affected shoulder. 
All cases were initiated on a treatment ladder that 
progressed in a stepwise fashion from activity 
modification and further courses of non-steroidal 
anti-inflammatory drugs with physiotherapy, to 
infiltration of the coraco-humeral interval with 
a lignocaine/hydrocortisone solution. The same 
consultant surgeon reassessed each patient at 
subsequent clinic visits. The duration of follow-
up was largely determined by the response 
to treatment. The results were recorded in a 
computerised database enabling detailed analysis 
(Microsoft® Access, Microsoft Corporation).
resUlTs 
The duration of the study was a four-year period 
(1999 to 2003). Twelve patients in total were 
identified as having coracoid impingement 
syndrome. The study group comprised eight men and 
four women. The average age was 44.3 years (range 
26 to 54 years). The average duration of patient 
follow-up was 14.4 months (range 3 to 35months).
The mean duration of shoulder symptoms, namely 
point tenderness of the coracoid and anterior shoulder 
pain or discomfort, was 8.9 months (range 1 to 25 
months; standard deviation 6.33months). Two thirds 
of the cases involved the dominant side (Table 1).
Six of the cases were of idiopathic origin and six were 
associated with trauma of varying aetiology. The 
traumatic cases comprised a fall down stairs, a fall 
from a stepladder, two road traffic accidents, an old 
lifting injury and a case of presumed repeated micro-
trauma to the shoulder joint secondary to strenuous 
gym activity. There were no incidences of iatrogenic 
causation. None involved major trauma (i.e. there 
were no associated fractures of the shoulder girdle or 
upper limb). All cases involved anterior shoulder pain 
of a chronic nature. Every patient experienced activity 
related symptomatology. The age distribution of the 
patients was slightly different to other published 
series2,6 in that there was preponderance towards 
individuals over 50 years of age (42%).
Only one patient had definite signs of concurrent 
shoulder pathology. This 54-year-old male was 
diagnosed with coracoid impingement syndrome in 
addition to evidence, of rotator cuff degeneration 
as confirmed by clinical findings and magnetic 
resonance imaging. This patient responded well to 
treatment with a subcoracoid nonsteroidal anti-
inflammatory injection in addition to rotator cuff 
strengthening physiotherapy.
The entire study group was evaluated with plain 
films. The diagnostic yield was poor as no cases 
of the ailment could be confirmed based on these 
findings. In one instance, the plain films showed an 
aberrant coracoid morphology but no definite coraco-
humeral narrowing. Five patients were further 
assessed with magnetic resonance imaging and 
this measure served mainly to exclude concurrent 
shoulder pathology i.e. rotator cuff lesions and other 
bony abnormalities. None of these cases showed 
conclusive evidence of abnormal spatial relationships 
between the position of the coracoid process in 
relation to either the humeral head or glenoid. One 
set of MRI films suggested a reduced coraco-humeral 
interval while another showed evidence of rotator 
cuff degeneration.
All patients were tender in the region overlying the 
coracoid process. All cases were positive for the 
coracoid impingement test. Pain and discomfort was 
elicited to a varying degree when the shoulder was 
placed in a position of cross arm adduction, forward 
elevation and internal rotation.
It was also noted that discomfort was evoked 
in extremes of shoulder abduction and internal 
rotation. Five of the patients were able to voluntarily 
identify this position as a source of discomfort and 
described situations such as depressing the door lock 
button in their cars as being painful. The arm is in a 
position of ninety degrees of abduction and maximal 
internal rotation during this manoeuvre. 
All cases were given trial courses of non-steroidal 
anti-inflammatory medication. Most cases 
had already been trialled previously with anti-
inflammatories by their primary healthcare 
providers. One patient responded well to activity 
modification and physiotherapy alone. The 
remainder had symptomatic relief following an 
injection of local anaesthetic and steroid solution 
into the subcoracoid region. Seven have had 
complete resolution of normal shoulder function 
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Table 1
PATIENT DETAILS
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M 26 Idiopathic Injection 12 9 No No Yes Yes Yes  
M 54 Trauma Injection 9 12 No No Yes Yes Yes Yes
M 54 Idiopathic Injection 1 21 Yes No Yes Yes Yes Yes
M 30 Idiopathic Injection 5 3 Yes No Yes Yes Yes Yes
F 48 Microtrauma Injection 13 12 Yes Yes Yes Yes Yes  
M 30 Trauma Injection 3 12 Yes No Yes Yes Yes  
F 54 Trauma Injection 8 17 No No No Yes Yes Yes
M 53 Idiopathic Injection 25 7 Yes Yes No Yes Yes  
M 40 Idiopathic Injection 6 35 Yes No Yes Yes Yes Yes
F 41 Idiopathic Physio/analgesia 9 7 Yes Yes No Yes Yes  
M 53 Trauma Injection 4 27 No Yes No Yes Yes  
F 48 Trauma Physio/analgesia 12 11 Yes Yes Yes Yes Yes  
Figure 1—
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following intra-articular injection. The remainder 
obtained temporary relief of varying durations and 
are being actively reviewed on an outpatient basis 
with further physiotherapy. Nobody in the series has 
undergone a coracoplasty but this may be necessary 
if symptoms persist on present treatment regimens.
DisCUssiOn
Although coracoid impingement is an acknowledged 
cause of chronic shoulder pain since 1909,4 it may 
still go unrecognised when evaluating affected 
patients. The classical presentation is chronic anterior 
shoulder pain with marked tenderness to palpation 
over the coracoid.1 The condition is precipitated by 
idiopathic, traumatic and iatrogenic causes.3 Any 
process which diminishes the coracohumeral interval 
can lead to significant impingement.1 
Many studies have attempted to definitively outline 
the pathogenesis of this condition. It is thought 
that impingement of the rotator cuff between 
the lesser tuberosity of the humeral head and the 
lateral aspect of the coracoid leads to shoulder pain.9 
Spatial relationships between the coracoid tip and 
surrounding bony structures have been analysed 
with both radiographic and cadaveric studies.6, 10 
Rotator cuff outlet morphology has also been 
assessed in affected patients.6
Gerber et al3 were first to assess the significance of 
the coracohumeral interval (Figure 1). Dines et al1 
later showed that coracohumeral decompression 
by excision of the lateral 1.5cm of the coracoid 
and re-attachment of the conjoint tendon lead to 
reproducible relief of symptoms. Friedman et al2 were 
the first to note degeneration of the subscapularis 
tendon in affected patients. This degeneration of 
the subcoracoid soft tissue was interpreted as the 
result of mechanical bony irritation and thus the 
morphologic pathological correlative for the coracoid 
impingement syndrome.
A recent cadaveric study suggests that anatomic 
variations of the coracoid are not the main cause 
of the pathology in this condition.10 It suggests 
that the problem is functional with anterior 
instability leading to a functional narrowing of the 
coracohumeral distance.
As has been stated in the literature, the diagnosis of 
coracoid impingement syndrome can be made most 
reliably on clinical findings.3 Radiological findings can 
help but no single radiological test can guarantee 
the diagnosis. MRI has been shown to be the most 
useful imaging modality as it can assess both the 
subcoracoid space and the coracohumeral distance.2, 8 
Shoulder arthrography can also be used to out-rule 
other diagnoses. The clinical test presently regarded 
as the gold standard is the coracoid impingement 
test.1 It describes painful clicking in a position 
of forward flexion and medial rotation of the 
shoulder in varying degrees of horizontal adduction. 
As has been demonstrated in cadaveric studies 
and MRI findings, internal rotation reduces the 
coracohumeral distance, thus leading to soft tissue 
subcoracoid impingement.2, 10 The subscapularis 
is the tendon most likely to be involved. Forward 
flexion with internal rotation is a functional position 
of the shoulder and will readily be identified as a 
provocative position even before the test is carried 
out in most patients. 
Coracoid impingement is generally treatable once 
identified. The usual treatment regime involves a 
stepwise process encompassing both conservative 
measures as a first line preference before proceeding 
to operative intervention in a minority of cases. It is 
important to remember that a possible overlap with 
other shoulder pathology may occur even in cases that 
respond to conventional therapeutic measures for 
this unusual condition. Most patients, as was seen in 
this series, will benefit from avoidance of the painful 
shoulder position, physiotherapy, anti-inflammatories 
and injections of local anaesthetic into the affected 
subcoracoid area. Various surgical procedures are 
documented and have proven successful in those 
not benefiting from other treatment modalities.1, 6 
In addition to open surgical decompression of the 
coracohumeral space with limited coracoplasty, 
arthroscopic treatment has also been shown to be 
effective.5, 7 Assuming that no other significant cause 
of shoulder pain in present, patients can expect 
effective relief from symptoms without compromising 
shoulder function in the long-term. This can be 
postulated from analysis of follow-up data in this unit 
and other published series.1, 6 
COnClUsiOn
Coracoid impingement syndrome is a relatively rare 
but well-defined clinical diagnosis that is worthy 
of consideration in the differential diagnosis of 
anterior shoulder pain. Further investigation is 
required to conclusively delineate its pathogenesis. 
This case series demonstrates the effectiveness of 
present treatment options once the diagnosis has 
been established. Clinical detection of the condition 
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is not unduly difficult when given appropriate 
consideration by the clinician. A heightened clinical 
awareness can help avoid undue diagnostic delay in 
cases where the condition is the primary cause of 
unresolved anterior shoulder pain.
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Case rePOrT
A 74-year-old lady presented with a four-month 
history of constant severe perianal pain, constipation, 
bright red PR bleeding, and anal discharge. She had a 
history of ischaemic heart disease and hypertension. 
She was on several cardiac medications including 
aspirin, clopidogrel, amlodipine, doxazosin, lisinopril, 
and nicorandil. On perianal examination a well-
circumscribed 3x4 cm posterior anal ulcer was noted. 
This was a deep ‘punched out’ ulcer with slough, 
and visible fibres of the internal anal sphincter in 
its base (photo 1). The surrounding skin was normal, 
and the ulcer was remote from pressure points. 
EUA and ulcer biopsy was performed. Histology 
revealed fibroadipose tissue with fibrosis and chronic 
inflammation, but no evidence of granulomata or 
malignancy. Stains for Mycobacterium tuberculosis 
and Treponema pallidum were negative. Colonoscopy 
and small bowel follow through were normal. 
Despite treatment with oral laxatives and regular 
dressings, her severe pain persisted with no evidence 
of ulcer healing. Defunctioning loop colostomy was 
performed to address her debilitating anal pain.
Around this time the authors became aware of 
nicorandil induced anal ulceration,1 the macroscopic 
and microscopic features of which are similar 
to those described in our patient. On this basis 
nicorandil was discontinued. The combination of 
faecal diversion and discontinuation of nicorandil 
resulted in progressive ulcer healing. 
DisCUssiOn
Nicorandil is an oral potassium channel activator 
with a nitrate component, used as a third line 
adjunct in the treatment of resistant angina. The
potassium activation dilates coronary and systemic 
arteries, while its nitrate component dilates venous 
capacitance vessels, thereby reducing both preload 
and afterload. However, it has been hypothesized 
that this drug results in a vascular steal phenomenon 
leading to redistribution of blood at vulnerable sites.2
Nicorandil associated anal ulceration was first 
reported in 2002.3 Our patient commenced 
nicorandil 10mg twice daily four years prior to 
developing anal ulceration, and her dose was 
increased to the maximal dose of 40mg twice 
daily ten months before presentation with the 
ulcer. All reported cases have ulcer morphology 
similar to that seen in our patient, specifically a 
deep ‘punched out’ ulcer with well-circumscribed 
Nicorandil related anal ulcer
aBsTraCT
Background  Anal ulceration is uncommon. Patients are typically referred because of 
severe anal pain, bleeding, discharge, and ulceration. It is important to exclude anal 
carcinoma, and to consider more unusual causes.
Methods  A 74-year-old lady presented with severe anal pain and ulceration. This was 
subsequently noted to be related to nicorandil, a potassium channel activator 
used in the treatment of angina. Discontinuation of nicorandil and faecal diversion 
allowed symptom relief and ulcer healing. 
Conclusion  Knowledge of the association between nicorandil and anal ulceration is 
essential in order to appropriately diagnose and manage this condition.
NICORANDIL RELATED ANAL ULCER
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edges. Our patient also had severe debilitating pain 
in common with other reported cases. Histology 
of this ulcer revealed inflamed epithelium with 
no evidence of granulation tissue or malignancy 
and gastrointestinal visualization failed to show 
other abnormalities. Histological and serological 
tests for other causes of anal ulceration, namely 
neoplastic, inflammatory (Crohn’s disease and 
Behcet’s disease), and infective causes (tuberculosis, 
syphilis, and HIV) were negative. Schistosomiasis 
and amebiasis were both excluded on the basis 
of a negative travel history. Analgesics, laxatives, 
and local debridement were unsuccessful in 
either healing the ulcer or relieving the pain, so 
a loop colostomy was fashioned prior to noting 
the association between nicorandil and anal 
ulcerations. This has resulted in complete pain relief 
and re-epithelialisation of the ulcer. Future cases 
might best be managed by discontinuation of the 
medication with cardiology input, reserving surgery 
for resistant cases only.
COnClUsiOn
Anal ulceration is a debilitating condition that patients 
may be reluctant to discuss with their cardiologist, 
and they are frequently referred to another specialist. 
Increased awareness of the potential link between 
nicorandil and anal ulceration may lead to more 
timely, and less aggressive management, by early 
modification of anti-anginal treatment. 
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Case rePOrT 
A 29-year-old man presented with a month-long 
history of left-sided groin discomfort. He was unable 
to straighten his left leg and had to stoop on walking. 
He had no ‘B’ symptoms. Physical examination 
revealed non-bulky right inguinal lymphadenopathy 
and fullness in the left flank. Testicular examination 
was normal. Haematological and biochemical 
parameters were normal. AFP and bHCG were normal.
Computed tomography (CT) showed invasion of the 
left psoas muscle and extensive intra-abdominal 
adenopathy involving the inguinal, iliac, para-
vertebral, pre-vertebral and mesenteric nodes 
(Figure 1a). There was also left-sided hydronephrosis 
and hydroureter identified. Positron emission 
tomography (PET) showed areas of increased uptake 
of fluorodeoxyglucose (FDG) in the abnormal 
areas identified on CT (Figure 2a). There were no 
additional areas of increased tracer uptake identified. 
Excisional biopsy of the right inguinal node showed 
lymphoepithelial – like carcinoma.
The patient was commenced on Docetaxel and 
Carboplatin chemotherapy. After two cycles of therapy, 
the patient underwent repeat CT scanning. This 
showed stable disease when compared to his baseline 
scan. His symptoms, which had initially improved, 
recurred and he once more complained of back 
pain on straight leg raising and his posture became 
stooped. It was decided to alter his chemotherapy and 
he was commenced on Etoposide, Cisplatin
and Ifosphamide (VIP). The patient’s symptoms 
improved dramatically after cycle 1 chemotherapy. 
After three cycles of VIP, a restaging CT scan was 
performed (Figure 1b). This demonstrated resolution of 
the extensive lymphadenopathy previously identified 
and disappearance of the hydronephrosis. The only 
abnormality was some residual asymmetry of the 
ileopsoas musculature. At this point, the patient 
reported tinnitus affecting his right ear. Audiometry 
showed a mild high frequency hearing deficit. For 
the remaining treatment course, carboplatin was 
interchanged with cisplatin. The patient received 
six cycles of VIP chemotherapy in total. At the end 
of treatment, a repeat CT scan showed persistence 
of asymmetry in the ileopsoas region with no other 
abnormality. A PET scan was performed which showed 
no evidence of active disease (Figure 2b). In view 
of his excellent response to treatment, the patient 
was referred for consolidation radiotherapy to the 
paraaortic, psoas, iliac, inguinal, and upper femoral 
nodal areas and he received 45 Gy in 25 fractions (left 
dog-leg distribution).
Lymphoepithelial-like carcinoma is a rare tumour 
type which has been described in multiple sites 
including uterine cervix, lung, stomach, skin and 
salivary glands.2-4 Its aetiology is unknown, however 
EBV-encoded RNA transript has been detected in 
the lymphoepithelial-like genome of tumour cells 
from various primary sites.1 It is possible therefore 
that Epstein-Barr virus is involved in tumorigenesis. 
There is scant information in the literature regarding 
Taxane-resistant lymphoepithelial-like 
carcinoma: Excellent response to VIP 
chemotherapy
aBsTraCT
Background  Lymphoepithelial-like carcinoma is a rare tumour type. The optimal treatment 
for this disease is not known. No effective therapies are described in the literature.
Aims This report describes a case of lymphoepithelial-like carcinoma and documents a 
therapeutic strategy which has proved effective.
Results  The patient was initially treated with a common platinum-based chemotherapy 
regimen incorporating a taxane (Carbplatin and Docetaxel). Disease stabilization 
initially occurred but the patient soon progressed. The patient was then treated 
with VIP chemotherapy and had a complete response.
Conclusion  VIP chemotherapy appears to be an effective therapeutic strategy in 
lymphoepithelial-like carcinoma.
TAXANE-RESISTANT LYMPHOEPITHELIAL-LIkE CARCINOMA: EXCELLENT RESPONSE TO VIP CHEMOTHERAPY
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prognosis and the natural biology of the disease. In 
an attempt to provide the most effective therapy, 
we conducted an extensive literature search of 
searchable databases. However we were unable 
to find any case series or even any reference to 
therapeutic regimens. We commenced the patient 
on a Taxane/ Platinum combination as this is a well-
tolerated regimen and effective against a broad 
range of cancer types. Though the patient had an 
initial clinical response, he quickly relapsed and 
VIP chemotherapy was commenced. The rationale 
behind this choice was that it is an effective regimen 
in the treatment of germ cell tumours and sarcomas. 
The patient responded very well to this regimen 
with resolution of his symptoms and normalisation 
of his PET scan. The use of consolidation external 
beam radiotherapy is not supported by any evidence 
based medicine and was employed here empirically.
On last review, eighteen months after completion of 
treatment the patient remains in remission.
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Figure 1a—  
CT SHOWED 
INVASION OF THE 
LEFT PSOAS MUSCLE
Figure 1b—  
AFTER 3 CYCLES OF 
VIP, A RESTAGING 
CT SCAN WAS 
PERFORMED
Figure 2a—  
PET SHOWED AREAS 
OF INCREASED 
UPTAkE OF FDG
Figure 2b—  
A PET SCAN SHOWED 
NO EVIDENCE OF 
ACTIVE DISEASE
66 IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 175 • NUMBER 3
C
A
S
E
 R
E
P
O
R
T
inTrODUCTiOn
Bellini Duct carcinoma, or Collecting Duct carcinoma 
(CDC), is a rare and aggressive tumour believed to 
arise from the distal collecting ducts of the nephron.1 
It has been classified as a variant of renal cell 
carcinoma by the WHO.2 It has distinctive clinical 
and histopathological features, and there have 
been approximately 100 case reports in the English 
literature since it was first reported in 1976.3
Case rePOrT
A 61-year old man complained of a short history 
of back pain and fatigue. He had no relevant past 
medical history. No signs were evident on clinical 
examination. An irregular 3.5cm cystic lesion was 
seen on CT in the lower pole of the left kidney, with 
stranding of adjacent fat (Figure 1). MRI lumbar 
spine demonstrated a large L4 metastatic deposit 
with extension into the spinal canal. (Figure 2) PET 
scan revealed multiple bony metastases only. A 
biopsy of L4 revealed metastatic adenocarcinoma. 
Immunohistochemistry was strongly positive 
for CK 20. CK 7 and CAM5 were negative. Renal 
biopsy reported an infiltrating adenocarcinoma in 
a desmoplastic stroma positive for low molecular 
weight cytokeratins, with perineural invasion 
(Figure 3). These tumour cells stained strongly 
CK7 positive (Figure 5) and there was focal 
restaining of CK20 (Figure 4). Despite the variation 
in immunohistochemistry findings, a diagnosis 
of Collecting Duct Tumour of the kidney with 
vertebral metastases was made. In January 2005, 
chemotherapy was commenced. After his second 
cycle he became profoundly neutropaenic and was 
treated for MRSA septicaemia. He succumbed to this 
over a short time.
DisCUssiOn
Renal carcinoma accounts for 3% of all adult 
malignancies, 0.4-2% of which are Collecting Duct 
Carcinoma.1 It affects a young population, the mean 
age at presentation being 55 years.
The majority of patients with CDC will present with 
stage IV disease, one series reporting a figure of 83%.4 
It is associated with a higher incidence of regional 
node involvement (50%), distant metastases (67%) 
and capsular invasion (83%) than other forms of 
renal neoplasm. Median survival after nephrectomy 
is 22 months.5
The diagnosis of CDC should be considered in those 
with a rapidly progressive cancer, or a large invasive 
renal tumour on CT imaging. A biopsy should be 
performed to distinguish it from other renal neoplasms 
as the prognosis is dismal despite radical nephrectomy.
The microscopic appearance is non specific, with 
a duct like or papillary architecture surrounded by 
a desmoplastic stroma. The columnar or cuboidal 
shaped cells can give rise to a hobnail appearance. 
The papillary appearance of the tumour can make 
it difficult to distinguish from papillary renal cell 
carcinoma.6
Collecting Duct Carcinoma of the 
kidney: A case report with variable 
immunohistochemistry
aBsTraCT
Background  Collecting duct carcinoma of the kidney is a rare tumour with distinctive 
clinical and histopathological features. Management of this malignancy remains a 
challenge because of advanced stage at presentation and aggressive clinical course.
Aims We describe a case of Collecting Duct Carcinoma with variable 
immunohistochemistry and review the pathology and management.
Results  Our patient died shortly after commencing systemic chemotherapy.
Conclusion  Advances in immunohistochemistry have aided in diagnosis of this 
tumour. Early detection and nephrectomy offer the best chance of cure. Newer 
chemotherapeutic regimens may improve survival in more advanced disease.
COLLECTING DUCT CARCINOMA OF THE kIDNEY: A CASE REPORT WITH VARIABLE IMMUNOHISTOCHEMISTRY
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Immunohistochemistry has been used to make a 
more definitive diagnosis in recent times. Staining 
of lectins such as soyabean, peanut, wheatgerm and 
Figure 1—
AN IRREGULAR 3.5CM 
CYSTIC LESION WAS 
SEEN ON CT IN THE 
LOWER POLE OF THE 
LEFT kIDNEY, WITH 
STRANDING OF 
ADJACENT FAT 
Figure 2—
MRI LUMBAR SPINE 
DEMONSTRATED A 
LARGE L4 METASTATIC 
DEPOSIT WITH 
EXTENSION INTO THE 
SPINAL CANAL
Figure 3—
RENAL BIOPSY 
REPORTED AN 
INFILTRATING 
ADENOCARCINOMA 
IN A DESMOPLASTIC 
STROMA POSITIVE 
FOR LOW 
MOLECULAR WEIGHT 
CYTOkERATINS, 
WITH PERINEURAL 
INVASION
Figure 4—
THERE WAS FOCAL 
RESTAINING OF Ck20
Figure 5—
THESE TUMOUR 
CELLS STAINED 
STRONGLY Ck7 
POSITIVE
Ulex europaeus 1 agglutinins and antibodies to high 
molecular weight keratins indicate a distal collecting 
duct origin to these tumours.7 This is in contrast to 
most renal cell cancers which express vimentin, and 
antibodies to low molecular weight cytokeratins. 
Immunohistochemistry results have not always been 
consistent, however, and diagnostic confusion can 
still occur. 
Because of its low incidence, CDC does not have 
a cytogenetic characteristic but a variety of 
heterogeneous chromosomal alterations unrelated 
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to other variants of renal cell carcinoma have been 
reported.8,9 It has been postulated that a better 
understanding of the genetics of this tumour will help 
explain the biological aggressiveness of most CDCs, 
while a small subset follow a relatively benign course.
Management of patients with CDC remains 
a challenge because of the advanced stage 
of presentation and often aggressive clinical 
course. Radical nephrectomy and loco-regional 
lymphadenectomy appears to be curative for organ 
confined cancer. Longterm disease-free survival 
has been reported in this setting after treatment 
with adjuvant therapy.6 Several combinations of 
chemotherapy have been investigated previously 
for advanced disease and have been found to be 
ineffective, such as MVAC and vincristine/actinomycin 
D.6 In recent times it has been suggested that CDC 
may behave more like urothelial than clear cell renal 
cancer. To investigate this theory a French group used 
the combination of cisplatin and gemcitabine, known 
to be effective and well tolerated in patients with 
transitional cell carcinoma. A complete response was 
achieved in two patients with metastatic disease.5 
They have recently reported further success in 
treating twenty patients with this regimen, resulting 
in 7.9 and 9.5 months progression free survival and 
overall survival respectively.10 Other studies have used 
combinations such as paclitaxel/carboplatin4 and 
doxorubicin/gemcitabine alternating with ifosfamide/
paclitaxel/cisplatin (TIP).11
In conclusion, Collecting Duct Carcinoma is a rare 
tumour, with an aggressive clinical course. Recent 
advances in immunohistochemistry have aided 
immensely in diagnosis. Further studies to investigate 
the genetic characteristics of the disease will allow 
better understanding of its biology and classification. 
Early detection and subsequent nephrectomy 
appears to offer the best chance of survival. Newer 
combinations of chemotherapy or targeted therapies 
may have a greater role in the future.
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inTrODUCTiOn
Michael Aloysius MacConaill was born in Ballymena, 
Co. Antrim in 1902,1 the eldest of five children; his 
father was a merchant and his mother was a mezzo-
soprano. His family moved to Belfast and Michael 
attended St Mary’s Christian Brothers School from 
where, in 1919, he obtained first place in the Queen’s 
University entrance scholarship examination.1 The 
first Dáil had met in Dublin’s Mansion House on the 
21st of January in that year and MacConaill joined its 
“parliamentary army”, becoming a field ambulance 
officer in Belfast during the War of Independence.2
At Queen’s, he broke the mould by becoming the first 
Catholic to be elected to the Students’ Representative 
Council and to become President of the Literary and 
Scientific Society.3 In the Medical School, he was 
encouraged by the Professor of Anatomy, Thomas 
Walmsley, to take an intercalated BSc degree and he 
graduated in Human Embryology and Anthropology 
with honours in July 1922.4 He was a clinical student 
in the Mater, graduating in 1925, and was a house-
surgeon there. Walmsley wished to appoint him as an 
Anatomy Demonstrator and, when this was blocked,3 
Walmsley arranged for a postgraduate scholarship.
Walking on water: The biomechanics of 
Michael A. MacConaill (1902-1987)
Biomechanics is a subject that draws on knowledge from many disciplines. One of 
its great practitioners in the last century was the Irish anatomist M.A. MacConaill. 
In this paper, we review some of MacConaill’s fundamental contributions to 
biomechanics, namely: the hydrodynamic theory of synovial joint lubrication, the 
kinematics of joint motion and conjunct rotations; and the theory of spurt and 
shunt muscles. The aim is to revisit these topics in the light of current research, and 
to draw some conclusions about the import of his research in the context of recent 
developments in the field. The paper concludes with a discussion of science in 
Ireland, the development of the field of biomechanics since MacConaill’s time, and 
some other matters.
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WALkING ON WATER: THE BIOMECHANICS OF MICHAEL A. MACCONAILL (1902-1987)
1 Figure 1 —
Anatomical Society 
of Great Britain and 
Ireland, Summer 
Meeting, Queen’s 
University, Belfast, 
May, 1931. Front Row, 
L to R; EJR Evatt, 
T Walmsley, TH Bryce 
(President), G Elliott-
Smith, AF Dixon, 
Second Row: L to R; 
CM West, SR Shea, 
MA MacConaill, 
Miss JL McNeill, 
F Davies, AJE Cave
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He was, however, appointed a Demonstrator in the 
following year and promoted to Senior Demonstrator 
in 1928. He was awarded his MSc in July 1928 for a 
thesis titled “The correlations of length, breadth, 
and height in forty mixed crania”,4 and he presented 
this work to a meeting of the Anatomical Society at 
Queen’s in 1931 (Figure 1).
MacConaill was awarded the Queen’s University 
Medical Travelling Studentship for 1929-30 to visit 
University College, London where he continued his 
work on statistical anthropology. From there he went 
to the University of Sheffield, initially as a Senior 
Demonstrator, but he was promoted to Lecturer by 
mid-1930. In 1942, MacConaill returned to Ireland to 
take up the Chair of Anatomy in University College, 
Cork. He revitalised the Department’s teaching 
and research, collaborating with Edward Gurr to 
develop tissue staining methods, with Eric Scher on 
the geometry of the dental arcades,5 and applied 
Boolean algebra to neuronal networks. He was 
elected a Member of the Royal Irish Academy in 1945 
and awarded a DSc by the Queen’s University of 
Belfast in 1950 and an MA by the National University 
of Ireland in 19641. In 1950 he took on the role 
Officer Commanding the Army’s First Field Medical 
Company,6 from which he retired in 1967 with the 
rank of Commandant.2 Michael MacConaill retired 
from UCC in 1973 and died in 1987.
MacConaill was one of the most prolific scientists in 
mid 20th Century Ireland. He published a great number 
of scientific articles and invited book chapters, and 
co-authored two highly regarded books: Synovial 
Joints: Their Structure and Mechanics7 and Muscles and 
Movements: A Basis for Human Kinesiology8 (Figure 2); 
this latter book also appearing in a second edition.9 
Besides these two books, MacConaill published two 
comprehensive series of papers on the mechanics 
of synovial joints, one series in the Irish Journal of 
Medical Science10,11,12,13,14,15 and another series in the 
Journal of Bone and Joint Surgery.16,17,18,19,20 His work on 
the mode of lubrication in synovial joints is still widely 
cited and his research into generalised methods for 
describing and analysing the motion of joints is well 
known as part of the science of kinesology which is 
central to medical specialities from orthopaedics and 
physiotherapy to rheumatology and rehabilitation. 
It is perhaps an indication of his reputation that was 
asked to contribute the chapter on human joints 
to the 15th Edition of the Encyclopaedia Britannica.21 
MacConaill can be justly seen as one of the pioneering 
contributors to biomechanics and it is appropriate to 
3
2
revisit and reinterpret his original work in the context 
of present research. Our aim is not only to draw some 
conclusions about the importance of his work for the 
development of the field but also to comment on the 
inter-relationship between anatomy, biomechanics, 
and rehabilitation in the wider sense.
researCH in BiOMeCHaniCs
SYNOVIAL JOINT LUBRICATION
According to MacConaill’s own recollections3 he 
was skimming through a physics textbook in a 
Sheffield bookshop when he noticed an account of 
the lubricating mechanism in engineering bearings 
that reminded him of synovial joints. This led him to 
theorize on the lubrication of mammalian joints, and 
develop the concept of ‘hydrodynamic’ lubrication of 
synovial joints; hydrodynamic lubrication occurs when 
one surface is slightly inclined relative to another 
so that, when the surfaces move, a wedge of fluid is 
trapped and pressurized between them, see Figure 3. 
MacConaill claimed that the slight incongruence in 
the surfaces in synovial joints allows the synovial 
fluid to be trapped between the cartilage layers as the 
bones rotate relative to each other. Furthermore, he 
contended22 that the menisci of joints did not exist, as 
had been usually assumed, to “abolish the effects of 
incongruity between male and female surfaces”, but 
rather to provide a flexible wedge to allow the joint 
Figure 3 —
(a) when two 
parallel surfaces 
move no pressure is 
developed, (b) when 
inclined surfaces 
undergo a relative 
movement the line 
CC’ is shortened to 
PP’ generating a 
pressure to support a 
load along WW’, and 
(c) this generates a 
pressure between the 
opposing surfaces 
(after MacConaill)22
Figure 2 —
Title page of the 1st 
Edition
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surfaces to maintain the correct relative inclination 
for hydrodynamic lubrication (Figure 4). This was an 
ingenious hypothesis and involved a completely new 
way of thinking about diarthrodial joints and the role 
of menisci. Later MacConaill followed-up his study 
of the knee and inferior radio-ulnar joints with an 
analysis of the acromio-clavicular joint,23 and of the 
foot24 and carpus.25
MacConaill’s contribution is acknowledged by 
Duncan Dowson, the world’s foremost authority 
on tribology when he states26 “MacConaill (1932) 
studied the structure of joints… …and concluded that 
the mode of lubrication must be hydrodynamic”. 
MacConaill’s analysis of synovial joint lubrication 
stood unchallenged for some time. His contribution 
is often referred to in biomechanics textbooks, and 
is still widely cited. However, several explanations 
have now supplanted it, one of which is ‘weeping 
lubrication’ whereby synovial fluid is exuded by the 
spongy cartilage to form the fluid layer separating 
the cartilages – therefore according to ‘weeping 
lubrication’ the synovial fluid is not dragged between 
the layers by the relative movement of the surfaces 
as MacConaill had theorized. MacConaill had a 
spat with the proponents of weeping lubrication 
in the journal Nature;27,28 he maintained that 
the source of the fluid layer, though interesting, 
was a “physiological problem” and that weeping 
lubrication “appears to complete the existing theory 
rather than supplant it, and is a valuable addition to 
our knowledge of biomechanics”.27 In a subsequent 
paper, MacConaill29 presents further arguments in 
favour of hydrodynamic lubrication. One argument 
was that the incongruency of the joint surfaces will 
always permit a layer of synovial fluid to be present 
except in one localised contact area. However, recent 
research has made it clear that the relative motion 
between cartilage layers at human joints is simply 
not fast enough for hydrodynamic lubrication to act 
alone. More recently, a theory of elastohydrodynamic 
lubrication has shown that the pressures generated 
are sufficient to deform the cartilage layers and 
therefore exude fluid.30 Furthermore, even more 
recently, a theory of ‘boosted lubrication’ proposes 
that when the joint is unloaded the cartilage 
expands again imbibing fluid and leaving the large 
hylauronic acid molecules on the cartilage surface to 
act as a lubricating gel.31
kINESIOLOGY AND THE MECHANICS OF JOINT MOTION
The motion of one bone relative to another at a 
joint may seem straightforward – it is not. In the 
4
most general case we can assume that one bone 
moves relative to another by translation in three 
directions and rotation in three directions, i.e. has six 
degrees-of-freedom. MacConaill begins his analysis 
by recapitulating the seemingly obvious fact that all 
motions of one limb relative to another are either 
spins or a swings. However, a thought-experiment 
will make it clear that, say, flexion-extension of the 
lower limb (what one might think of as a swing) 
involves also spin at the ball-and-socket joint of 
the hip. Therefore, most motions of joints are 
composite motions of swings and spins. The next 
step in the analysis is to define a pure swing; to do 
this MacConaill draws on the concept of the ‘ovoid-
of-motion’; if a bone is rotated into every possible 
position then the locus of a point on the bone would 
describe a closed surface – this surface is the ovoid 
-of-motion (Figure 5). The shape of the ovoid-of-
motion depends on the geometry of the articulating 
surfaces and their degree of congruency.
Any swing that describes a line that is the shortest 
possible distance between two points on the ovoid 
of motion (the line would be a ‘great circle’ if the 
ovoid of motion was a sphere) is defined as a cardinal 
swing. MacConaill’s insight came from an analysis of 
a succession of cardinal swings.10,16 Consider making, 
say, three cardinal swings of the upper limb as follows: 
(i) hold the upper limb by the side, elbow straight, 
5 Figure 5 —
An ‘ovoid of motion’ 
can be imagined for 
a joint by rotating 
the bone (about H 
in the Figure) and 
letting any point on 
the bone describe a 
loop (O in the Figure). 
All possible loops 
constitute a surface 
(like an ‘eggshell’) 
around the point H. 
[If the centre 
of rotation was 
constant, the ovoid 
of motion would be a 
sphere.]
Figure 4 —
The femur (F) is 
and the tibia (T) 
are separated by 
a meniscus which 
creates an incline in 
the surfaces needed 
for hydrodynamic 
lubrication (after 
MacConaill)22
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palm facing the thigh; (ii) flex the shoulder through 90 
degrees in the AP plane (the palm faces medially), (iii) 
swing the upper limb through 90 degrees (the palm 
faces forward), (iv) lower the upper limb through 90 
degrees towards the body (the palm remains facing 
forward). This succession of three cardinal swings will 
not have returned the arm to the same position; a 
consequential motion of external rotation of the arm 
will have occurred. Naming the closed loop of cardinal 
swings as diadochal motion (Gr. diadochos, successive), 
MacConaill noted that any set of three swings that 
form a closed loop (not just 90 degree swings as in 
the foregoing example) on the ovoid of motion would 
result in a net rotation of some magnitude, which he 
termed a conjunct rotation. 
MacConaill worked out the magnitude of the 
conjunct rotation from first principles32 and 
computed the relationship between the degree 
of conjunct rotation consequent on a diadochal 
motion. He examined how the articular kinematics 
depends on the shape of the articulating surface32. 
Furthermore, “the arrangement of articular 
ligaments… must allow the conjunct rotation 
imposed on the moving part by the shape of the 
fixed surface”20. If several diadochal motions are 
carried out in succession, eventually the ligaments 
will restrain conjunct rotation at the joint. The only 
way to avoid this is to apply counter-rotations, 
and this requires counter-rotatory muscle actions. 
Therefore rotary muscles are brought into play 
even in pure (i.e. cardinal) swings. MacConaill 
emphasised the importance of understanding 
this for rehabilitation33 and physiotherapy.34 These 
concepts, while not generally common knowledge 
in biomechanics, are invoked as the theoretical 
foundation of various therapies. Zatsiorsky, a 
leading biomechanician of the former USSR and 
now working in Penn State University describes 
MacConaill’s contribution to articular kimematics 
in his textbook Kinematics of Human Motion,35 
and a recent editorial by Di Fabio36 concludes “The 
conceptual and intuitive framework provided by 
MacConaill many years ago still provides a wonderful 
anatomical and mechanical conceptualisation for 
justifying [….] treatments in the clinic”. 
SPURT AND SHUNT MUSCLES
In an article published in the Irish Journal of 
Medical Science in 1946, MacConaill12 introduced the 
concept of spurt and shunt muscles (Figure 6a). The 
biomechanical basis for the classification may be 
summarized using the following notation:
6a
6b
• let c be the distance along the stable bone 
between a muscle’s attachment site and the 
joint (called the cisarticular length). 
• let q be the distance between the joint and the 
attachment site on the moving bone (called the 
transarticular length). 
Figure 6b shows c and q for the spurt muscle. 
Taking the spurt muscle and resolving its force into 
a component perpendicular to the moving bone 
(denoted ⊥SpurtF ) and a component parallel to the 
moving bone (denoted //SpurtF ), simple mechanics 
shows that, when c / q > 1 as it is for spurt muscles, 
then ⊥SpurtF will be greater than 
//
SpurtF (for all but 
extreme extension) whereas the opposite would be 
the case for shunt muscles with greater component 
of the force (a centripedal force) being towards the 
joint which tends to ‘shunt’ the bones together. 
Spurt muscles need an antagonist but shunt muscles 
do not. (A complete mathematical treatment is given 
in MacConaill).37 Based on the argument that shunt 
muscles will be required in rapid limb rotations to 
provide a ceptripedal force, Basmajian38 performed 
electromyographic experiments to confirm the 
spurt/shunt classification system. 
The concept of spurt and shunt muscles is not 
without its critics, even though it is treated as 
Figure 6 —
Spurt and shunt 
muscles. (a) shows 
the direction of 
movement of the 
bone. The spurt 
muscle pulls more 
directly across 
the bone in most 
positions other 
than full extension 
whereas the shunt 
muscle pulls more 
directly along the 
moving bone, (b) 
biomechanical 
analysis (see text).
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settled knowledge in reference works such as Gray’s 
Anatomy.39 The modern treatment of this subject 
focuses on calculation of forces exerted by muscles 
by assuming an optimization function such as a 
minimization of muscle stresses.40,41 
DisCUssiOn
Michael MacConaill was a notably original thinker 
in biomechanics and an interdisciplinary researcher 
avant-la-lettre. Though discussion of his personality 
is, of course, not within our remit yet we note 
Professor John A. Murphy, in his history of UCC,42 
describes him as: learned, idiosyncratic, redoubtable, 
erudite. Not only could MacConaill make the 
fundamental contributions to biomechanics, but 
he could turn his hand to publishing a rann in the 
Irish Times43 to the memory of the Lecky Professor of 
History in another University. 
IN MEMORIAM: EDMUND CURTIS, M.A.
A mhic dhílis d’Eirinn, a chara do cháirdibh 
Shasana,
A ghiolla na h-éigse do neartuigh le 
mórshaothar staire,
A ghaisce na nGaodhal: ba chathbhuilleach 
láidir do bhearta,
‘S ag caoineadh do dhéidh-se le géar-ghol 
atámuid, a Eamuinn.
MacConaill’s scientific papers have proved to be 
enduring contributions to several problems in 
biomechanics, particularly understanding of the 
lubrication of synovial joints.22 However, his more 
widely published work on the movement of joints 
has been eclipsed by more rigorous treatments based 
on control systems theory incorporating the central 
nervous system as the controller.40 Nonetheless the 
concept of consequential movements is still used, it 
seems, particularly among practitioners. The theory 
of spurt and shunt muscles has been the subject of 
some criticism, and rightly so in our opinion. A robust 
defence is given by MacConaill in the Journal of 
Anatomy44 but, from a biomechanical point of view, it 
is unclear why the moving (i.e. distal) bone should be 
distinguished from the stationary (i.e. proximal) bone 
when all movements are relative.
* O loyal son of Erin, O friend of the friends of England,
 O servant of learning fortified by great works of history,
 O valiant Gael, great and powerful thy deeds,
 And, Edmund, ‘tis keening with bitter tears after you we are.
MacConaill was also prepared to make some 
futuristic speculations in his papers. For example, in 
his classic 1932 paper22 referred to above, he studied 
how collagen fibres are aligned in a stress field; he 
hypothesised as follows: “as iron filings are to a 
magnetic field so are collagen fibres to a tension 
field”. This was a function/form relationship for 
cartilage, and it anticipated current research on the 
relationship between the microstructure of tissues 
and stresses to which they are exposed during 
growth, a subject that is now seen as central to 
tissue engineering and regenerative medicine.45 His 
theoretical paper on myomechanics concludes with 
the statement that our neuromuscular circuits are 
geared to gravity.37
It is interesting to note that MacConaill’s early 
research had been in ethnology. In fact, it seems 
MacConaill’s first paper was published (when 
MacConaill was only 21 years of age) on the subject 
of the ethnology of the people of Rathlin Island.46 
He continued to study ethnology while in Sheffield 
where he published several papers reporting 
correlations between hair and eye colour, and 
stature.47,48,49 However, this kind of research was 
discontinued in the early 1940s, perhaps because, 
to quote a modern historian, “it [became] virtually 
unthinkable for liberal intellectuals (which included 
most scientists) to operate with this concept [of 
race]. Indeed many doubted that it was legitimate 
to enquire systematically into the genetically 
determined differences between human groups, for 
fear that the results might provide encouragement 
for racist opinions”.50 In this respect it is interesting 
to note the renewed interest in genotype variations 
in human populations.
From the early 1930s onwards, MacConaill 
maintained a research interest in the biomechanics 
of the locomotor system. He applied a rigorous 
mathematical approach for each problem he 
tackled. In this we can see similarities with the work 
of the Trinity polymath of an earlier generation, 
the Rev. Samuel Haughton, MD. Haughton also 
used mathematics to analyse the musculoskeletal 
system.51,52 For both Haughton and MacConaill, 
mathematics (and particularly geometry) had pride 
of place among the approaches for understanding 
the behaviour of biological systems – this was, 
and is, rather unusual.53 (However it was not an 
Irish trait; another Irish anatomist, Abraham Colles 
declared: “Mathematics applied to the human body 
is altogether impractical”.54
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Herries Davies suggests that the relative lack of 
success of science in “Free State Ireland” was because 
the people were “too introspective to display much 
enthusiasm for the thoroughgoing internationalism 
basic to science – too concerned with Irish language 
revival and literary censorship to be aware of the 
momentous developments taking place elsewhere”.55 
It is interesting that Herries Davies would make such 
a speculation and the impetus for him to do so is 
perhaps worthy of investigation in itself; but, in the 
one case we have before us, MacConaill was both a 
language enthusiast and an internationalist – his 
books were translated into several languages,2 and he 
was a founding member of the International Society 
of Electrophysiology and Kinesiology (see Figure 7) 
– a society which is very active today. Perhaps the 
explanation does not lie in the introspection of 
the people, but in the lack of funding for research 
prevented the continuity essential to building up 
research strength within the universities. Today 
research in biomechanics is inter-institutional, inter-
disciplinary, and international in a way that was not 
possible in MacConaill’s time. It is inspiring to have 
Irish names of the reputation of Michael MacConaill 
to number among the founders of the field.
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‘Are you a witch or are you a fairy,
Or are you the wife of Michael Cleary?’
(Childrens’ nursery rhyme)
Bridget Cleary (nee Boland) was brutally burned to 
death by her husband, in the presence of her father 
and several other close relatives, in the kitchen of 
her small cottage in rural Tipperary in 1895. She was 
twenty-six years old at the time of her death and 
worked as a dress-maker. Her husband was thirty-
five and worked as a cooper; they had been married 
for seven years and had no children. 
The story of Bridget Cleary’s death, sometimes 
mistakenly referred to as the last witch-burning in 
Ireland, has from the outset excited both scholarly 
interest and the interest of the general public 
in this country and further afield. A recent RTE 
documentary1 and a feature film proposed for 2006 
has again brought this story to public attention. 
Bridget Cleary had been unwell, possibly with 
bronchitis or pneumonia and an associated delirium, 
for the two weeks prior to her death. Testimony in 
court from the key witnesses to her killing suggested 
that Michael Cleary became convinced during her 
illness and, possibly, in the months beforehand, that 
his wife had been abducted by the fairies, and that 
they had left a changeling in her place. He seems to 
have been supported in this view by Jack Dunne, a 
local storyteller or seanchai and cousin of Bridget 
Cleary. Dunne was an expert in fairy mythology and 
some locals believed that he had himself ‘spent time 
with the fairies’ in the past. Other members of Bridget 
Cleary’s family also appear to have colluded with the 
story of fairy possession to a greater or lesser extent, 
and cooperated with Michael Cleary in performing 
several rituals and administration of herbal medication 
to his wife in the days leading up to her death. 
Michael Cleary consulted a priest, doctor and two 
local herbal medicine experts in the days prior to 
killing his wife, in efforts to help her. Several days of 
ritualised cruelty, involving forced administration 
of herbal medicines, threatened burning and 
interrogation as to her true identity ended when 
Michael Cleary doused his wife with paraffin oil 
and burned her to death. Bridget’s father, aunt and 
three of her first cousins were present in the small 
house at the time of her death but later claimed 
they were so intimidated by Michael Cleary that they 
could not intervene to stop the worsening violence 
in the days leading up to this. After killing his wife, 
Michael Cleary claimed that he had killed only a 
fairy changeling and, as a result, his real wife would 
be returned to him within three days. Following her 
death and burial by himself in a shallow grave near 
their home, he waited for three consecutive nights at 
a nearby ancient ring-fort or ‘fairy-fort’, apparently in 
wait for her return to him.
The burning of Bridget Cleary: Psychiatric 
aspects of a tragic tale
aBsTraCT
Background  Bridget Cleary was brutally burned to death by her husband in the presence 
of her father and several close relatives in rural Ireland in 1895. The story has 
attracted public attention for more than a century now, for numerous reasons. 
Aims The issue of psychiatric illness in this tragedy, and the role of fairy mythology in belief 
systems in 19th Century rural Ireland are reviewed, particularly in relation to providing 
explanations for physical and psychiatric illness, along with learning disability.
Methods  Reference was made to a wide range of sources featuring the burning of 
Bridget Cleary.
Results  There is some evidence to suggest that the actions of Michael Cleary and other 
key protagonists were influenced by Capgras syndrome and folie a plusiers. 
Conclusions  Delusional belief in fairy mythology may have coloured the psychological 
make-up, motivations and behaviour of some of the people involved in the killing of 
Bridget Cleary.
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In the subsequent trial he was found guilty of 
manslaughter and served fifteen years of a twenty-
year prison sentence before emigrating to Canada. 
Bridget Cleary’s father, Patrick Boland, and her 
cousins Jack Dunne, Patrick and Michael Kennedy 
were found guilty of lesser crimes for their roles in 
her death and the concealment of her body. 
PSYCHIATRIC ASPECTS
Michael Cleary was undoubtedly sleep deprived, 
agitated and distressed in the days prior to killing his 
wife. In a petition to the Lord Lieutenant written by 
him in 1905, appealing for part of his sentence to be 
remitted, he wrote: ‘Petitioner (i.e. Michael Cleary) 
attended to the wants of his wife during her illness 
both night and day until he was in a manner just as 
bad as deceased’.2 
He went to considerable lengths to arrange that 
Mass be said in his cottage to help his wife. He also 
arranged for the local doctor to call and assess his 
wife. Most controversially of all the aid he sought, he 
acquired herbs from a local ‘herb doctor’ and went 
to considerable lengths to make his wife take them, 
along with boiled ‘new’ milk or ‘beestings’ (i.e. the 
milk first produced by a cow after calving, thought to 
have curative properties). Micheal Cleary’s father also 
died during this time and he did not leave tending 
his sick wife to attend the wake or funeral.
In this stressful context, it is possible that Michael 
Cleary may have developed a brief psychotic episode 
around the time he killed his wife. There is no evidence 
to suggest that he had a history of psychiatric illness 
prior to or subsequent to killing his wife, but his 
mental state and psychiatric history was not formally 
assessed as part of the investigation into her death. 
The particular phenomenology of such a psychotic 
state may be described as the Capgras syndrome.
First described by Capgras and Reboul-Lachaux in 
1923,3 the Capgras syndrome involves delusional 
misidentification of a person or people, usually 
someone who has close emotional ties to the 
patient. While the form of this phenomenon is 
a delusion, the content is culture-dependent.4 
For example, a present day manifestation may 
involve the development of a delusion that an 
extraterrestrial impostor has replaced the person 
in question. The patient will often acknowledge the 
similarities in physical appearance between their 
loved one and the impostor, but they may perceive 
minor and telling differences. 
For Michael Cleary, the cultural context was that of 
19th Century working-class rural Ireland where belief 
in fairy mythology and a plethora of associated 
superstitions was still strong in many places. Therefore 
(assuming that he was psychotic), for Michael Cleary 
to become convinced that his wife was actually a 
changeling left by the fairies would not have been a 
surprising manifestation of Capgras syndrome. 
It has also been suggested that Michael Cleary, who 
was a stronger and more dominant character than 
the others involved, may have induced some of them 
to share in his delusional beliefs. This phenomenon 
has been described as ‘folie a deux’ or, when more 
than two people are involved as in this case, ‘folie a 
plusiers. It may in part explain the actions of Bridget 
Cleary’s father and male cousins who cooperated 
with her husband in holding her down, forcibly 
giving her herbs and milk and interrogating her as to 
her true identity in the days leading up to her death. 
Furthermore, it is possible that delusional 
misidentification and fairy possession may have 
been suggested to Michael Cleary by the comments 
of Jack Dunne (‘That is not Bridgie Boland’), whose 
expertise in the area of fairy mythology was 
acknowledged in the local community.
A less likely possibility is that Michael Cleary was 
fabricating psychiatric symptoms both before and 
after killing his wife, in an effort to avoid the charges 
of murder or manslaughter. 
The possibility that the some of the key protagonists 
in this tragedy may have had learning disabilities 
has never been explored. The presence of learning 
disability might explain in part why fairy mythology 
was invoked so readily by some of them to explain 
events. Michael and Bridget Cleary were both literate 
and had their own trades, so they were unlikely to 
be disabled. Jack Dunne, however, who was illiterate 
and whose limp and short stature were likely to be 
vestiges of childhood polio, may have had a learning 
disability and this may have been a factor in his 
enthusiasm for fairy mythology. 
Angela Bourke’s masterly review of this case also 
raises other psychiatric aspects relating to the 
treatment of people with both psychiatric illness and 
learning disabilities in 19th Century Ireland.2 Bourke 
cites other examples of perceived fairy possession 
and burning in rural Ireland, involving children with 
physical deformities or mental retardation. She argues 
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that fairy mythology may have been used to provide 
a rationale for such conditions, which may have 
been puzzling and difficult to accept for parents and 
other family members. At a more sinister level, fairy 
mythology may have been consciously used to justify 
both ambivalent feelings towards and cruel treatment 
of people who were different from the norm. 
Bourke also highlights the stark contrast between 
the rapid advances in science, technology, literacy 
and the organization of society that was taking place 
in 1895 (a year that saw the discovery of X-rays and 
the first cinema shows) and the more traditional 
society of the Clearys and their relatives, based as 
it was on oral history and traditions such as fairy 
mythology. Transcultural psychiatry did not then 
exist as a discipline, but if it had it might have shed 
some light on the sociocultural context of Michael 
Cleary’s beliefs about his wife’s fairy possession.  
COnClUsiOns
The burning of Bridget Cleary was undoubtedly a 
gruesome tragedy, yet it has fascinated people for 
over a century now, for different reasons. Political 
opponents of the Home Rule movement in Ireland at 
the time used the story to suggest that the Irish were 
incapable of self-government. Writers and folklorists 
such as Lady Gregory and William Butler Yeats were 
drawn to the fairy-mythology aspects of the story. 
Only in more recent years has the story attracted the 
attention of psychiatrists.5
As Michael Cleary and the other people involved 
in Bridget Cleary’s killing were never formally 
psychiatrically assessed, an article such as this can 
only speculate on their psychological make-up and 
the role, if any, of psychiatric illness on their actions. 
Nevertheless, this story is useful in highlighting how 
a distinctly Irish sociocultural context may have 
coloured psychological make-up, motivations and 
behaviour in a time not long before the increasingly 
globalized Ireland of today. 
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The author of this book Richard Lathe has a 
background in brain research, neuroscience research, 
as well as industrial research.  In the book he moves 
from diagnostic issues to the genetic contributions 
to autism.  Then he discusses prevalence of autism 
and proposes an additional element from the 
environment i.e. that the limbic brain is damaged 
by environmental toxins including heavy metals.  
Controversially he suggests that this accounts for the 
increasing diagnosis of autism are not just due to 
changes in diagnostic criteria or greater awareness of 
the condition which most of us believe.  He discusses 
in considerable detail the physiological changes 
in the body, which affect the brain and behaviour.  
These matters are discussed in much greater detail 
and with much greater expertise than in other books 
on autism.  For that very reason this is an original 
book on autism.  Many books on autism don’t cover 
or cover in minimal detail the material that he covers. 
For that reason this is a significant addition to 
anybody’s autism library and would be of interest to 
all those professional and lay people with an interest 
in autism.  For the lay person there are abbreviations 
and a glossary at the end which is most helpful.  
This glossary will considerably extend the targeted 
readership for the book.  He deals with many issues 
which parents ask clinicians but clinicians wouldn’t 
be in a position to answer because the majority 
of clinicians don’t have his understanding of basic 
science.  His hypotheses are of great importance 
because there is still much that we don’t know about 
autism and autism is a condition with genetic and 
environmental inputs.  Clearly the major strength of 
the book is on the environmental inputs to autism.  
There is no doubt that there are gastrointestinal tract 
problems in autism but these are given minimal 
attention in books on autism.  This is corrected in this 
book.  When I received this book to review I already 
had my copy of it and had read it in advance of the 
request to review it.  I had already recognised the 
importance and the uniqueness of the book.  The 
references in the book are exhaustive and indeed 
take up 59 pages.  This makes the book very useful to 
postgraduate students, to researchers in autism, and 
anybody who wants to pursue their knowledge to a 
deeper level.
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Physicians Guidelines and US Preventative 
Services Task Force Recommendations
American College of Physicians
ISBN 1-930513-60-7
Edited by Vincenza Snow, MD
R Costello
RCSI Education & 
Research Centre, 
Smurfit Building, 
Beaumont Hospital, 
Dublin
The background to this book is that in 1981 the 
American College of Physicians received a three-
year grant to develop a programme called the 
“Clinical Efficacy Assessment Project”.  This project 
aimed to review the clinical literature on specific 
topics so that they may best identify the best 
scientific papers, then reanalyse, reformulate and 
present information on these to practitioners 
so that they could readily determine the use of 
diagnostic tests, procedures and treatments.  
The latest outcome from this project which has 
continued through to the current time is a synopsis 
of clinical guidelines which cover the management 
of several chronic diseases and in a separate section 
appropriate use of antibiotics in respiratory tract 
infections and a further section of screening and 
prevention of several chronic conditions.
In general this evidence based practice guideline 
book has many valuable benefits which would make 
it an attractive proposition for any Physician in 
practice.  The most important being that these are 
practical evidence based guidelines on important 
topics.  The consensus printed is a joint opinion of 
several of the world leading authorities and thus is 
of a sound nature and maturely conceived.   Another 
advantage to this book is that it is written in a 
uniform style with careful editing and in addition the 
papers whilst concise are quite pithy in nature.  It is 
a particular aim of the clinical practice guidelines to 
take on difficult areas of management, for example, 
management of newly detected atrial fibrillation. I 
found this chapter and that on the management of 
Type II diabetes and the pharmacological treatment 
of acute major depression particularly valuable.
I would recommend this book whole-heartedly 
to anybody in clinical practice dealing with such 
common clinical issues.


